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♦ Summary  
Background: Trematode infections impose a great burden on the developing world by 
impairing life quality, productivity and life span of an individual. The prerequisite for 
efficient treatment and control of the diseases is the use of a quick and sensitive diagnostic 
tool which could replace the multi-diagnostic approach that is still used. The metabolic 
profiling approach implies the use of spectroscopic tools such as nuclear magnetic resonance 
(NMR) spectroscopy and mass spectrometry (MS) on potentially interesting biofluids and 
tissues, and is coupled with multivariate mathematical data modelling. It has been applied to 
many different field of research, such as biochemistry, medical sciences, drug pathway 
discovery, non-communicable diseases, nutrition and psychological disorders, and has been 
established as an efficient method for biomarker recovery and pathway deciphering. There is 
growing interest in metabolic profiling in systems biology. The first attempt to bring together 
metabolic profiling with the epidemiology of neglected tropical diseases was in mid-2002, 
when urine samples were obtained from more than 500 individuals in a rural Western part of 
Côte d‘Ivoire. However, it was impossible to extract any meaningful information with regard 
to specific parasitic infection. The high degree of metabolic variation of the studied 
population in terms of age, genetic and nutritional background and the fact that the majority 
of individuals harboured three or more parasites concurrently might explain this observation.  
 My thesis outline was put forward once the metabolic profiles of selected parasitic 
infections in suitable rodent models, namely Schistosoma mansoni and Trypanosoma brucei 
brucei in the mouse, and Schistosoma japonicum in the hamster, were established as an 
alternative to directly exploring human populations in order to ascertain if characteristic 
biomarkers of infection could be found for single host-parasite scenarios. The success of these 
experimental investigations encouraged further studies, including the extension of metabolic 
profiling to other host-parasite models, in order to gain insight into specificity of biomarkers 
and to reveal the diagnostic potential of this metabolic profiling approach.  
Goal and objectives: The overarching goal of this Ph.D. project was to deepen our 
understanding of trematode-induced metabolic changes in selected rodent models, and to 
critically assess the potential of a metabolic profiling approach applied to biofluids and tissue 
samples for biomarker recovery that may contain diagnostic and prognostic properties.  
The specific objectives were (i) to optimise faecal sample preparation for subsequent 
1
H NMR 
spectroscopy, and to assess metabolic variation in faecal samples with regard to species (i.e. 
human, rat and mouse), gender and age, (ii) to assess longitudinally the biochemical changes  
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in urine, plasma and faecal water of E. caproni-infected mice, and to compare the diagnostic 
capacity of different biofluids collected from infected and uninfected control mice, (iii) to 
gain information about E. caproni-induced changes in selected tissue samples e.g. (liver, 
kidney, spleen, ileum, jejunum and colon) of infected mice and correlate identified 
biomarkers with the previously extracted markers in the biofluids, which might reveal 
infection-related systems level changes (iv) to evaluate the remote and direct impact of three 
different trematodes (E. caproni, F. hepatica, S. mansoni) on the rodent host neural metabolic 
composition. 
Methods: E. caproni- and S. mansoni-infected mice and uninfected control mice and F. 
hepatica-infected rats and uninfected control rats were kept in the animal facilities of the 
Swiss Tropical Institute under environmentally-controlled conditions (temperature, 22°C; 
relative humidity, 60-70%; light/dark cycle, 12/12 hours). Animals were acclimatized for 1-2 
weeks prior to infection, in order to avoid stress-induced deviations of the metabolic profiles. 
Urine, plasma and stool were usually sampled on a weekly basis for high resolution 
1
H 
nuclear magnetic resonance (NMR) spectroscopic analysis and tissues removed (liver, kidney, 
splee, gut, brain) upon dissection of the animals at the end of each experiment for 
1
H magic 
angle spinning (MAS) analysis. Biofluids were stored at -40°C and tissues at -80°C pending 
NMR analysis.  
1
H NMR spectroscopy was applied for acquisition of all biofluids and brain extracts, 
whereas for all other tissues, 
1
H MAS NMR, a semi-solid technique, was performed. 
Multivariate statistical methods were implemented on all spectral data, after pre-processing, in 
particular principal components analysis (PCA) and partial least squares-discriminant analysis 
(PLS-DA) with incorporation of orthogonal signal filtration in a MATLAB environment were 
utilised. Assignments of the spectral peaks were made from the literature and confirmed via 
statistical total correlation spectroscopy (STOCSY), or via standard 2-dimensional (2D) NMR 
experiments conducted on selected samples. 
Findings: Comparing the diagnostic templates, all three biofluids showed interesting 
deviations between uninfected control and E. caproni-infected mice. Urine and plasma were 
considered as most suitable biofluids due to the large number of potential biomarkers  
identified and because faecal water showed high fluctuations in the metabolic concentrations 
over time and a high degree of variation from one animal to another which was significantly 
higher than in urine and plasma. More detailed metabonomic investigations were performed  
Summary 
14 
 
with E. caproni to assess systems impact on the mouse host. Resulting changes in the 
metabolic profiles of biofluids and tissue samples were correlated with each other, and 
revealed new insights into the biological pathomechanisms of this trematode, e.g. impact on 
gut microbial species and a trematode-induced imbalance of the transporter system in the gut. 
Whereas E. caproni did not induce any biochemical changes in the neural profile, rats 
infected with F. hepatica, and mice infected with S. mansoni showed strong deviations from 
uninfected control animals. F. hepatica-induced changes in the rat brain nucleotide 
metabolism was correlated to certain cytokine levels, e.g. IFN-γ, IL-5 and IL-13, and was 
consistent with modulation of the immune mechanisms.This finding provides a rationale for 
deeper analysis into the interaction of parasitic worms with the central nervous system of the 
host organism.  
Conclusion and outlook: The remaining questions which still need to be addressed revolve 
around how to transfer the technology of biomarker detection into human populations, 
whereas the main obstacles pose the effect of multiparasitism on biomarkers, the specificity 
and cross-species transferability. However, we are confident that this will be resolved with 
more thorough biomarker evaluation, cross-species comparisons, co-infection models in 
suitable rodents and well selected and monitored human populations with single-infections. 
With the additional acquisition of highly specific biomarkers of disease via MS-based 
methods, a database of single infection markers in rodents can be completed and offer a 
quantity of possible biomarker-candidates also in humans. Succeeding the leap from rodent to 
human, metabolic profiling could lead to a novel diagnostic tool, replacing the multi-
diagnostic assay for the broad panel of tropical diseases. 
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♦ Zusammenfassung 
Hintergrund: Trematoden-Infektionen stellen eine enorme Belastung für die Bevölkerung in 
Entwicklungsländern dar, durch eine Einschränkung der körperlichen und geistigen 
Fähigkeiten, der Produktivität und der individuellen Lebenserwartung. Eine akkurate und 
praktische Diagnostikmethode, welche die herkömmliche Multidiagnostik für 
Tropenkrankheiten, ersetzen könnte, ist die Voraussetzung für eine effiziente Behandlung und 
Infektionskontrolle. 
Das Erstellen von metabolischen Profilen basiert auf der Analyse von biologischen 
Matrizen mit spektroskopischen Methoden, vor allem der nuklearen magnetischen 
Resonanzspektroskopie (NMR) und Massenspektrometrie (MS), welche mit multivariaten 
statistischen Datenanalysen gekoppelt werden. 
Die Technik des metabolischen Profilierens wurde schon in vielen 
Naturwissenschaftlichen Disziplinen erfolgreich angewandt, vor allem in der Biochemie, 
Medizin, Pharmazie, Ernährung und Psychologie. Das metabolische Profilieren konnte als 
effiziente Methode für Biomarker Extraktion und Entschlüsselung von metabolischen 
Netzwerken etabliert werden und erfährt daher steigendes Interesse in der Systembiologie. 
Der erste Versuch metabolisches Profilieren in einer epidemiologischen Studie über 
vernachlässigte tropische Krankheiten einzubauen wurde im Jahre 2002 unternommen. Es 
wurden 500 Urinproben in einem ländlichen Gebiet im Westen der Elfenbein Küste 
gesammelt und mittels 
1
H NMR Spektroskopie analysiert. Die Interpretation der Daten 
gestaltete sich jedoch schwierig, da der Grossteil der Bevölkerung eine hohe inter-individuelle 
Variabilität in Bezug auf Alter, genetischem und ernährungsbedingtem Hintergrund aufweist 
und aufgrund der Tatsache, dass die meisten Individuen mit mindestens drei Parasiten infiziert 
waren. 
Der Rahmen meiner Doktorarbeit wurde festgesetzt, nachdem die metabolischen 
Profile ausgewählter Parasiteninfektionen in passenden Nagetier-Modellen (Schistosoma 
mansoni und Trypanosoma brucei brucei in der Maus, und Schistosoma japonicum im 
Hamster), etabliert waren. Der Erfolg dieser drei Studien ermutigte uns die 
Profilierungsmethode auf andere Wirts-Parasiten Modelle auszuweiten, um einen Einblick in 
die Spezifität von Biomarkern zu gewinnen und um das diagnostische Potential der Methode 
zu evaluieren. 
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Allgemeines Ziel und spezifische Ziele: Das Hauptziel dieser Doktorarbeit war, einen 
tieferen Einblick in metabolische Veränderungen nach einer Trematodeninfektion im  
Nagetierwirt zu gewinnen. Das diagnostische und prognostische Potential, welches die neue 
Technologie der metabolischen Charakterisierung von biologischen Matrizen um Biomarker 
zu gewinnen birgt, sollte kritisch beurteilt werden. 
Die spezifischen Ziele waren (i) Optimierung der Stuhlproben Präparation für 
1
H 
NMR Spektroskopie und eine Untersuchung der Variabilität der Proben in Bezug auf Spezies 
(Mensch, Maus und Ratte), Geschlecht und Alter; (ii) Untersuchung von biochemischen 
Veränderungen in Urin, Plasma und Stuhlproben von Echinostoma caproni-infizierten 
Mäusen während des gesamten Infektionsverlaufs um die diagnostische Kapazität der drei 
biologischen Matrizen zu vergleichen; (iii) Erhalten von Information über E. caproni-
induzierte Veränderungen in ausgewählten Geweben (Leber, Niere, Milz, Ileum, Jejenum und 
Kolon) um die darin gefundenen Biomarker mit den vorherig extrahierten Veränderungen in 
den Bioflüssigkeiten zu korrelieren um die holistische Auswirkung des Wurmparasiten im 
Wirtstier beschreiben zu können; und (iv) Evaluation von direkten und indirekten 
Auswirkungen von drei verschiedenen Trematoden (E. caproni, Fasciola hepatica, S. 
mansoni) auf das Zentrale Nervensystem (ZNS) des Nagetierwirts. 
Methoden: E. caproni- und S. mansoni-infizierte Mäuse and nichtinfizierte Kontroll-Mäuse 
und F. hepatica-infizierte Ratten und uninfizierte Kontroll-Ratten wurden in den Tierräumen 
des Schweizerischen Tropeninstituts unter kontrollierten Bedingungen gehalten (Temperatur: 
22°C; relative Feuchtigkeit: 60-70%; hell/dunkel Zyklus: 12/12 Stunden). Die Tiere wurden 
vor der Infektion für 1-2 Wochen akklimatisiert um Stress-induzierte Abweichungen der 
metabolischen Profile zu vermeiden. Urin, Plasma und Stuhlproben wurden üblicherweise 
einmal pro Woche für 
1
H NMR Spektroskopie gesammelt und die Organe (Leber, Niere, 
Milz, Darm und Hirn) wurden während der Sektion für 
1
H Magic Angle Spinning (MAS) 
Analysen entnommen. Urin, Plasma und Stuhlproben wurden bei -40°C und die Gewebe bei -
80°C gelagert bis zu NMR Analyse. 
Alle Bioflüssigkeiten und Hirnextrakte wurden mittels 
1
H NMR Spektroskopie 
gemessen, während die Daten der Gewebe mittels 
1
H MAS NMR, einer semi-soliden 
Technik, generiert wurden. 
Alle prozessierten Daten wurden mit multivariaten statistischen Methoden analysiert, 
inklusive der Principal Components Analysis (PCA) und der Partial Least Squares- 
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Diskriminant Analyse (PLS-DA) mit inkorporiertem orthogonalem Signal Filter in 
MATLAB. Die spektralen Regionen wurden mittels Literatur bestimmt und mittels Statistical  
Total Correlation Spectroscopy (STOCSY) oder 2-dimensionalen (2D) NMR Experimenten 
bestätigt, welche an ausgewählten Proben durchgeführt wurden. 
Resultate: Der Vergleich von Urin, Plasma und Stuhlproben auf diagnostische Tauglichkeit 
offenbarte interessante Unterschiede zwischen E. caproni-infizierten und nicht-infizierten 
Mäusen. Während Urin und Plasma als potentielle diagnostische Kandidaten, aufgrund einer 
hohen Quantität an gefundenen potentiellen Biomarkern und einer angemessenen biologischer 
Stabilität in Frage kommen, wurden Stuhlproben als am wenigsten geeignet eingestuft, da sie 
sowohl eine hohe Zeit-abhängige als auch inter-individuelle Variabilität zwischen den 
Mäusen aufweisen. Um ein detailierteres metabolisches Gesamtbild von dem Effekt der E. 
caproni-Infektion zu erhalten, wurden die erhaltenen Veränderungen aller analysierten 
Kompartimente (Gewebe, Urin, Plasma und Stuhlproben) gemeinsam in Betracht gezogen. 
Dieses Gesamtbild eröffnete neue Einblicke auf die biologischen Auswirkungen des 
Parasiten, wie zum Beispiel den Einfluss auf die Zusammensetzung der Darmbakterien oder 
eine Trematoden-induzierte Inhomoeostase des intestinalen Transportersystems. 
Untersuchungen an Hirnextrakten von Mäusen, die mit E. caproni infiziert waren, 
zeigten keine Veränderungen, während die S. mansoni- und F. hepatica-Infektion in den 
entsprechenden Tiermodellen (Maus bzw. Ratte) einen deutlichen Einfluss auf das neuronale 
metabolische Profil nach sich zog. Die Veränderung in der zerebralen Nukleotid 
Komposition, verursacht durch den Leberegel F. hepatica, konnte mit den Konzentrationen 
bestimmter Zytokine (IFN-γ, IL-5 und IL-13) korreliert werden und scheint zugunsten von   
F. hepatica einen immunmodulatorischen Effekt auszuüben. Dies verdeutlicht wie 
fundamental die Untersuchung eines Parasiten-induzierten Effekts auf das 
Zentralnervensystem des Wirts ist. 
Schlussfolgerung und Ausblick: Es bleibt immer noch zu klären wie einfach oder schwierig 
sich diese neu erworbenen Technik der Biomarker Identifikation auf humane Populationen 
übertragen lässt. Die hauptsächlichen Schwierigkeiten liegen hierbei an der Auswirkung der 
Multiplen-Infektionen auf die Marker sowie auf die Spezifizität und Inter-Spezies 
Übertragbarkeit. Mit einer rigorosen Evaluation von potentiellen Markern für Diagnostik, 
Inter-Spezies Vergleichen, Ko-Infektionen im geeigneten Nagetiermodell und ausgewählten  
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Human Populationen mit Mono-Infektionen, kann man diese Hindernisse ausräumen. Mit 
dem Ausbau der Technologie mittels Hochauflösungs MS können zusätzlich hochspezifische  
Biomarker detektiert werden, wie z. B. Parasiten-sekretierte Enzyme, die normalerweise in 
sehr niedrigen Konzentrationen im Plasma oder den Exkrementen des Wirtes vorliegen und 
daher via NMR Spektroskopie nicht nachweisbar sind. Dies würde die Palette der Biomarker 
Kandidaten erweitern und gleichzeitig das Problem der Spezies-Übertragbarkeit lösen, da 
solche Marker nicht Wirtsabhängig sind. 
Sobald die Übertragbarkeit auf den Menschen etabliert ist, könnte eine solche 
Biomarker Identifikations Strategie zu einer neuen Diagnostik Methode führen, welche, 
anderst als die herkömmlichen multiplen Nachweismethoden, multiple Fingerprints in einem 
Test kombiniert, und somit die wichtigsten Infektionskrankheiten abdeckt. 
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Marchesi and his group members at the Department of Microbiology at the University 
College Cork (UCC), Cork, Ireland.  
Basel University: Prof. Stefan Dirnhofer at the Institute for Pathology at Basel University, 
finally provided us with his histological know-how by analyzing various tissues for our 
experiments in shortest time, and made the production of the slices even possible.  
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1  Introduction 
1.1 Food-borne trematodiasis 
1.1.1  General aspects 
Infections with food-borne trematodes have been reported worldwide, but the highest 
prevalence are found in Southeast Asian countries (e.g. Thailand, Laos and the Philippines) 
(Keiser and Utzinger, 2007b).
 
 A map of the distribution of the main food-borne trematodes is 
shown in Figure 1.1 (Keiser and Utzinger, 2007b). More than 10% of the world‘s population 
is at risk of food-borne trematodiasis and the estimated number of infections in 2004 was 40 
million (WHO, 1995). Endemic regions face infection-related losses in productivity and 
actual working hours, impaired mental development in schoolchildren and a lowered life 
quality in general (Dickson et.al., 2000; Fried et.al., 2004; Keiser and Utzinger, 2004; Urbani 
and Palmer, 2001). Food-borne trematodiases are not only a direct burden on the human 
population, but also pose, as zoonotic diseases, a remarkable veterinarian problem and are, 
hence, responsible for huge economic loss (Anantaphruti, 2001; Gajadhar et.al., 2006).  
 
Figure 1.1. Map of distribution of the major food-borne trematodes [Keiser 2007] 
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Despite efforts to reduce infection prevalence, food-borne trematodiasis is far away from 
being controlled, much less eliminated, but rather is being considered as an emerging global 
health problem (Chai et.al., 2007; Mas-Coma et.al., 2005; Saijuntha et.al., 2007).  
Food-borne trematodiasis belongs to the so-called neglected tropical diseases (NTDs) 
(Hotez et.al., 2006; Sripa, 2008). The NTDs include currently 14 diseases, most of them listed 
also by the World Health Organisation (WHO), such as Chagas disease, cholera, dengue 
haemorrhagic fever, human African trypanosomiasis, leishmaniasis, leprosy and 
schistosomiasis. NTDs are particularly rampant in rural settings in developing countries 
characterised by poor sanitation and health care. Importantly, the majority of the NTDs have 
been controlled or have been eliminated locally in industrialised countries and do not have an 
epidemic or pandemic capacity due to their geographical restriction.  
The epidemiology and global distribution of food-borne trematodiasis has changed in 
the last decades. Hygiene education, more efficient drug treatment with broad-spectrum 
anthelminthic drugs, the use of chemical fertilisers and food control contributed to reduced 
infections in urban industrialized Asian cities, whereas increasing population density with 
lack of improved sanitation, increasing production of fish in aquaculture and sustained 
malnutrition lead to increased burden in some endemic regions, and opened up new endemic 
locations (Keiser and Utzinger, 2004; Keiser and Utzinger, 2005).  
Trematodes belong to the phylum of plathelminthes, characterised by a flat shape, 
bilateral symetry, lack of segmentation and the presence of an oral and ventral sucker. Most 
trematodes are endoparasitic, hermaphroditic worms with complex life cycles, often including 
several intermediate and one (or several) definitive host(s). The classification of the flukes is 
mainly based on the physiological location in the host organism, which include liver 
(Fasciola spp., Clonorchis spp. and Opisthorchis spp.), blood (Schistosoma spp.), lung 
(Paragonimus spp.) and the gut, which offers habitat for a reported 70 species (Fried et.al., 
2004) amongst which are Echinostoma spp. and Fasciolopsis spp..  
The effects of food-borne trematodes on their host mainly depend on the location of the 
mature worms, but also on infection intensity, whereby with low numbers of worms the host 
remains asymptomatic, large infection burdens induce a high morbidity. Most noticed 
infections induce inflammation and eosinophilia due to constant irritation by the eggs or the 
worm itself, inducing acute and chronic pathology. The main symptoms of intestinal fluke 
infections, caused by Echinostoma spp., include diarrhoea, ulceration of the bowels mucosa  
 56 
 
 
and abdominal pain. The liver flukes (C. sinensis F. hepatica, and O. viverrini) can directly 
damage the liver tissue and induce jaundice. Furthermore, the development of a 
cholangiocarcinoma has been associated with chronic infection with C. sinensis and             
O. viverrini (Srivatanakul, Sriplung et al. 2004). Paragonimus spp., residing in the lung, cause 
chest pain, remittent fever and a chronic productive cough containing the eggs of the parasite 
(Liu et.al., 2008).  
Diagnosis of a food-borne trematode infection is based on examination of stool (or 
sputum in the case of Paragonimus spp.) samples under a microscope for detection of parasite 
eggs, the polymerase chain reaction (PCR), immunological and molecular methods, such as 
the enzyme-linked immunosorbent assay (ELISA), whereby PCR and ELISA show a high 
level of cross-reactivity between different trematode species and require trained personnel and 
relatively sophisticated and costly equipment (Bergquist et.al., 2009; Bergquist, 2008; Kumar 
et.al., 2008; Muller et.al., 2007). Detection of parasite eggs in faeces, on the other hand can 
be unreliable, as eggs are missed out particularly in early stages of infection or at light 
infection intensity (Keiser and Utzinger, 2004; Upatham and Viyanant, 2003).  
 
1.1.2 Echinostomiasis 
Human echinostomiasis poses a burden in Southeast Asia and the Far East, mainly where high 
prevalences of infection have been reported. A study in the Indonesian Lake Lindu Valley 
revealed average infection-prevalences of 42.6% amongst the population (Carney, Sudomo 
1980). Reports of infection-prevalences from Taiwan range from 11% to 65% (Carney 1991), 
whereas an average prevalence of 5% was reported in the Chinese Guangdong and Fujian 
provinces ((Li, 1991). Transmission is related to the consumption of raw or undercooked 
freshwater food and the use of night soil (human excrements) as fertilizer in fishponds which 
goes hand-in-hand with socio-economic factors including malnutrition, poverty and lack of 
hygiene education. Furthermore, population explosion leads to an increased aquaculture and a 
growing free-food market, hence wider distribution of metacercariae-infected aquatic food 
products. Control of the disease is also difficult, as the human cycle operates along with a 
separate, silvatic lifecycle, which keeps inflectional reservoirs maintained (e.g. intermediate 
hosts and eggs in freshwater bodies) (Graczyk and  
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Fried, 1998; Toledo and Fried, 2005). Adult echinostomes live in the intestine and bile duct of 
a wide variety of vertebrate hosts, mainly aquatic and semi-aquatic mammals and birds.  
E. caproni, which is used in the present experimental set-up, inhabits the ileum and jejunum 
in the small intestinal part of the mouse host and undergoes an anteriad shift towards 
jejunum/duodenum with growing age, e.g. 8 weeks (Fried and Huffman, 1996).  
The life cycle of E. caproni is shown in Figure 1.2 The life cycle follows the typical 
pattern of the food-borne trematodes, and includes two intermediate hosts. Fertilized eggs are 
released by the main host faeces into freshwater bodies (1) where they develop into 
miracidiae (3) after approximately 2 weeks at temperatures between 22 and 28°C. The 
miracidiae hatch preferably in the late morning hours and actively penetrate the foot region of 
the first intermediate host, which is an aquatic snail (4), the main species of which belong to 
Biomphalaria spp. and Lymnaea spp.(Huffman and Fried, 1990). After transformation into 
sporocysts (4A) and then rediae (4B) in the heart region, and migration to the digestive gland-
gonade complex, the developing cercariae (4C, 5) emerge from the first intermediate host and 
infect the kidney region of the second intermediate host, which can be the same or other snail 
species or Rana tadpoles (grown freshwater fish, respectively). The developing metacercarial 
cysts (6), in turn, are taken up with consumption of the second intermediate host by the main 
host (Huffman and Fried, 1990), in which the metacercariae encysts in the duodenum (7). 
Juvenile and adult E. caproni reside in ileum and jejunum, and shift with age towards 
duodenum (8). The maturation and residence of the fluke in the gut of the main host can 
induce pathology, particularly with high infection-burdens. Human echinostomiasis is 
characterised by diarrhoea, abdominal pain, eosinophilia, edema and anorexia, particularly 
among individuals with heavy infection intensity and can damage the intestinal mucosa, by 
causing catarrhal inflammation and erosions. Light infections, on the other hand, induce 
mainly gastric pain and anaemia (Graczyk and Fried, 1998). The presence of the fluke in the 
small intestinal part (e.g. ileum, jejunum) of the host can result in gut architectural changes in 
the mouse, such as villi fusion, erosion and crypt hyperplasia (Toledo and Fried, 2005) as well 
as intestinal dilation (Balfour et.al., 2001). A number of compounds are available with 
echinostomicidal activity, whereby praziquantel is the most effective. The benzimidazoles, 
(e.g. albendazole and mebendazole) also have some effect (Cross and Basaca-Sevilla, 1986; 
Keiser and Utzinger, 2004; Pungpark et.al., 1984). A panel of new active substances has been 
tested at the Swiss Tropical Institute in in vitro and in vivo studies. 
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Figure 1.2. Life cycle of E. caproni [adapted from CDC; http:www.dpd.cdc.gov/dpdx/ 
HTML/Fasciolopsiasis.htm; accessed September 2008] 
 
Tribendimidine, the synthetic peroxide, OZ78 and two derivatives of artemisinin (i.e. 
artesunate and artemether), achieved high worm burden reductions after a single oral dose 
administered to E. caproni-infected mice (Keiser et.al., 2006a; Keiser et.al., 2006c; Keiser 
et.al., 2006d). This high efficacy holds promise for the development of alternative drug 
treatments and emphasise broader experimental examination including clinical trials.  
 
1.1.3 Fascioliasis 
Fascioliasis a worldwide veterinarian, and to a lesser extent human problem and is caused 
mainly by infection with F. gigantica and F. hepatica. Whilst the former is geographically 
restricted to South America and Africa, the latter shows a broader geographical distribution. 
An estimated 2.4 million people suffer from fascioliasis and 180 million individuals live in  
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endemic regions (Mas-Coma, 1998). Like most food-borne trematode infections, also 
fascioliasis has changed its distribution pattern in the last decades, particularly due to 
migration, urbanisation and new irrigation programmes (Keiser and Utzinger, 2005; Mas-
Coma et.al., 1999). Most human infections are reported from the Andean highlands of Peru 
and Bolivia, Iran and Egypt (Bjorland et.al., 1995; Haseeb et.al., 2002; Stork et.al., 1973).  
The importance of fascioliasis as veterinarian problem in countries with high 
dependence on livestock production cannot be overemphasised, as infected sheep and cattle 
suffer from anorexia, anaemia and weight loss, which in turn leads to a massive productivity 
loss of milk, meat and wool.  
 
 
Figure 1.3. Life Cycle of F. hepatica [adapted from CDC; http:www.dpd.cdc.gov/dpdx/ 
HTML/Fascioliasis.htm; accessed September 2008] 
 
The life cycle of F. hepatica (Figure 1.3) deviates slightly from that of Echinosoma spp. and 
is simpler as it only includes one intermediate host snail, e.g. Galba truncatula (Flynn et.al., 
2007). Encystment of the free-swimming cercariae (5) happens on freshwater vegetation, e.g. 
lettuce or watercress, where the infective stage, the metacercariae (6), is taken up by the  
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mammalian host. The metacercariae encyst in the intestinal lumen (7), penetrate the gut wall 
and enter the perivisceral cavity, where they start migrating towards the liver (8). Once the 
juvenile flukes reach the liver, they burrow through the hepatic tissue for 5-7 weeks and feed 
on the parenchymal cells, which causes massive mechanical liver damage including extensive 
haemorrhages and fibrosis. Residence of the adult worms in the bile ducts induces anaemia 
and hyperplasia (Lim et.al., 2007). Infection with F. hepatica is characterised by two different 
stages of pathology; whereas the acute stage is induced by the inflammation of the liver, as 
reaction to the migration of the larval stages and includes epigastric pain, fatigue and fever 
(Saba et.al., 2004). The second, or biliary stage, is caused by the residence of the mature fluke 
in the bile ducts and their waste products and are characterised by jaundice, abdominal pain 
and biliary cholic.  
The current drug of choice against F. hepatica and F. gigantica infection is 
triclabendazole. Emetine as an alternative treatment can resolve in serious adverse effects and 
albendazole and mebandazole did not show activity against the liver fluke (Keiser and 
Utzinger, 2004). Artemether and OZ78 were also assessed for in vivo activity against F. 
hepatica in a series of experiments, and showed promising results (Keiser et.al., 2008; Keiser 
et.al., 2006b; Keiser and Utzinger, 2007a). Most interestingly, single administrations of both 
drugs in rats infected with F. hepatica triclabendazole-resistant strains showed 100% 
clearance of the worms (Keiser et.al., 2007). 
 
1.2 Schistosomiasis 
 It is estimated, that 779 million people are at risk of schistosomiasis and a 207 million 
individuals are infected with one or possibly two of the five human pathogens, namely S. 
haematobium, S. intercalatum, S. japonicum, S. mansoni and S. mekongi (Chitsulo et.al., 
2000; Manzella et.al., 2008a; Manzella et.al., 2008b; Steinmann et.al., 2006). The global 
burden due to schistosomiasis has been estimated at 1.7 up to 4.5 million disability-adjusted 
life years (DALYs) (Brooker and Utzinger, 2007; Hotez et.al., 2006). The geographical 
distribution of schistosomiasis covers 74 countries, mainly in Africa and Asia (Chitsulo et.al., 
2000) (Figure 1.4).  
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Figure 1.4. Global geographical distribution of schistosomiasis [Steinmann et.al., 2006] 
 
Similar to the distribution of F. hepatica, also S. mansoni underwent an increase in the last 
decades mainly due to water resources development projects (small and large dams and 
irrigation schemes) to meet the agricultural need of the growing population density (Chitsulo 
et.al., 2000). 
Undetected, sub-clinical infection with schistosomes can lead to non-specific 
manifestations, which impose a burden on the individual, including impaired cognitive 
development of children, undernutrition and growth stunting, infertility, increased 
succeptibility to co-infection, energy decrease and a resulting decrease in work output (King 
and Dangerfield-Cha, 2008).  
The main difference between the life cycle of schistosomiasis (Figure 1.5) and the food-
borne trematodes, is the transmission to the main host. After the miracidiae hatch from the 
eggs (1,2), they penetrate the intermediate host snail, which is a Biomphalaria species (3) in 
the case of S. mansoni, and develop into cercariae with a bifurcated tail (5). After evasion 
from the snail into freshwater bodies, the cercariae are able to actively penetrate the skin of 
the main host (6), where they undertake a body migration passing the lung and moving further 
to the liver where they transform into schistosomula (7). This last premature stage continues 
migration via blood circulation (8) to the liver, where they mature into adults (9) and finally 
reach their determined tissue of residence such as the mesenteric veins for S. mansoni adults 
where oviposition commences (10). 
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Figure 1.5. Life cycle of S. mansoni [adapted from CDC;http:www.dpd.cdc.gov/dpdx/ 
HTML/Schistosomiasis.htm; accessed September 2009] 
 
 In contrast to other trematodes, which are hermaphrodites, the schistosome sexual 
reproduction organs are distributed to male and female individuals. The female has a thinner 
and longer shape and is constantly embedded in the gynaecophoric channel which the male 
forms (Gryseels et.al., 2006). In the African species (S. mansoni and S. haematobium) , the 
female produces hundreds of eggs per day, whereas the oriental species, S. japonicum has a 
10-fold higher egg output, which is an important issue for understanding the pathophysiology 
of schistosomiasis.  
 The different stages of the schistosome induce different pathological reactions. The 
penetration of the host skin by the cercariae can induce urticarial rash and itching. The so-
called ―Katayama fever‖ represents the acute form of schistosomiasis and is caused by the 
migration of the immature worms. Fever, eosinophilia, fatigue and non-productive cough 
reflect the induced systemic hypersensitivity reaction (Gryseels et.al., 2006). Chronic 
infection establishes due to egg output of the female. Eggs can get trapped in various body 
compartments, such as liver, spleen, cerebrospinal system and can, due to their metabolic  
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activity e.g. secretion of proteolytic enzymes, induce inflammatory reactions followed by 
tissue necrosis and granuloma formation around the eggs. Tissue replacement by fibrotic 
deposits implicates tissue architectural changes and impairment of blood flow (Gryseels et.al., 
2006; Manzella et.al., 2008a). 
 Praziquantel is the drug of choice against schistosomiasis, whereas derivatives of 
artemisinin are active against the immature stages (Utzinger et.al., 2007). There are ongoing 
drug studies to extend the arsenal of treatments against schistosomiasis (Xiao et.al., 2007), 
which are urgently required as it is dangerous to rely on only one drug, particularly in terms 
of resistance development. 
 
1.3  The metabolic profiling approach 
 Metabonomics is a ―quantitative measurement of time-related multiparametric 
metabolic responses of multicellular systems to pathophysiological stimuli or genetic 
modification‖ (Nicholson et.al., 1999) 
 The combination of spectroscopic methods with a multivariate statistical approach has 
opened up a complete new way of understanding systems based on biochemical conditions 
and introduced a complementary chapter to the other main –omics sciences; namely 
genomics, proteomics and transcriptomics (Holmes et.al., 2008b; Lindon et.al., 2006; 
Nicholson, 2006; Nicholson et.al., 2005). Starting off successfully with biomarker extraction 
in models of toxicity or infection (Allwood et.al., 2008; Coen et.al., 2003; Martin et.al., 2006; 
Saric et.al., 2008; Wang et.al., 2004; Wang et.al., 2008; Wang et.al., 2006), psychological 
disturbances (Allwood et.al., 2008; Denkert et.al., 2006; Holmes et.al., 2006; Tsang et.al., 
2006), nutritional deviations (Holmes et.al., 2008a) or non-communicable diseases, such as 
heart disease (Ordovas and Mooser, 2006), the metabolic profiling approach has proven to be 
highly efficient, reproducible and to offer a myriad of new biological insights. The amount of 
possible matrices is almost as wide as the fields the approach can be possibly applied and 
include biofluids (urine, plasma, faecal water, cell extracts), semi-solids, such as sperm or 
bacterial colonies, tissue, bone/cartilage and also synthetic material. The basic metabolic 
profiling approach is so well established and robust nowadays, that the extracted biochemical 
knowledge can be integrative completed with data from additional analytical platforms, such 
as PCR, degrading gel electrophoresis (DGGE) (Li et.al., 2008) or  
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ELISA in order to link gut microbial changes and deviating cytokine levels (unpublished 
data) respectively, to underlying metabolic conditions.  
Amongst all spectroscopic techniques, 
1
H nuclear magnetic resonance (NMR) 
spectroscopy has proved to produce the quantitatively highest amount of definable metabolic 
markers. Thus far this technique has been used for decades in structural biochemistry and 
molecular biology for matrices with very low component diversity, and has mainly served the 
purpose of molecular structural identification (Fiorito et.al., 2008). Only with the 
development of multivariate statistical analysis methods did it become possible to deal with 
inter-group differences between the spectra of urine, plasma or tissue, which contain 
thousands of partially overlapping resonances. Other spectroscopic techniques commonly 
used for metabolic profiling include MS, which has an inherent higher sensitivity than NMR 
spectroscopy and is most efficient when coupled to preceding separation methods, such as 
high-performance and ultra-performance liquid-chromatography (HPLC-MS/UPLC-MS) and 
gas chromatography (GS-MS) or capillary electrophoresis (CE-MS). Although, MS is not yet 
as well-established for biomarker recovery purposes as 
1
H NMR spectroscopy, it is essential 
for structure elucidation and it also bears the potential to become a crucial tool in the recovery 
of potentially highly specific, but low abundant markers of disease, such as parasite-derived 
enzymes.  
 The multivariate statistical methods, also referred to as ―chemometrics‖ are capable in 
dealing with large or high-dimensional datasets, which are a typical feature of metabonomics 
and other –omics sciences (Eriksson et.al., 2004; Eriksson et.al., 2001; Trygg et.al., 2007). 
The most popular approaches are the linear projection methods principal components analysis 
(PCA) and projection to latent structures (PLS) analysis, which are able to deal with complex 
biological datasets and also handle noise and incomplete data structures. PCA belongs to the 
unsupervised multivariate methods, which means that there is no prior class-assumption 
included in the analysis, whereas PLS is a supervised method and delivers a quantitative value 
of how well the created model fits into the assumption of class. Although there are various 
methods of multivariate analyses (e.g. Bayesian statistics, neural networks, etc.) PCA, PLS 
and further development of these two methods, such as the hierarchical PCA (H-PCA) and 
hierarchical PLS (H-PLS) or orthogonal PLS (O-PLS) have established as main tools for 
metabolic profiling.  
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1.4  Spectroscopy 
1.4.1 NMR spectroscopy 
Certain isotopic nuclei possess an inherent magnetic moment, called spin, which is the crucial 
prerequisite for NMR spectroscopy. When isotopes with spin are brought into a magnetic 
field, they will absorb and then re-emit electromagnetic energy in the range of radio 
wavelengths, whereby the interaction of spin and magnetic field determine the frequency at 
which the radio frequency is absorbed and can vary due to magnetic field strength, type of 
nucleus and the electronic environment surrounding the isotope. Nuclei without spin (I=0) are 
called NMR silent and have got only one energy level, whereas 
1
H, 
13
C and 
31
P and possess a 
net spin of I=1/2 which can manifest as 2 different energy levels (Figure 1.6 A) following the 
equation 2I+1. In isotope populations with spin ½, when placed in an external magnetic field, 
slightly more isotopes will align with the magnetic field, which is the lower energy state than 
alignment against the magnetic field and the resulting difference in population is defined as 
―Bolzmann distribution‖. NMR spectroscopy manipulates and acquires data out of the 
resulting bulk magnetisation vector (Figure 1.6 B), which makes it a relatively insensitive 
technique. Once the nuclei are brought into the centre of the magnetic field, and are aligned, a 
radiofrequency pulse is applied which flips the bulk magnetisation vector from z-axis 90° 
down to the x-axis (Figure1.6 C) (Claridge, 1999).  
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Figure 1.6. Basic alignment of nuclei in a static magnetic field and subsequent oscilation of the bulk 
magnetisation vector after the application of a radio frequency pulse 
 
The actual phenomenon of magnetic resonance results from the relaxation of the nuclei back 
to their original state and is recorded initially as a free induction decay (time domain data) 
which is converted into frequency data by Fourier transformation for the purpose of 
interpretation (Figure 1.7).  
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Figure 1.7. To obtain an interpretable 
NMR spectrum, the initial time-
domain signal must be converted into 
frequency-domain spectral signals by 
Fourier transform algorithms  
 
 
 
Two types of relaxation back to equilibrium, give a measure of the size of the molecule, 
where large molecules relax faster than small compounds. T1 is the spin-lattice relaxation time 
and measures how fast the disturbed nucleus can reach equilibrium with the constant magnetic 
field B0 and involves transfer of energy with surrounding nuclei. T2, the spin-spin relaxation 
indicates the time it takes for an exited nucleus to decay to its zero energy state along the x-y 
plane.  
The chemical shift, spin-spin coupling and the peak intensities represent other spectral 
and molecular descriptors. The chemical shift is a relative scale and is expressed in parts per 
million (ppm), and calculated by δ = [γ (solute in Hz)- γ (reference in Hz) x106] / 
[spectrometer frequency in Hz)]. The reference substance is usually chosen as sodium 3-
trimethylsilyl [2,2,3,3-2H4] propionate (TSP) and set arbitrarily to 0 ppm. Each nucleus 
experiences a slightly different effect of the applied external magnetic field according to its 
exact chemical and electrical environment since the electron cloud surrounding each nucleus 
exerts a small shielding effect against B0. Thus protons that are surrounded by a dense 
electron cloud will be more shielded from the magnetic field and will appear at a relatively 
upfield shift. Therefore, each nuclear environment is unique resulting in the generation of 
characteristic spectral signatures for each molecule. 
Spin-spin coupling or J-coupling is based on the interaction of neighbouring NMR 
active nuclei and reveals structural details of the molecular composition. The characteristic 
multiplicities of peaks, follow the n+1 rule, for example a proton with no neighbouring (n=0) 
protons over 1-3 bonds will be shown as singlet in the spectra, whereas a proton, surrounded 
by 2 other protons, will manifest as a triplet (Figure 1.8). 
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Figure 1.8. Peak multiplicity of ethanol based on the n+1 rule for the impact of neighbouring protons 
 
Since NMR is based on quantum mechanics, the peak intensities are directly proportional to 
the number of nuclei with same neighbouring conditions.  
Two-dimensional (2D) NMR spectroscopic methods are a key tool in structure 
elucidation, and include homo-nuclear assays, such as 
1
H-
1
H 2D J-resolved spectroscopy 
(JRES), which shows the exact multiplicity of each peak, correlation spectroscopy (COSY) 
(Ernst, 1986) and total correlation spectroscopy (TOCSY) (Bax, 1984). Both the latter 
methods indicate interaction of the same nuclei in one molecule, but whereas COSY shows 
only J-coupling between pairs of nuclei that are adjacent, e.g. up to 3 bonds away, TOCSY 
extracts correlation for all homonuclei within one spin system.  
Heteronuclear experiments between different NMR active nuclei generate information 
connected between two different NMR active isotopes. For example heteronuclear multiple 
quantum correlation experiment (HMQC) can be used to identify a direct coupling of protons 
to carbons. The information extracted from HMQCs is often combined with heteronuclear 
multiple bond experiments (HMBC) which are complementary experiments and reveal weak 
J-couplings, e.g. protons which are bound to a certain carbon over 2, 3 or 4 bonds. Applying 
both the experiments can give an enormous amount of extra information about molecular 
structures where assignment based on the simpler homonuclear experiments is difficult.  
NMR spectroscopy is very efficient. A standard one-dimensional spectrum can be 
acquired and interpreted within a few minutes. Moreover, the technique is non-destructive and 
requires only small sample sizes (e.g. mg for tissue and 20 µl for original liquid samples).  
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Many of the peaks in the commonly used biomatrices are already defined and if not, structural 
analysis via 2D NMR methods or via coupling with MS and other spectroscopic methods 
allow identification of unknown regions. All these factors, and the ease of the sample 
preparation and the low relative cost for individual samples, have made NMR spectroscopy a 
most powerful tool in metabolic profiling. Drawbacks of this spectroscopic platform are the 
high initial cost of equipment and the inherently lower sensitivity, compared to other 
spectroscopic methods, such as MS.  
 
1.4.2 Magic Angle Spinning 
Apart from biomarker extraction from biofluids, which serves, in particular in this thesis 
project, diagnostic purposes, the analysis of tissue can contribute to understanding of drug 
pathways (Yap et.al., 2006), organ malfunction (Tate et.al., 2000) and entire systems by 
linking several physiological compartments (Martin et.al., 2006). Solid state analysis NMR 
spectroscopy has been revolutionised by MAS. This method is not sample-destructive and can 
overcome the problems of restricted motion, chemical shift anisotropy and physical 
heterogeneity, which direct NMR analysis of semi-solid tissues has to face (Garrod et.al., 
1999; Waters et.al., 2000). The restricted motion of the molecules in a solid structure impedes 
the total averaging of the dipolar coupling (D) and the shift anisotropy to zero, which is 
expressed as broad NMR resonances. Both these factors depend on the angle between the 
static magnetic field and the inter-nuclear vector, in the form 3cos
2θ -1, and rotating a solid 
sample with the magic angle of 54.7° which averages the equation to zero, enables a high-
resolution spectra with sharp lines and splittings to be obtained (Andrew, 1962).  
 
1.4.3 Mass Spectrometry  
Although NMR spectroscopy has its advantages over MS in metabolic profiling, due to better 
evaluated methods of biomarker recovery and a higher reproducibility, MS-technologies have 
gained more and more importance as highly complementary structure elucidation tool in 
coupling with chromatographic separation methods (Gika et.al., 2007; Lenz et.al., 2005; Lenz 
and Wilson, 2007; Wilson et.al., 2005) and also as pathway decoder in simple biological 
systems, such as protozoan (Kamleh et.al., 2008) organisms. With its high inherent sensitivity 
MS holds promise to add low abundant but highly specific biomarkers to  
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the already established pool of NMR recovered discriminatory compounds and construct more 
specific fingerprints of pathological states.  
 Mass spectrometers should fulfil certain prerequisites, which include the generation of 
ions from the analyte, in a first step, followed by their separation in an analyser according to 
mass. For structure elucidation purposes it is advantageous to have an additional ion 
fragmentation-analyser system, whereas for metabolic profiling purposes, e.g. quantitative 
screening of metabolites, a reduced amount of data is easier to handle and thus no further 
fragmentation of ions would be performed. A detector measures mass and abundance of the 
emerging ions and data can be processed. The mainly applied source of ionisation in 
metabonomics is electrospray (ESI), which is based on the application of a strong electric 
field that interacts with the passing analyte and forms highly charged droplets that desorb in 
form of multiple charged ions, which in turn improves sensitivity. The analyser systems are 
diverse and the more recent developments lean towards higher sensitivity, such as the time-of-
flight analysers, where bundled ions are accelerated before detection. Also Orbitrap Fourier 
transform (FT)-MS (FT-MS) delivers ultra-high mass resolution by using hydrophilic 
interaction chromatography (HILIC) columns, which separate out the lipid fractions before 
the rest metabolic composition enters the MS (Kamleh et.al., 2008). 
The outcome of such an MS acquisition is exemplified in Figure 1.9, where the mass 
spectrum of methanol is shown.  
 
Figure 1.9. Mass to charge distribution of methanol and its fragments 
 
 
 
100
50
R
e
la
ti
v
e
 a
b
u
n
d
a
n
c
e
 %
 
15 30
m/z
15
18
32
31
29
CH
3
OH
 70 
 
Usually the molecular ion implies the molecular weight and appears at the highest m/z ratio, 
e.g. 32 in the case of methanol. The intensity at 15 indicates the defragmented methyl group 
whereas the mass difference of 17 can be related to the loss of a hydroxyl group.  
MS is only as efficient as its previous separation. LC and GC are the preferred 
separation methods apart from the manual solid phase extraction and all three methods are 
based on the same mechanistic principles of the interaction of the mobile phase, which has to 
be separated (liquid or gas), with a stationary phase, which is the column matrix. The physico-
chemical characteristics of a compound determine the strength of interaction between the 
different molecules in a sample and the column matrix and are expressed in retention time 
which indicates the emerging of the compound from the matrix.  
 
1.5 Chemometric analysis 
1.5.1 Principal components analysis  
The principal component analysis (PCA) is normally the first approach to be applied to a 
multivariate data set, and consists of a single X-matrix, organised in n rows (observations, in 
this case individual urine spectra) and k columns (descriptors, i.e. for this data set spectral 
shift regions). In the PCA all spectral information for a given object is compressed into a 
single data point and projected on to a scores plot revealing general information about the 
distribution of the data, e.g. clustering, time trajectories and eventual outliers. The 
concomitant loadings plot contains the metabolic information responsible for individual 
differences in space and is directly applicable to the scores plot (Figure 1.10).  
 The PCA projects every observation as single point into an n-dimensional space, 
whereby every single descriptor, e.g. the integral belonging to a certain chemical shift region, 
represents one dimension, and determines the localisation of the observation in the metabolic 
hyperspace. The resulting swarm of points needs to be mean centred in order to facilitate 
direct comparison of variables (Fig. 1.11 a, b) before applying a first principal component 
(PC) analysis chosen to visualise the maximum variability in the data set (Fig. 1.11 c). The 
following PCs are always orthogonal to the previous PC (d) and explain less and less variance 
with every step. Two PCs define a hyperplane (Fig. 1.11 e) onto which the points or 
observations can be projected in order to generate the scores plot (Figure 1.11 f).  
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Figure 1.10. Explanatory capacity of PCA, adapted from original by Dr. Tsz M. Tsang 
 
The number of PCs for each data set will be as many as the variables within the data set, but 
the lower PCs will contain only noise. Thus the number of PCs calculated in each model will 
depend upon two parameters, fit the goodness of fit of the model (R
2
X), and the predictive 
ability of the model (Q
2
X), and is chosen at an optimal region where both values are as high 
as possible. The former shows how robust the set of data is, e.g. if one point is taken out, how 
probable it would be that it is going to be at the same place by projecting it back. The latter 
indicates the probability that the location of a new data point can be predicted correctly. 
 
1.5.2. Partial least squares analysis  
PLS analysis correlates the spectral content (usually in the X-matrix) to additional 
quantitative information, such as physiological or pathological measures (e.g. packed cell 
volume, bodyweight, etc.) or infection intensity, which is outlined in a measurement response 
or y-matrix and fitted to X by maximising the covariance between the two matrices (Eriksson 
et.al., 2004; Eriksson et.al., 2001; Trygg, 2002; Trygg et.al., 2007). Furthermore, PLS can 
also act in a qualitative way, and be applied as discriminant analysis, where a 0/1 dummy 
matrix indicates class relationship. 
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Figure 1.11. Geometrical demonstration of the basic PCA principle  
 
Although PLS-DA is applied frequently to biological data sets in order to get a 
measure of model predictability, PLS bears an inherent risk of delivering false biomarkers, as 
it can potentially relate x-internal variation to the y-dataset and thus construct artificial 
causalities. Thus supervised methods are usually constructed using a training set and then the 
resultant model tested with a validation set (observations which have been removed prior to 
modelling the training set). This process is known as cross validation and is often performed 
internally within an algorithm, for example in the Umetrics software every 7
th
 observation is 
left out and back predicted. Another way to avoid this false link is the addition of an 
orthogonal component to the X-dataset which comprehends all X-internal variation and 
removes it from correlation analysis with the Y-matrix. Orthogonal PLS is generally applied 
in biomarker detection assays rather than PLS. Geometrically, the main difference between 
PLS and PCA is that data points are projected in two hyperspaces instead of one. Location in 
X (predictor space) and Y (response space) is based on the information in the two different 
data matrices, and the aim of the statistical analysis is to search for positional correlation 
between them. 
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Figure 1.12. Approximation of PCs in X in a partial least squares analysis happens with considering 
correlation to the second matrixY and vice versa  
 
 The first PC in X and Y is calculated to give the best approximation of each swarm of 
points, but also to contain an optimal correlation between the two point locations 
(Figure.1.12). The second components aim to approximate and optimize the positional 
correlations between X and Y-hyperplane, whereas in X the second component has to be 
orthogonal to the first but not in Y.  
 
1.5.3.  Statistical total correlation spectroscopy  
Figure 1.13. Statistical total correlation spectroscopy, revealing structural or pathway relation 
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Statistical total correlation spectroscopy is a multivariate approach to resolve molecular 
structure for one molecule or to indicate biological relationships between compounds (e.g. 
biological or physical relationship) and is based on the correlation of intensities or datapoints 
over multiple spectra (Cloarec et.al., 2005). In Figure 1.13, for example, STOCSY analysis on 
the apex of the hippurate triplet at chemical shift 7.55, revealed strong correlations with all 
other hippurate chemical shifts (7.64 (triplet), 7.84 (doublet) and 3.97 (doublet)), - here only 
the aromatic region is shown. STOCSY offers an alternative to 2D NMR techniques in 
structure elucidation, which suffer resolution problems, compared to 1D spectra, thus cannot 
deal with low abundant metabolites or metabolic resonances hidden by overlapped and 
particularly dense chemical shift regions. STOCSY deals with the digitised spectra rather and 
is not restricted by visual means and internuclear proximity. Thus it has become an essential 
tool for structure elucidation in metabolic profiling and is also applicable to paired data sets as 
heteronuclear-STOCSY (HET-STOCSY), such as parallel acquisitions of two different 
magnetic active nuclei.  
Statistically, the correlation matrix (C) used for STOCSY is calculated by C=1/(n-1) 
X1
t
X2, whereas X1 and X2 are built by the autoscaled matrices of n x v1 and n x v2, 
respectively (n = number of spectra; v = number of variables in the spectra for each matrix).  
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2  Goal and specific objectives 
 
The overarching goal of this Ph.D. project was to deepen our understanding of trematode-
induced metabolic changes in selected rodent models, and to critically assess the 
biomarker recovery potential of a metabolic profiling approach applied to biofluids and 
tissue samples that may contain diagnostic and prognostic properties. 
 
1.  To optimise sample preparation for subsequent 
1
H NMR spectroscopy, and to assess 
metabolic variation in samples with regard to species (i.e. human, rat and mouse), 
gender and age.  
 
2. To assess longitudinally the biochemical changes in urine, plasma and water of E. 
caproni-infected mice, and to compare the diagnostic capacity of different biofluids 
collected from infected and uninfected mice. 
 
3. To gain information about E. caproni-induced changes in selected tissue samples e.g. 
(liver, kidney, spleen, ileum, jejunum and colon) of infected mice and correlate 
identified biomarkers with the previously extracted markers in the biofluids, which 
might reveal infection-related systems level changes.  
 
4. To evaluate the remote and direct impact of three different trematodes (E. caproni, F. 
hepatica, S. mansoni) on the rodent host neural metabolic composition. 
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3.1  Abstract 
The metabolic composition of faecal extracts provides a window for elucidating the complex 
metabolic interplay between mammals and their intestinal ecosystems, and these metabolite 
profiles can yield information on a range of gut diseases. Here, the metabolites present in 
aqueous faecal extracts of humans, mice and rats were characterised using high-resolution 
1
H 
NMR spectroscopy coupled with multivariate pattern recognition techniques. Additionally, 
the effects of sample storage and preparation methods were evaluated in order to assess the 
stability of faecal metabolite profiles, and to optimize information recovery from faecal 
samples. Finally, variations in metabolite profiles were investigated in healthy mice as a 
function of time. Inter-species variation was found to be greater than the variation due to 
either time or sample preparation. Although many faecal metabolites were common to the 
three species, such as short chain fatty acids and branched chain amino acids, each species 
generated a unique profile. Relatively higher levels of uracil, hypoxanthine, phenylacetic acid, 
glucose and aromatic amino acids were present in the rat, with β-alanine being unique to the 
rat and glycerol being unique to the human. Human faecal extracts showed a greater inter-
individual variation than the two rodent species, reflecting the natural genetic and 
environmental diversity in human populations. Faecal composition in healthy mice was found 
to change over time, which might be explained by altered gut microbial presence or activity. 
The systematic characterization of faecal composition across humans, mice and rats, together 
with the evaluation of inherent variation, provides a baseline for future studies seeking to 
determine faecal biomarkers of disease and/or response to dietary or therapeutic interventions. 
 
3.2  Introduction 
There is growing awareness both of the beneficial role the gut microbiota can play in 
maintaining homeostasis in human health and of the adverse association of certain microbial 
species with diseases as diverse as cardiovascular diseases and autism.
1-6
 This link has led to 
renewed interest in the characterization of the microbial content in the mammalian intestine. 
Several studies have used faecal material as a medium for assessing the presence of diseases, 
such as chronic pancreatitis, inflammatory bowel disease (IBD) and colon cancer.
7-11
 
Moreover, the potential anti-carcinogenic activity of microbial metabolites present in feces, 
particularly short chain fatty acids (SCFAs), has been investigated by exposing cultured cells 
to faecal extracts.
12
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High-resolution 
1
H NMR spectroscopy of biofluids such as urine and plasma can be used 
to generate diagnostic information relating to many physiological and pathological conditions, 
particularly when used in conjunction with pattern recognition methods.
13-17
 Recent studies 
have shown that 
1
H NMR spectral profiles of faecal extracts carry diagnostic information for 
diseases, including Crohn‘s disease and ulcerative colitis.8 However, unlike urine and plasma 
which are relatively well-characterised in terms of their metabolite composition and extent of 
inter-species variation,
18,19
 temporal variation and the effect of sample preparation in the 
faecal metabolite profile have not yet been assessed. 
Here, we characterise inter-species differences between humans, mice and rats in the 
content and temporal stability of the faecal metabolite profiles, and explore the effect of 
different faecal sample preparation methods. Our rationale for choosing mice and rats is that 
these vertebrates are widely used in disease model studies. The ultimate objective of this 
study is to provide a baseline for future investigations applying faecal profiling to monitor the 
effect of dietary and pharmaceutical interventions, changes in lifestyles and progression and 
regression of diseases. 
 
3.3 Material and Methods 
3.3.1 Faecal Sample Collection.  
A single stool specimen of 12 healthy humans (6 women and 6 men; age: 31.8 ± 10.2 years, 
range: 24-51 years) was obtained from a previous metabonomic study, cross comparing IBD 
patient subgroups (e.g., Crohn‘s disease, ulcerative colitis) and healthy controls,8 and 
measured using 
1
H NMR spectroscopy. This study was approved by the medical ethics 
committee of the Cork University Hospital (Cork, Ireland) and written informed consent was 
obtained from each participant. 
Female NMRI mice and female Wistar rats were purchased from RCC (Itingen, 
Switzerland) and kept in groups of 4 at the animal facilities of the Swiss Tropical Institute 
(Basel, Switzerland), as described elsewhere.
20
 In brief, the animals were approximately 6-
week-old when faecal sample collection commenced, and the average body weight of mice 
and rats was 25.6 g and 87.4 g respectively. Animals had free access to water and rodent food  
from Eberle NAFAG (Gossau, Switzerland). Faecal samples were acquired between 08:00 
and 10:00 to minimize variation introduced by diurnal rhythm. The experiments were  
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approved by the local government of Basel (permission nos. 2070 and 2081), and handling of 
the animals and collection of feces was according to Swiss national regulations. 
A second rat strain of 8 Sprague-Dawley (SD; Crl:CD(SD)IGS BR) males (age: 7 weeks; 
weight: 175.5-200 g) was obtained from Charles River Laboratories (Wilmington, MA, 
USA). The animals were provided with food and water ad libitum. All in-life studies were 
reviewed and approved by the Institutional Animal Care and Use Committee. 
 
3.3.2 Exploration of Metabolic Variation across Species 
The inter-species variation was assessed in human spectra (n = 12), the Wistar female rat 
group (n = 10) and finally, female NMRI mice (n = 12). Both rats and mice were 9-week-old 
at the time of sampling. 
 
3.3.3 Exploration of Metabolic Variation with Age  
The biochemical variation in faecal metabolite profiles was evaluated in two groups of NMRI 
female mice (n1 = 10; n2 = 12), in Wistar female rats (n = 10) and male SD rats (n = 8). The 
first batch of 10 mice was tested for metabolic differences between sample collection at the 
age of 6 weeks (baseline) and 53 days later. A more detailed time course study was performed 
in a second batch of 12 mice where faecal samples were obtained at 8 different time points 
beginning when the animals were 6 weeks of age and ending at week 11 (sampling days: 1, 3, 
7, 10, 14, 21, 28 and 35). Faecal samples obtained from 10 female Wistar rats were prepared 
under the same conditions and assessed over a 23-day period (starting at the age of 6 weeks). 
Additionally the stability of faecal composition was assessed over a 24-hour time frame 
(consistent with a typical acclimatization period in metabolism cages) in 8 male SD rats. 
 
3.3.4 Effect of Sample Preparation and Storage on the Metabolic Profile.  
The effects of lyophilization, sonication and filtration on the composition and stability of the 
faecal metabolite profile were assessed in feces of the Wistar rat group. Full experimental 
details are given in the supplementary material. Human samples were compared in terms of 
storage and spectra were acquired from the same faecal sample before and after freezing. 
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3.3.5 
1
H NMR Spectroscopic Analysis of faecal Samples  
For the human samples, 200-300 g of stool was mixed with 400 μl of phosphate buffered 
saline (PBS; 1.9 mM Na2HPO4, 8.1 mM NaH2PO4, 150 mM NaCl, pH 7.4), containing 10% 
deuterium oxide (D2O), which acts as a field frequency lock for the spectrometer, and 0.01% 
sodium 3-(trimethylsilyl) [2,2,3,3-
2
H4] propionate (TSP) (pH 7.4), which was used as a 
chemical shift reference (δ 0.0). The resulting samples were centrifuged at 14,000 gav for 10 
min to remove particulates. 
1
H NMR spectra were acquired for each sample using a Bruker 
DRX 600 NMR spectrometer operating at 600.13 MHz for 
1
H equipped with 5 mm broad 
band probe (Bruker; Rheinstetten, Germany). A standard 1-dimensional (1-D) solvent 
suppressed NMR spectrum was acquired for each sample using the pulse sequence [RD-90
o
-
t1-90
o
-tm-90
o
-ACQ]. Water suppression was achieved by irradiation of the water peak during 
the recycle delay (RD = 2 s), and mixing time (tm = 100 ms). The 90
o
 pulse length was 
adjusted to approximately 10 s and t1 was set to 3 s. The spectral width was 20 ppm and a 
total of 64 transients were collected into 32k data points for each spectrum. 
The faecal spectral data for rats and mice were acquired with the same pulse program and 
parameters used for human faecal extracts, but with 128 scans, to compensate for the lower 
sample weight available in the rodent models (see supplement and material for further 
details). 
Metabolite assignments were made by reference to the literature
21-26
 and by using 
statistical total correlation spectroscopy (STOCSY) with an in-house developed script (Dr. O. 
Cloarec, Imperial College London).
27
 Assignments were confirmed with standard two-
dimensional (2-D) 
1
H-
1
H correlation spectroscopy (COSY), total correlation spectroscopy 
(TOCSY), 
1
H-
13
C heteronuclear single quantum correlation (HSQC) and heteronuclear 
multiple bond correlation (HMBC), performed on selected samples. The COSY and TOCSY 
acquisition parameters, described in detail elsewhere,
28,29
 were measured on a 600 MHz NMR 
spectrometer, whereas the 
1
H-
13
C HSQC and HMBC spectra
30-32
 were acquired on a Bruker 
Avance 800 NMR spectrometer (Rheinstetten, Germany) operating at 800.13 MHz. 
 
3.3.6 Data Analysis  
The NMR spectra were corrected for phase and baseline distortions using an in-house 
MATLAB script (Dr. T. Ebbels, Imperial College London). Spectra were normalized to total 
unit area (excluding the region containing the residual water resonance  4.7-4.9) and  
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imported into MATLAB for multivariate analysis. Interpretation of the data was based on 
principal component analysis (PCA) and orthogonal projection to latent structure-discriminant 
analysis (O-PLS-DA)
33
 of the spectra, in conjunction with visual analysis. PCA provides 
visualization of clustering, systematic variation (e.g., time-related changes) and outliers by 
projecting a swarm of coordinates into an n-dimensional hyperspace referred to as a scores 
plot. Each coordinate represents one individual NMR spectrum, the position of which is 
determined by its summed spectral intensity ratio. This is plotted on a plane defined by the 
highest variance of the swarm of points.
34
 Each principal component (PC) is a linear 
combination of the original spectral descriptors. Since the first PC relates to the maximum 
variance in the data set, subsequent PCs are all orthogonal to the preceding PC and explain 
progressively less of the variance. 
The O-PLS-DA model approach gives information about systematic differences in the 
data related to the biological ‗class‘ and allows maximum discrimination between two or 
more classes. As with PCA, the data can be displayed as scores plots indicating similarity 
between samples, but additionally the method generates correlation coefficient plots enabling 
interpretation of the discriminating features in the spectral data. These coefficients plots are 
colored according to the significance of correlation to ‗class‘ (e.g., species, time, etc.) with 
red representing high significance and blue encoding for low significance. Back-scaling to the 
covariance matrix is used to maintain the original spectral structure to facilitate 
interpretability of the coefficient plots.
33
 These methods are adapted from the standard O-PLS 
method defined by Trygg et al.
35
 
The O-PLS-DA models were constructed using NMR spectral data as the X-matrix and 
class information as the Y-matrix. One orthogonal component was used to remove variation 
unrelated to class and a 7-fold cross validation of the data was carried out to measure the 
robustness of the model. The plots were performed in MATLAB with an in-house developed 
script (Dr. O. Cloarec, Imperial College London).
33
 The significance of the differences 
between two classes in O-PLS-DA was assessed by a correlation coefficient. We designated a 
cut-off value of 0.53; higher coefficients indicate statistical significance (p ≤ 0.05) of any 
given metabolite in discriminating between two classes when considering a group size of 12. 
 
Finally, integration over selected peak regions as determined by the highest weighting 
coefficients in the model assessing time related variation was performed in MATLAB using a 
previously published method,
36
 modified by K. Veselkov. The pair wise comparison of  
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metabolic changes at time points of interest was performed using a Mann-Whitney test with 
Bonferroni adjustment for p values in multiple comparisons. 
 
3.4 Results 
3.4.1 Composition of Metabolite Profiles  
Faecal extracts for all three species were characterised by 
1
H NMR spectroscopy and the 
metabolites identified are summarized in Table 3.1. Faecal spectra from the mouse, rat and 
human shared several similarities in profile as the direct comparison of the 1-D 
1
H NMR 
spectra in Figure 3.1A-C shows. For example, all spectra contained visible resonances from 
SCFAs (n-butyrate, propionate and acetate), the branched chain amino acids (BCAA; i.e., 
valine, isoleucine and leucine), glutamate, aspartate, tyrosine and phenolics. An example of 
metabolite assignment for a mouse faecal extract is provided in a typical 2-D TOCSY 
spectrum in Figure 3.2. 
 
3.4.2 Impact of Species, Age/Time and Sample Preparation on the Metabolic Profile  
Three different sources of variation (i.e., species, age/time and sample preparation) and their 
impact on the faecal metabolome were considered in this study. Differences in the faecal 
metabolite profiles relating to sample preparation methods were minor in comparison with the 
variation in profile attributable to species or age/time. A detailed summary of the effect of 
sample preparation methods on metabolite profile variability is given in the supplementary 
material. A global PCA of the aqueous faecal extracts shows the relative contribution of 
species and age/time differences to the variation in the faecal profiles (Figure 3.3A). The most 
influential factor in describing the variation in the data set was species, which was 
differentiated in the first PC explaining 77.4% of the total variance in the data, followed by 
age/time which was differentiated in the second PC. Spectra of faecal samples from mice, 
humans and rats formed distinct clusters. Whilst the spectra of faecal samples from mice and 
rats formed relatively tight clusters in both the PCA and PLS-DA scores plots, the human 
faecal samples were distinct from the other two species and more dispersed, reflecting greater 
variation in the inter-sample metabolic composition. 
 
A closer assessment of the human control group revealed some degree of differentiation 
between samples from men and women, due to higher levels of SCFAs (particularly acetate  
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and n-butyrate) in male faecal extracts. Age did not introduce any systematic variation into 
the faecal profiles (see supplementary material). Samples from humans and mice showed the 
clearest differentiation in the first PC with those from rats lying in between, in a separate 
cluster (Figure 3.3A). Thus, all three species had biochemically distinct faecal extract NMR 
profiles with the greatest similarity demonstrated between mice and rats, and the second 
closest group pairing being rats and humans. The particular metabolites which predominantly 
introduced variation into the spectral profile according to species or age difference are 
examined in the following sections. 
 
3.4.3 Species Differences in Metabolic Profiles between Rat, Mouse and Man  
In addition to common metabolic features, several marked inter-species differences were 
observed and are summarized in Table 3.1. Human faecal samples were characterised by 
lower levels of lactate and various amino acids, such as phenylalanine, alanine, threonine, 
glucose and the BBCAs. Glucose resonances were only visible in 4 of the 12 human samples 
and were associated with the presence of uracil and fumarate, which were otherwise not 
detectable by visual inspection. In addition, the faecal profile in several human individuals 
contained glycerol (Figure 3.1A) which was not observed in either of the rodent species, and 
relatively higher concentrations of acetate and propionate (Figure 3.3B). Higher levels of 
glucose, hypoxanthine, phenylacetic acid, fumarate, tyrosine uracil and glycine were found in 
rats and resonances from β-alanine were only visible in the rat (Figure 3.1C). 
From a direct comparison between female NMRI mice and female Wistar rats using the 
supernatant of sonicated slurry, higher levels of uracil, glutamate, n-butyrate, propionate and 
acetate occurred in the rat, whereas alanine and the BCAAs were present in lower levels 
which is highlighted in the O-PLS-DA plot (Figure 3.3C). Relatively low levels of 3-hydroxy-
phenylpropionic acid (3HPPA) were present in approximately 50% of the samples obtained 
from mice, whereas this metabolite was only observed in one human and one rat faecal 
sample. 
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Figure 3.1. 1-D 
1
H NMR spectra of (A) human, (B) mouse and (C) rat faecal water. The numbers 
refer to the metabolites presented in Table 3.1. 
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Figure 3.2. 600 MHz 
1
H-
1
H 2-D TOCSY spectra of a faecal extract from a female NMRI mouse. 
Keys: 1, leucine; 2, iso-leucine; 3, valine; 4, lactate; 5, threonine; 7, lysine; 8, arginine; 10, proline; 11, 
glutamate; 12, methionine; 13, glutamine; 14, aspartate; 22, formate; 24, n-butyrate; 25, α-
ketoisocaproate; 26, propionate; 27; α-keto-β-methyl-N-valerate; 28, α-ketoisovalerate; 29, α-
hydroxyisovalerate; 31, myoinositol. 
 
The C18 axial methyl signals from bile acids were found in all three species but the identity of 
the bile acids differed between the species. Rats and mice excreted higher levels of 
taurocholic/tauro-β-muricholic acid with the latter being relatively higher in mice as described 
previously,
37
 whereas deoxycholic acid was the prominent bile acid prevalent in human faecal 
samples (Figure 3.3D) which is consistent with previous studies.
38,39
 However, in 50% of the 
human faecal samples the C18 bile acid methyl signal was obscured by a broad envelope of 
resonances that distorted the spectral baseline in this region which made detailed assignment 
difficult.  
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Figure 3.3. (A) Diagram showing the relative effects of two different sources of variation (species and 
age/time). PCA scores plots of faecal samples analyzed showing differentiation between species (first 
PC) and time (second PC). The outlier in the human group (male, 26-year-old), is due to higher levels 
of the SCFAs and a shift at the acetate region (δ 1.92); (B) O-PLS-DA coefficient plots of rats versus 
humans, and (C) rats versus mice. The color scale indicates the significance of metabolite variations 
between the two classes and its maximum is model-dependent. The numbers refer to the metabolites 
listed in Table 3.1; (D) comparison of the bile acids in all three species for region δ 0.63-0.78 ppm. 
C 
D 
x10 x1
0.9
0.1
C
o
rr
e
la
ti
o
n
 c
o
e
fi
c
ie
n
ts
 (
a
.u
.)
O
-P
L
S
 c
o
e
fi
c
ie
n
ts
 (
a
.u
.)
8.5        8        7.5       7        6.5       6        5.5       5 4.5       4       3.5       3       2.5       2        1.5 d 1H
rat
human
22
40
18
20
19
18
21
21
39
34
26
9
6 5
26
1-3
A 
A 
B 
Species variation in the faecal metabolome 
67 
 
 
3.4.4 Age-Related Metabolic Changes in Aqueous Faecal Extracts  
The biochemical variation in faecal metabolite profile of the first group of 10 NMRI female 
mice revealed highly significant changes in the metabolic profile. In comparison to the 
baseline samples, those obtained 53 days later showed a marked decrease in various amino 
acids, including aromatic amino acids (phenylalanine and tyrosine), BCAAs (valine, leucine 
and isoleucine), lysine, aspartate, glutamate, alanine, methionine and glycine. Apart from the 
change in the relative amino acid concentrations, there was a significant decrease in lactate 
and an increase in uracil with time. The sum of the metabolic changes over time in the second 
group of 12 mice were visualized in a PCA trajectory (Figure 3.4A) which showed 
substantial, time-dependent movements between days 1 and 35, particularly along the first 
PC. To obtain a deeper understanding of the significantly changing metabolites, an O-PLS-
DA model was calculated for a series of pair wise comparisons between day 1 with days 3, 7, 
21 and 35 (Figure 3.4B). Significantly lower levels of phenylalanine were observed at all time 
points when compared with day 1 (coefficient 0.69-0.81), whilst tyrosine underwent a 
significant decrease at days 7 (coefficient 0.67) and 21 (coefficient 0.72). Lactate was 
decreased from day 7 with significance increasing at later time points (coefficient 0.57-0.71). 
Amongst the metabolites which increased compared to day 1, were three SCFAs (n-butyrate, 
propionate and acetate), which showed a significant change comparing either of the later time 
points with day 1. The coefficients ranged from 0.56-0.63 for acetate, 0.65-0.76 for 
propionate and 0.64-0.81 for butyrate. Threonine and hypoxanthine were significantly 
differentiated by class at day 35 (coefficients 0.82 and 0.79, respectively), whilst threonine 
showed the same coefficient of 0.82 already at day 21. Uracil was significantly increased at 
days 3 and 35 when compared to day 1, but not at the intermediate time points (coefficients 
0.62 and 0.71). Resonances from several of the metabolites which showed time-dependent 
variations were integrated using an automated curve fitting program, and the relative 
concentration in relation to the total spectral integral determined (Figure 3.4C). The p-values 
were assessed using a nonparametric 1-way analysis of variance (Mann-Whitney) test in 
MATLAB. Uracil increased significantly at days 21 and 35 compared to day 1 (p < 0.001), 
similar to hypoxanthine which increased at three different days, 3, 21 and 35 compared to day 
1 (p < 0.01). Succinate underwent a significant decrease after 35 days (p < 0.001), whilst 
lactate decreased already after 5 days (p < 0.05) and maintained its significance over the 
course of the experiment. 
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Figure 3.4. (A) PCA trajectory plot of faecal spectra obtained from the mean values for a group of 12 
female NMRI mice over a 5-week study period. Mice were 6-week-old at the onset of the experiment. 
Each point in the plot represents average values of the first and second PC at a certain time point of faecal 
collection, e.g., at days 1, 3, 7, 10, 14, 21, 28 and 35. The error bars along the first PC and the second PC 
are expressed by 2 standard deviations of the mean; (B) O-PLS-DA coefficient plots, comparing day 1 of 
animal handling (class 1) with either of the later time points (class 2). The numbers refer to the 
metabolites in Table 3.1; * resonances from sugars and amino acid CH groups; (C) Normalised integrals 
of 5 selected regions with corresponding metabolite identity, proportional to concentrations of metabolites 
in a solution, (black, hypoxanthine , blue, uracil; red, lactate; marine, succinate; yellow, butyrate; orange, 
glucose; green, formate) changed significantly during the experiment. The error bars are defined by two 
standard deviations of the mean. Significant changes are given in the text. 
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An additional comparison of day 3 with days 21 and 35 also revealed statistical significant 
differences (p < 0.001). Formate decreased after 21 and 35 days (p < 0.001), whilst butyrate 
increased already after day 3, compared to day 1 (p < 0.01) and maintained significance at all 
later time points. Glucose showed an inconsistent picture. Days 3 and 7 were significantly 
lower, compared to day 1 (p < 0.05), whilst a day 1 to day 35 comparison did not differ at all. 
Comparing days 5 and 19 to day 33 showed statistical difference (p < 0.01). The data (Figure 
3.1) are expressed as mean ± 2 standard deviations of the mean. 
Although time-dependent trends in increasing acetate and propionate were evident, 
accurate integration of these resonances was not possible due to extreme inter-sample 
variation which resulted in an inhomogenous pattern of resonance overlap with n-butyrate and 
other metabolites in the case of propionate and acetate. 
Faecal samples obtained from 10 female Wistar rats obtained at the age of 6 weeks and 
23 days later, were assessed and demonstrated time-related changes in the profile. A decrease 
in the amino acids phenylalanine, tyrosine, glycine, alanine and the BCAA was observed, 
which was consistent with the findings in mice. However, unlike the mouse model, the levels 
of SCFAs and uracil did not change significantly with increasing age of the rats. Rat faecal 
profiles proved to be stable in lyophilized samples over a short period of time, e.g., 24 h. 
 
3.4.5 Effect of Sample Preparation and Storage Conditions on Metabolic Profiles on Faecal 
Extracts  
Differences in the faecal metabolite profiles relating to sample preparation methods were 
minor in comparison with the variation in profile attributable to species or age/time. The 
effects of freezing, lyophilization and two different sterilization methods and their associated 
variability are detailed in the supplementary files. In brief, the processes of freezing and 
lyophilization increased the BCAA levels and lyophilization decreased the SCFAs. Of the two 
assessed sterilization methods (sonication and filtration) only sonication had an observable 
effect in comparison with the untreated sample. Like lyophilization, sonication led to lower 
relative contribution of the SCFAs to the spectral profile. 
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Table 3.1. List of metabolites found in three species, human (h), mouse (m) and rat (r). *specific for one 
species; </> relatively lower/higher amount of the metabolite found in feces in species comparison; 
**shows trend but is not significant to the p-value 
Metabolite Proton group δ
1
H (ppm) Species
1 leucine α-CH, γ-CH, δ-CH3, δ-CH3 3.72(t), 1.69(m), 0.97(d), 0.94(d) m = r > h
2
iso-leucine α-CH, β-CH, γ-CH2, δ-CH3, δ-CH3 3.68(d), 1.93(m), 1.25(m),1.47(m), 0.99(d), 1.02(d) m = r > h
3 valine α-CH, β-CH, γ-CH3, γ-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d) m = r > h
4 lactate α-CH, β-CH3 4.11(q), 1.33(d) m = r > h
5 threonine α-CH, β-CH, γ-CH3 3.60(d), 4.26(m), 1.33(d) r > h**
6 alanine α-CH, β-CH3 3.81(q), 1.48(d) m > r > h
7 lysine α-CH, β-CH2, γ-CH2, δ-CH2, ε-CH2 3.77(t), 1.92(m), 1.73(m), 1.47(m), 3.05(t)
8 arginine α-CH, β-CH2, γ-CH2, δ-CH2, 3.76(t), 1.89(m), 1.59(m), 3.17(t)
9 acetate CH3 1.92(s) h > r > m
10 proline α-CH, β-CH2, γ-CH2, δ-CH2 4.15(t), 2.05(m),2.38(m), 2.00(m), 3.39(t) r > h**
11 glutamate α-CH, β-CH2, γ-CH2 3.78(m), 2.06(m), 2.36(m)
12 methionine α-CH, β-CH2, γ-CH2, δ-CH3 3.87(m), 2.10(m), 2.65(dd), 2.15(s)
13 glutamine α-CH, β-CH2, γ-CH2, 3.78(m), 2.15(m), 2.46(m)
14 aspartate α-CH, β-CH2 3.92(m), 2.70(m),2.81(m)
15 asparagine α-CH, β-CH2 4.01(m), 2.87(dd),2.96(dd)
16 ethanolamine NH-CH2, HO-CH2 3.15(t), 3.78(t)
17 glycine CH2 3.55(s) r > h = m
18 uracil CH, CH 5.81(d), 7.59(d) r > m > h
19 tyrosine CH, CH 7.23(d), 6.91(d), 2.93(t), 3.25(t) r > m > h
20 phenylalanine 2,6-CH, 3,5-CH, 4-CH, ArCH2, NH2CH 7.44(m), 7.39(m), 7.33(m), 3.17(dd),3.30(dd), 
3.99(dd)
m > r > h
21 glucose 1-CH, 2-CH, 1-CH, ring protons 5.23(d), 3.25 (m), 4.67 (m), 3.35-4.0 (m) r > m > h
22 formate CH3 8.46 (s) r = m > h
23 tryptophan 4-CH, 7-CH, 2-CH, 5,6-CH, 5,6-CH, 
NH2CH, CH2
7.79(d), 7.56(d), 7.34(s), 7.29(t), 7.21(t), 4.06(dd), 
3.49(dd),3.31(dd)
24 butyrate CH3, α-CH2, β-CH2 0.9(t), 2.16(t), 1.56(m) r = h > m
25 α-ketoisocaproate CH2, CH, 2xCH3 2.61(d), 2.1(m), 0.94(d)
26 propionate CH2, CH3 2.19(q), 1.06(t) h > r > m
27 α-keto-β-methyl-N-
valerate
CH, CH2, CH2, terminal-CH3, βCCH3 2.93(m), 1.7(m), 1.46(m), 0.9(t), 1.1(d)
28 α-ketoisovalerate CH, 2xCH3 3.02(m), 1.13(d)
29 α-hydroxyisovalerate α-CH, β-CH, CH3, CH3 3.85(d), 2.02(m), 0.79(d), 0.84(d)
30 urocanate CHCOOH, CH(ring), C5, C3 6.4(d), 7.13(d), 7.41(s), 7.89(s)
31 myoinositol 1,3-CH, 2-CH 3.53(dd), 4.06(t)
32 fumarate CH3 6.53 (s)
33 3-hydroxyphenyl 
propionic acid
CH2, CH2COOH, ring protons 2.47 (t), 2.85 (t), 6.8 (m)
34 succinate 2x CH1 2.42 (s) m > r > h**
35 glycerol half CH2, half CH2, C2--H 3.56 (dd), 3.64 (dd), 3.87 (m) h*
36 β-alanine NCH1, CH2COOH 3.19 (t), 2.56 (t) r*
37 bile acid
38 5-aminovalerate CH2NH2, CH2COOH, CH 3.02 (t), 2.24 (t), 1.65 (m)
39 phenylacetic acid CH2, ring protons 3.52 (s), 7.29 (t), 7.36 (t) r > m > h 
40 hypoxanthine ring protons 8.11 (s), 8.099 (s) r > m > h 
41 malonate CH1 3.133(s) h*
42 trimethylamine CH3 2.88(s)
43
3-hydroxyphenyl 
propionic acid
CH2, CH2COOH, ring protons 2.47 (t), 2.85 (t), 6.8 (m)
44 5-aminovalerate CH2NH2, CH2COOH, CH 3.02 (t), 2.24 (t), 1.65 (m)
45 bile acid 0.7 (m)
46 myoinositol 1,3-CH, 2-CH 3.53(dd), 4.06(t)
47 urocanate CHCOOH, CH(ring), C5, C3 6.4(d), 7.13(d), 7.41(s), 7.89(s)
48 methanol CH 3.36(s)
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3.5 Discussion 
In order to establish their diagnostic biomarker utility, detailed examination of readily 
accessible biofluids that can be collected in a non-invasive fashion should be pursued. 
Although faecal extracts might not represent the first choice of most analyses for metabolic 
profiling, the intimate connection of the faecal metabolites with the gut microbiota is 
undeniable. Furthermore with the growing appreciation of the importance of the gut microbes 
in mammalian disease
1-6
 it is now time to evaluate variations in metabolite composition 
between humans and widely used experimental animals. 
Extracts of faecal water hold promise as a biological medium for diagnosing disease
8-12
 and 
can help to characterise the symbiotic metabolic relationship between the mammalian host 
and its associated microbiome. However, the utility of a biofluid or tissue extract, and the 
reliability of candidate biomarkers identified in that medium are partially dependent on the 
normal physiological variation in biochemical composition and on the stability of the 
metabolic profile. The biochemical composition in aqueous faecal extracts obtained from 
three different mammalian species, including temporal/age variation and the effect of sample 
preparation, have been investigated in the current study with a view to assessing the reliability 
of feces as a medium for identifying biomarkers of disease. Species age/time and sample 
preparation methods were all found to be sources of variation in the metabolic profile of 
faecal extracts, in decreasing order of magnitude of effect. The sample preparation method 
used exerted minimal influence on the spectral profile, and the magnitude of variation induced 
by different methods was negligible in comparison to species differences. It can therefore be 
assumed that information and data relating to the identification of candidate biomarkers for 
pathological conditions or therapeutic interventions will be transferable across studies and 
laboratories. 
 
3.5.1 Inter-Species Differences in the Faecal Metabolite Profile  
The faecal metabolite profiles of the three species investigated (humans, rats and mice) shared 
some similarities but also contained metabolite patterns that were unique to each species. 
Metabolites that were conserved across the three species included many of the amino acids 
and the SCFAs (n-butyrate, propionate and acetate), whereas glycerol was unique to humans  
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and β-alanine was specific for rats. Unsurprisingly the variation in the faecal profiles from 
human samples was much greater than for either mice or rats which were largely 
homogeneous and formed tight clusters in the PCA scores plots (Figure 3.3A). The greater 
diversity in the human profiles is also reflective of exposure to greater environmental gut 
microbiome variation and host genetic variation than laboratory animals kept genetically 
uniform and under environmentally-controlled conditions. The inhomogeneity of the human 
samples is found to be influenced by the gender of the participants but not by age (range: 24-
51 years). This result mirrors the difference in the relative degree of variation typically 
observed in urinary metabolite profiles.
19
 Faecal excretion of relatively high concentrations of 
SCFAs, predominantly acetate, in men has not to our knowledge previously been reported. In 
fact, contrary to these findings Wolever and colleagues (1996)
40
 reported that serum 
acetate:propionate ratios did not differ between men and women. Whilst some human 
metabolites like the BCAAs, lysine, asparagine and the SCFAs (acetate, n-butyrate and 
propionate) were found in all analysed human samples in similar relative concentrations, other 
components such as the bile acids were highly variable in concentration and presence. 
Interestingly, uracil, glucose and fumarate appeared to co-vary in the human samples but this 
was not the case in either of the rodent species investigated. The glucose and pyrimidine 
transporters in the small intestine share a similar distribution and mode of action.
19
 In addition 
to showing the greatest dispersion, human samples were also most divergent from the other 
groups, with rats and mice being the most similar to each other in profile. Rat faecal profiles 
were characterised by relatively higher concentrations of uracil and the aromatic amino acids 
tyrosine and phenylalanine, in comparison with the two other species. Particularly high uracil 
levels in the rat were associated with the presence of β-alanine which was not observed in 
either human or mouse faecal samples. Both components are intermediates in the degradation 
of cytosine (Figure 3.5).
41
 The high levels of β-alanine and cytosine in the rat faecal samples 
suggest a higher presence of potential inhibitors of the uracil transporters in the jejunum of the 
rat, which actively transports uracil from mucosa to serum. It could be shown that 
phenylalanine, which was also increased in the rat faecal sample, acts as a fully competitive 
inhibitor of the uracil transporter.
42
 The degradation of uracil to β-alanine by certain intestinal 
bacteria may account for the relative higher levels of β-alanine found in rat feces.43,44 
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3.5.2 Influence of Age/Time on the Faecal Metabolite Profile 
The O-PLS-DA models, differentiating samples obtained sequentially over a 5-week 
period on the basis of time, were significant with reasonably strong Q
2
 values (0.48-0.88).  
These results indicate that the faecal profile was not stable over the duration of the study. The 
PCA trajectory (Figure 3.4A) also supports this observation, showing an initial deviation from 
the metabolic starting position in the first week of the study and then a period of relative 
stability followed by another deviation in biochemical composition of faecal content 3 weeks 
after the initial sampling point. 
 
Figure 3.5. Degradative pathway of uracil: Key for enzymes: 1, uridine phosphorylase; 2, 
dihydropyrimidine dehydrogenase; 3, dihydropyrimidinase; 4, 3-ureidopropionase; 5, 3-alanine-pyruvate 
transaminase; 6, malonate semyaldehyde dehydrogenase. 
 
Although the global trend in time-related variation in the faecal metabolome was clear, the 
inter-animal variation was relatively high as demonstrated by the error bars in the PCA scores 
plot in Figure 3.4A. The metabolic components predominantly associated with this temporal  
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variation included the SCFAs (acetate, propionate and n-butyrate) which increased with time 
along with tyrosine and uracil, whereas alanine and succinate decreased over the study 
duration. Both rats and mice showed similar temporal variation in the faecal metabolite 
profile. However, the metabolic profile was relatively stable in rats over short periods (up to  
24 h), particularly when lyophilized samples were used. Since the relative contributions of the 
SCFAs are reduced following the lyophilization process, this is consistent with the SFCAs 
showing higher temporal variation than other faecal components. The mice were 
approximately 6-week-old at the beginning of the experiment. Female mice typically become 
sexually mature when aged between 6 and 7 weeks,
45-48
 therefore some of the initial 
metabolite changes in the first week may be related to the onset of sexual maturity since this 
is known to have an effect on the composition of the microbiota. However, this is unlikely to 
account for the metabolic changes evolving after day 14 of the study (corresponding to mice 
aged approximately 8 weeks). Also, since the nature of changes in specific metabolites over 
time were largely consistent throughout the total duration of the study, with the exception of 
lactate, succinate and threonine, the initial perturbations in metabolite profile changes are 
more likely to derive from a shift in the gut microbiota presence or activity which is 
independent of the onset of sexual maturity.
47,48
 
As demonstrated in other publications, the variation in the biochemical composition of 
feces caused by age/time or inter-individual differences are small compared to the variation 
induced by diseases such as Crohn‘s disease, ulcerative colitis or bowel cancer.7-9 The 
characterization of variation in the ‗normal‘ faecal metabolome presented here, and the 
indication of the more stable metabolic components of the faecal profile, should facilitate 
establishing the degree of confidence with which future disease-related studies can be 
interpreted in assessing systemic metabolic changes induced by nutritional interventions (e.g., 
pre- or probiotic administration), as well as lifestyle choices. 
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4 Use of Echinostoma spp. in studies on chemotherapy and metabolic 
profiling 
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4.1 Abstract 
In this chapter we briefly summarize the use of echinostomes in chemotherapeutic studies, 
and provide a comprehensive overview of metabolic profiling using an Echinostoma caproni-
mouse model. In vitro and in vivo assays with Echinostoma spp. are suitable means for 
screening of anthelminthic drugs. Indeed, these models have been utilized for more than three 
decades and play an important role for discovery and development of novel drugs and 
treatment options against major trematode infections. Rapid diagnosis of infection and 
monitoring of disease progression and resolution are of pivotal importance for personalized 
health care and disease control at the population level. Spectroscopic profiling of the host 
metabolism, in combination with multivariate statistical methods, is a powerful approach for 
biomarker discovery that give rise for diagnosis and prognosis of infection and disease stages, 
and for subtle monitoring control interventions. The comparison of biofluids and tissue 
samples obtained from mice experimentally infected with E. caproni and from non-infected 
control animals revealed a high number of biomarkers in different kinds of biofluids (e.g., 
blood plasma, faecal water and urine). Several tissues also showed significant metabolic 
changes after a chronic infection with E. caproni. Whilst urine and blood plasma are obvious 
and convenient choices for diagnostic purposes, the study on tissue samples complemented 
the information extracted from biofluids and aided in a deeper understanding of biochemical 
mechanisms of disease. 
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4.2 Introduction 
This chapter reviews the use of echinostomes in chemotherapeutic studies and in metabolic 
profiling. Chemotherapy is one of the main pillars for the control of food-borne trematode 
infections, including echinostomiasis. However, the current chemotherapeutic arsenal is 
limited to two drugs; namely (i) triclabendazole for the treatment of fascioliasis, and (ii) 
praziquantel against clonorchiasis, opisthorchiasis, paragonimiasis, and intestinal fluke 
infections 
4
. Disposing of only two drugs for diseases that affect at least 40 million 
individuals, with some 750 million people at risk (more than 10% of the world‘s population) 
is potentially dangerous. Moreover, food-borne trematodiasis is emerging 
22
 and there is 
considerable concern regarding the development of drug-resistant parasite strains as 
unexpectedly low cure rates have been observed in clonorchiasis patients following 
praziquantel administration 
61
. A vaccine against food-borne trematodiasis is not expected to 
arrive for at least another decade or so. Changing human behavior as a means to reduce 
transmission of the diseases is a formidable challenge due to cultural habits (e.g., 
consumption of raw fish and other aquatic products) 
62
. Hence, development of novel 
trematocidal drugs is of great importance in the period while praziquantel and triclabendazole 
remain effective. An Echinostoma-mouse model holds promise in trematocidal drug discovery 
and development, and metabolic profiling can serve as a platform for biomarker discovery 
with diagnostic, prognostic, and drug/vaccine target potential. 
In the next part we summarize studies that have utilized Echinostoma spp. as a drug 
discovery tool. Emphasis is placed on in vivo, in vitro, and scanning electron microscopic 
(SEM) investigations. Spectroscopy is another interesting tool that has been applied in drug 
discovery and development 
63
. However, whilst spectroscopy has been widely used in drug 
research and development (R&D) for antiparasitic drugs 
64
 to our knowledge, it has not been 
specifically applied to echinostomiasis. Advances in the technology of spectroscopy lend 
themselves to profiling the metabolic response of the host organism to parasite invasion. 
Hence, the third part of the chapter is focused on illuminating the role of the spectroscopic 
strategies in profiling host-parasite and host-parasite-drug interactions. The main focus of its 
application to E. caproni has been to establish a comprehensive metabolic response of the 
mouse to an E. caproni infection 
65
, and to compare the biochemical profiles in the biofluids 
and tissues of infected with non-infected control mice. 
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Table 4.1 Use of the E. caproni-mouse model for chemotherapeutic studies 
Year, 
Reference 
Model Treatment Dose (mg/kg) 
Worm 
burden 
reduction (%) 
1971, 66 E. miyagawai in mice 
Male fern extract 1 x 400 64.5 
Acriquine 1 x 300 86 
Dichlorophen 1 x 200 80 
Trichlorophen 1 x 200 84 
Chloxyl 1 x 100 100 
Bithionol 1 x 100 100 
Phenasal 1 x 100 100 
Piperasine salt of 
phenasal 
1 x 100 100 
1975, 67 E. caproni in mice 
Brotianide 1 x 75 100 
Niclofolan 1 x 10 100 
Nitroxynil 1 x 25 100 
Oxyclozanide 1 x 50 100 
Rafoxanide 1 x 50 100 
Tribromsalan 1 x 100 100 
Niclosamide 1 x 200 100 
Hexachlorophene 1 x 200 100 
Bithionol 1 x 300 80 
1979, 68 E. caproni in mice Flubendazole 
1 x 200 0 
5 x 200 100 
1980 69 E. caproni in mice 
Thiabendazole 5 x 200 0 
Oxybendazole 5 x 200 0 
Cambendazole 5 x 200 5 
Fenbendazole 5 x 200 20 
Parbendazole 5 x 200 50 
Mebendazole 5 x 200 100 
1986 9 
E. ilocanum in rats and 
gerbils 
Mebendazole 50 mg per animal 100 
1995 70 E. caproni in ICR mice 
Clorsulon 1 x 100 100 
Rafoxanide 1 x 50 100 
Mebendazole 1 x 1000 No effect 
Arprinocid 1 x 100 No effect 
1998 71 
E. caproni in BALB/c 
mice 
Albendazole 1 x 100 Not reported 
2006 (Keiser et al., 
2006b) 
E. caproni in NMRI mice Tribendimidine 1 x 125 100 
2006 (Keiser et al., 
2006d) 
E. caproni in NMRI mice OZ78 1 x 1000 100 
2006 (Keiser et al., 
2006a) 
E. caproni in NMRI mice Artemether 1 x 1100 100 
E. caproni in NMRI mice Artesunate 1 x 700 100 
E. caproni in NMRI mice Artemisinin 1 x 1500 99 
E. caproni in NMRI mice Arteether 1x 1300 75 
E. caproni in NMRI mice Praziquantel 1 x 50 100 
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4.3 Use of Echinostoma caproni in trematocidal drug discovery and development 
4.3.1 Evaluation of Echinostomicidal activity in vivo 
Rodents infected with Echinostoma spp. are suitable models for anthelminthic studies, 
justified as follows. First, it is relatively straightforward to maintain the life cycle in the 
laboratory. In the case of E. caproni, for example, mice are used as the definitive host and 
Biomphalaria glabrata snails as first and second intermediate host 
12
. In contrast, studies 
utilizing Clonorchis sinensis, one of the most important liver flukes 
72
, require rats as the 
definitive host, as well as the digestion of infected fish material to obtain metacercariae 
73
, and 
hence the life cycle is considerably more challenging to maintain in the laboratory. Second, 
E. caproni has a short development period of only 10-14 days in rodents 
12
. This model 
therefore produces rapid results and is more cost-effective than host-parasite models with a 
longer development and a more complex life cycle. Moreover, the Echinostoma-mouse model 
is not only useful for anthelmintic studies on echinostomes, but can also serve as a pre-screen 
to test for in vivo trematocidal activity of compounds. However, it should be kept in mind that 
the feeding behavior (echinostomes do not feed on blood) and the location of Echinostoma 
spp. in the definitive host differ from the major food-borne trematodes, the liver flukes (e.g. 
C. sinensis, Fasciola hepatica, and Opisthorchis viverrini) and the lung flukes (Paragonimus 
spp.). So for example, depending on the pharmacologic characteristics (e.g. absorption and 
distribution) of the drug, the in vivo drug efficacy between the individual fluke infections 
might vary. 
Table 4.1 summarizes in vivo studies that employed Echinostoma spp. for drug screening 
studies. The first investigation we could identify dates back to 1971 
66
. The majority of 
studies employed E. caproni in the mouse, but also E. ilocanum in rats and gerbils 
9
, and 
E. miyagawai in mice 
66
 were utilized. Drug efficacy was analyzed as early as 24 hours post-
treatment 
67
. High activities against E. caproni and E. miyagawai were observed with single 
oral doses of chloxyl, phenasan, niclosamide, niclofolan and hexachlorofen 
66, 67
.  
Some of these drugs were commonly used in the first half of the 20
th
 century to treat 
infections with different food-borne trematodes in humans; however, patients often suffered 
from severe adverse events 
74, 75
. Four studies analyzed the echinostomicidal effect of 
different benzimidazoles. Several of the benzimidazoles (e.g., thiabendazole) showed no 
activity even after long treatment courses or when administered at high doses 
69, 70
.  
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On the other hand, complete worm burden reductions were observed in two studies with 
multiple treatment courses of mebendazole 
9, 69
.Praziquantel, tribendimidine, artemisinin and 
two of its derivatives (artemether and artesunate), and the synthetic trioxolane OZ78 were 
tested recently in the E. caproni-mouse model 
76, 77
. A single 50 mg/kg oral dose of 
praziquantel resulted in 100% worm burden reduction. High doses of artesunate (700 mg/kg), 
OZ78 (1000 mg/kg), artemether (1100 mg/kg), and artemisinin (1500 mg/kg) were required to 
yield cure rates of 99-100%. The need for high doses of artemisinin and two of its main 
derivatives to achieve high efficacy in the E. caproni-mouse model might be explained with 
E. caproni being a non-hematophagous feeder. Hence, this intestinal fluke does not degrade 
hemoglobin to generate free heme, which is a possible activator/receptor for the artemisinins 
1
. Indeed, previous studies found that considerably lower doses of the artemisinins and 
synthetic trioxolanes administered to rats infected with F. hepatica, or mice infected with the 
blood fluke Schistosoma mansoni resulted in high worm burden reductions (Keiser, 2006d, 
Utzinger et al. 2007). Finally, tribendimidine is considered a promising broad spectrum 
anthelmintic  drug, which has recently been approved by Chinese food and drug regulatory 
authorities 
78
. Complete worm burden reductions were achieved in the E. caproni-mouse 
model following the administration of a single 125 mg/kg oral dose or higher 
77
. 
 
4.3.2 Drug sensitivity assay with Echinostoma caproni in vitro 
Several studies have examined the echinostomicidal properties of different drugs in vitro
67, 76, 
79
. Since echinostomes have a short development period in vivo, these trematodes can be 
obtained within a couple of days for subsequent in vitro studies. Another advantage of this 
model is that mice tolerate high infection intensities with echinostomes, leading to a large 
quantity (up to 100) of worms that can be recovered from the intestine of mice 
13
. In contrast, 
only a low number of flukes can be obtained from other food-borne trematode-rodent models, 
e.g., F. hepatica-rat model delivers, on average ~5-8 flukes 
80
. For in vitro chemotherapeutic 
studies, echinostomes were recovered from mice 11-14 days post-infection and incubated in 
the presence of the compound to be analyzed in NCTC 135 culture medium, or Hanks‘ 
balanced salt solution (HBSS), supplemented with antibiotics. Worms were observed for up to 
five days and mortality recorded 
67, 76, 79
. Drug effects might also be assessed by motility 
disturbances (e.g., activity or paralysis), or morphological changes such as relaxation, 
shrinkage, curling, tegumental disruption, or worm disintegration. 
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Excysted juvenile Echinostoma worms 
81
 might also prove useful for in vitro 
chemotherapeutic studies. Assays with juvenile E. caproni obtained from metacercariae, 
treated in a trypsin-bile salts excystation medium at 39°C 
81
1997), for example, do not require 
the definitive host, hence are ethically sound, rapid to obtain, and inexpensive. 
 
4.3.3 Scanning electron microscopy (SEM) studies 
The tegument of trematodes is one of the most susceptible sites of damage following 
chemotherapy, and drug effects are readily examined by the evaluation of treated worm 
specimen by SEM. Indeed, SEM analysis deepens our knowledge of the sites and mechanisms 
of action of anthelmintics 
82
. Structural changes in the tegument following drug 
administration can be analyzed by means of SEM under in vitro and in vivo conditions. 
Tegumental responses are often analyzed with increasing incubation periods in vitro or 
progressing time post-treatment in vivo. While surface structures of normally developed 
control specimens of E. caproni have been studied in detail using SEM 
83
, thus far only one 
study has evaluated the effect of drugs on this intestinal fluke by the same tool 
77
. Fig 4.1 
depicts the oral sucker (OS) and the ventral sucker (VS) of an adult E. caproni specimen 
recovered from an untreated control mouse. For comparison, Fig 4.2 shows an E. caproni 
trematode recovered from a mouse treated with a single 150 mg/kg oral dose of 
tribendimidine (Figs 4.2a and 4.2b), and 700 mg/kg artesunate (Figs 4.2c and 4.2d). Typical 
features of drug-induced damage included a reduced opening of the oral sucker (Figs 4.2a, 
4.2b and 4.2d), focal damage of the tegument as eruption (Fig 4.2c), furrowing, or sloughing 
(no image shown). 
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Figure 4.1. Previous page: SEM observation of an E. caproni trematode recovered from a mouse 14 
days after an experimental infection. (a) Ventral sucker (VS), and tegumental spines (S), (b) Anterior 
part with oral sucker (OS), papillae (P), collar spine sockets (CSS), and spines (S) 
 
 
 
 
Figure 4.2. SEM observation of an E. caproni trematodes recovered from mice following treatment 
with tribendimidine (a, b), and artesunate (c, d). (a) Reduced opening of oral sucker (OS) 4 h after 
administration of a single 150-mg kg
-1
 oral dose of tribendimidine. (P) papillae. (b) Reduced opening 
of oral sucker (OS) 8 h after administration of a single 150-mg kg
-1
 oral dose of tribendimidine. (VS) 
ventral sucker. (c) Eruption (E), and tegumental spines (S) on the ventral midbody surface 4 h after 
administration of a single 700 mg kg
-1
 oral dose of artesunate. (d) Reduced opening of oral sucker 
(OS) 8 h after administration of a single 700-mg kg
-1
 oral dose of artesunate. (P) papillae 
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4.3.4 Spectroscopy 
Both nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) have 
been used to elucidate the mechanism of action of antiparasitic drugs. The general pre-
metabonomics applications of NMR and MS include structural identification of possible 
target proteins and pathway steps for new drug developmental angles, and the monitoring of 
drug degradation 
84-86
. For example, it was demonstrated that the antibiotics pentalenolactone 
and koningic acid inhibit the glycosomal enzyme of Trypanosoma brucei. NMR analysis was 
able to indicate that these compounds bind to the cysteine residue of the active site of the 
enzyme 
87
. Other examples include the investigation of the inhibition of the merozoite surface 
protein in Plasmodium falciparum by suramin and its analogues 
88
, the interaction of 
antiparasitic guanyl hydrazones with the cell membrane of Trypanosoma cruzi 
63
, and the 
evaluation of methylene blue as an antimalarial drug candidate against drug-resistant parasite 
strains 
64
. 
Further extension of spectroscopy has allowed direct application to profiling metabolic 
changes in the tissues and biofluids of host organisms infected with parasites. The advent of 
postgenomic disciplines such as transcriptomics, proteomics, metabonomics, and lipidomics 
has opened up a wealth of new possibilities in characterizing the response of an organism to 
physiological and pathological challenges (Nicholson et al. 2002), and has facilitated the 
increasingly popular ‗systems biology‘ approach. A clear role for genomics, proteomics (see 
chapter 9) and metabonomics has been established in parasitology with respect to diagnostics, 
characterizing host-parasite interactions, and in monitoring and evaluating therapeutic 
responses to intervention. 
 
4.4  Metabonomic investigation on Echinostoma caproni in the mouse model  
4.4.1 What is metabonomics? 
Metabonomics, also known as metabolomics and metabolic profiling 
41, 89
, involves the 
generation of multivariate profiles or fingerprints of biological samples using multivariate 
statistics, applied to high-resolution analytical methods such as NMR spectroscopy, MS and 
capillary electrophoretic chromatography. The approach has been used for the 
characterization of metabolic phenotypes of healthy, diseased and treated subjects 
90
, and the 
diagnosis and monitoring of a wide variety of clinical and physiological conditions, ranging  
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from cardiovascular disease 
51
 to nutritional intervention 
91
. Although gas chromatography 
(GC)-MS, capillary electrophoresis chromatography, and infrared spectroscopy have all been 
used successfully as metabonomics tools, applications in parasitology have been limited 
largely for NMR-based studies with one or two liquid chromatography (LC)-MS examples 
beginning to emerge. Studies by Vasta and colleagues have used high performance thin layer 
chromatographic analyses to examine metabolic profiling in mice infected with E. caproni. 
Significant changes were discovered in the neutral lipid profiles in both feces and urine of 
mice infected with E. caproni relative to the uninfected controls (Vasta, Fried and Sherma 
2008). 
In the current chapter we will focus on NMR-based metabolite profiling with a brief 
discussion of the current capability and potential of LC-MS for diagnosing and characterizing 
parasite infections with particular consideration to E. caproni. 
NMR spectroscopy. NMR has been an important tool in analytic and organic chemistry for 
several decades. Early studies on biofluids (typically urine and blood) were performed using 
visual means of interpreting molecular changes in the spectra. However, in 1989 a 
breakthrough occurred in spectral analysis involving the application of computer-based 
methods for data reduction and assessing similarity/dissimilarity between various spectra 
(Nicholson and Wilson 1989), and NMR-spectroscopy (especially 
1
H NMR spectroscopy) 
became an efficient and convenient analytical tool used in a diversity of medical and 
biological fields, and currently represents an important tool in systems biology 
92
. 
NMR spectroscopy measures the interaction of nuclei with an applied electronic magnetic 
field. The frequency or position of the chemical shift scale will be determined by the electron 
cloud surrounding a particular nucleus which provides a shielding effect from the magnetic 
field. Hence, the exact resonance of a nucleus is related to its chemical environment, and 
therefore gives information regarding chemical structure of a molecule. In addition, 
neighboring nuclei interact via bonding electrons, and hence carry information regarding the 
neighboring nuclei. Coupled nuclei, show multiplicity of peaks, which is determined by the 
number of protons on the adjacent atoms and is given by n+1 peaks, where n is the number of 
neighboring spin-coupled nuclei. Furthermore, the intensity of a resonance peak in NMR 
spectra is proportional to the concentration of nuclei present in a particular chemical  
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environment. Therefore, NMR spectroscopy can provide quantitative information as well as 
structural information on the metabolites or compounds in a biological sample. For 
methodological details the reader is referred to Claridge (1999). 
Mass spectrometry. The initial application of MS to metabolic profiling originated from cell 
culture systems and plant studies (Fiehn 2002). Nowadays MS is increasingly utilized in the 
metabolic profiling of biofluids, because of its inherently high sensitivity, and its ability to 
target different classes of molecules in the metabolic spectrum, depending on the chosen type 
of MS platform and the characteristic of the sample. Thus MS is a highly complementary 
technique to NMR. MS is ideally coupled with a previous, separation of the mixture via LC or 
solid phase extraction. LC-MS is the most popular method of metabolic profiling after NMR 
spectroscopy 
93, 94
, but also GS-MS and MS-MS finds increasing application. In practice, the 
combination of multiple analytical platforms will provide the most precise information, 
because every single technique contributes a unique set of data shaping the overall metabolic 
picture 
95, 96
. 
For MS analysis of biological matrices, after appropriate chromatographical separation, the 
fraction is introduced into the ionisation source, where the molecules gain (positive ionisation 
mode) or lose (negative ionisation mode) one ion, and are further separated by MS according 
to the mass-to-charge ratio (m/z) of the ions. Where hard ionisation sources are used the 
molecular fragments can provide structural information as well as an accurate relative 
molecular mass, which can be useful in molecular assignment. The data generated consist of a 
chromatographic retention time and a mass to charge (m/z) ratio and thus there is significantly 
less overlap with metabolite signals generated by LC-MS than one-dimensional (1D) NMR 
analysis since the data are already dispersed in two dimensions. However, analytical drift in 
either the chromatographic conditions or the m/z value can be problematic and several 
algorithms have been produced to address the peak or signal alignment. An additional factor 
which requires consideration in MS analysis is the fact that differential ion suppression effects 
across samples can produce artefacts and render quantification of metabolites difficult. 
Chemometric tools. Spectra from biological samples, such as blood, urine, faecal water, and 
tissues generally contain several thousands of resonances, which are partly overlapping and 
thus can observe important information. In order to extract the maximum information from 
the large amount of raw, complex data, multivariate statistical methods are used for data 
reduction and to visualize the data in simple graphs. 
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Prior to multivariate analysis a series of pre-processing steps are usually applied to the 
spectral data to enable more accurate interpretation. These include procedures such as peak 
alignment and registration, smoothing, centring of baselines, and normalization of each 
spectrum to a constant sum such that concentration differences between samples can be 
removed. 
 
Figure 4.3. Schematic of sample acquisition and data handling; (a) acquisition of metabolite profiles 
followed by (b) mathematical modelling of the data to establish pre- (filled square) and postinfection 
(open square) penotypes for each parasite. Key: 1, hippurate; 2, phenylacetylglycine 
 
There are two basic types of multivariate statistical methods: (i) unsupervised, and (ii) 
supervised approaches. Unsupervised methods are generally used for reducing the complexity 
and the volume of the data and use no prior knowledge of class or measure of response. 
Following data reduction approaches according to defined algorithms, the data are displayed 
as co-ordinates in a 2- or 3-dimensional (2D or 3D) plot, which can be examined to obtain 
information on outliers, trends and similarities within the data. The most widely applied 
unsupervised method is principal component analysis (PCA) (Fig 4.3). In contrast with 
unsupervised methods, the main feature of supervised methods is to use knowledge of class 
membership to optimise the difference between two or more classes. Thus in this context 
supervised methods are generally used to predict the biological ‗state‘ of an organism, e.g., 
infected or non-infected. For supervised methods, cross-validation is necessary by using a part 
of the data as ―training set‖ in order to construct the model and the remaining part of the data 
as a ―test set‖ to validate the model. Some of the main supervised methods are soft 
independent modelling of classification analogy (SIMCA), partial least squares (PLS) 
analysis 
54
 and, more recently, also Bayesian methods 
97
. At its simplest these linear 
projection methods allow rearrangement of the original variables (in this case spectral data  
(a) Data (b) Analysis
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points) to form a new component which describes the maximum direction or dimension of 
variation in the data. Subsequent components are calculated to be orthogonal and describe 
progressively less variation. Thus a plot of the first two or three components allows 
visualization of similarity between objects (in this case biological samples) based on their 
spectral composition. 
Further improvement in data modelling can also be obtained by implementation of a 
mathematical filter, such as orthogonal signal correction, to remove systematic variation in 
the data set that is unrelated to the property of interest. For example, in determining whether 
an animal is infected, systematic variation introduced by age or sex differences may 
compromise the model. Orthogonal PLS discriminant analysis (O-PLS-DA) 
98
 has been used 
successfully to remove the influence of such potential sources of variation. 
 
4.4.2 Experimental protocol 
Here we use NMR spectroscopy to characterise the metabolic features of an E. caproni-mouse 
model and to illustrate our metabolic profiling strategy. A standard metabonomic protocol for 
exploring the effects of parasite infection is summarized in Fig 4.4. Briefly, urine, plasma and 
stool from E. caproni-infected, and age- and sex-matched uninfected mice were collected at 
weekly intervals over a 33-day time course, and measured using conventional 
1
H NMR 
spectroscopy. Each NMR experiment required approximately 5 min to acquire. At the end of 
the experiment all animals were sacrificed and tissues (liver, kidney, spleen, ileum, jejunum, 
and colon) were obtained for 
1
H magic angle spinning (MAS) NMR analysis. All samples 
were stored frozen at -80°C prior to analysis by 
1
H NMR spectroscopy or MS. A suite of 
multivariate statistical methods beginning with unsupervised methods, such as PCA, and 
progressing to supervised approaches, such as PLS-DA, were used to analyze the spectra. 
 
4.4.3  Biomarker identification and diagnostic potential of biofluids in an Echinostoma 
caproni infection 
Characteristic spectral profiles of several mammalian biofluids are already well established, 
including those of urine, plasma and faecal water extracts 
99-104
. Urine and plasma have 
already been assessed for their diagnostic potential in various single parasite-rodent models 
including Schistosoma mansoni 
105
, Schistosoma japonicum 
106
, Trypanosoma brucei brucei 
96
, Trichinella spiralis 
107
 and Plasmodium berghei (Li et al. submitted).  
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Figure 4.4. Schematic draft of the experimental protocol used to acquire biological samples from mice 
infected with E. caproni for metabolic profiling 
 
More recently, faecal water composition in relation to physiological variation and 
characterization has been assessed in more detail 
108, 109
. 
These biofluids are relatively straightforward to obtain in a minimally invasive manner, and 
are present in reasonably large quantities. Hence, these biofluids can serve as suitable 
biological matrices for disease diagnostics. Furthermore, urine, plasma and stool are to some 
extent representative of the organism as a whole, as they reflect to a high degree malfunctions 
and impaired homoeostasis in metabolic composition. Typical metabolites detected in each of 
these three types of biological samples are listed in Table 4.2. In the E. caproni-mouse model, 
all three biological samples were found to alter with infection and progressive changes in the 
spectral profiles were monitored over time. Alterations in the metabolic composition of the  
samples reflect the response of the host organism as it strives to compensate for the invasion 
of the parasite and maintain homeostatic control.  
Collection of 
biological samples        
days 1, 5, 8, 12, 19, 
26, 33 post-infection
Collection of 
tissues on day 
35 post-infection
Acclimatization of mice 
for 1 week
Infection with 30               
E. caproni metacercariae & 
uninfected control group
Microbial monitoring 
Physiological 
monitoring               
*PCV, weight
Sample preparation MS/NMR
Data aqcuisition MS/NMR
Unsupervised analysis  
PCA
Supervised analysis              
O-PLS-DA
Identification of candidate 
biomarkers
Histopathology
* Packed cell volume
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Plasma. The strongest differentiation of the E. caproni-infected group of mice occurred 
between days 12 and 26 post-infection, and the most striking differences related to increases 
in the concentrations of lipoproteins, triacylglycerols, and saturated and unsaturated fatty 
acids after day 12 post-infection. This observation is consistent with the well documented 
degradation of biological membranes by this intestinal fluke 
110
. Other infection-related 
changes included a depletion of the branched chain amino acids (BCAAs; e.g., leucine, 
isoleucine, and valine) and choline/glycerophosphocholine. 
Urine. Urine has been emphasised to represent an ideal diagnostic template 
111, 112
, as it 
collects the waste products of the whole organism, and can reflect the metabolic status of an 
individual to a high degree. Some urinary biomarkers can be directly related to kidney failure, 
organ damage, nutrient uptake, microbiotal composition, etc. 
91, 113
. Urine is relatively easy to 
obtain and probably the best metabolically characterised biological template at all 
99, 102-104
. 
E. caproni-infected mice showed decreased levels of 2-ketoisocaproate, which could be due 
to the depletion of leucine in plasma, which acts as precursor in a transamination reaction 
114
. 
Significantly lower levels of urinary taurine was a consistent feature in infected mice and is 
likely to derive from the high level of lipid degradation in the gut, caused by E. caproni, thus 
creating a higher demand for lipid digestion. As taurine is involved in bile acid conjugation 
and fat emulsification, it is likely that the urinary depletion of the compound is due to the 
higher demand. Taurine is conjugated with chenodeoxycholic acid and cholic acid in the liver, 
where primary bile salts are formed and excreted in urine. Deconjugation of taurine happens 
via gut bacterial species, after the lipids formed a micellar form together with the bile salts, in 
order to cross the intestinal wall. Hepatic taurine is then absorbed by the blood circulation 
115
. 
It is conceivable that an infection with intestinal flukes results in changes in the bacterial 
composition due to the close proximity and direct influence of E. caproni. Indeed, the most 
prevalent alterations in the urine profile were the relative concentrations of gut microbial 
synthesized compounds, such as decreased 2-ketoisocaproate, acetate, hippurate, and 
increased phenylacetylglycine, p-cresol glucuronide and, trimethylamine. The specific change 
in p-cresol glucuronide is likely to reflect an alteration in either the presence or activity of 
Clostridium subspecies, as p-cresol is a known metabolite of both, C. difficile and 
C. scatologenes 
116, 117
. 
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Table 4.2. List of metabolites found in urine (ur), plasma (pl) and stool (st) of 7-8 week-old mice (NMRI strain, 
female mice) 
 
 
 
Metabolite Coupling pattern (Hz) δ (ppm) Biofluid
2-hydroxyisobutyrate 2xCH3 1.36 (s) ur
2-hydroxyisovalerate α-CH, β-CH, γ-CH3, γ'-CH3 3.85(d), 2.02(m), 0.79(d), 0.84(d) st
2-ketoisocaproate α-CH, β-CH, γ-CH3, γ'-CH3 3.85(d), 2.02(m), 0.79(d), 0.84(d) ur, st
2-ketoisovalerate CH, 2xCH3 3.02(m), 1.13(d) pl, st
2-oxoglutarate β-CH2,  γ-CH2 3.02(t), 2.5 (t) ur
3-aminopropionate (β-alanine) NCH2, CH2COOH 3.19 (t), 2.56 (t) st
3-hydroxybutyrate half α-CH2, half α-CH2, β-CH, γ-CH3 2.32 (m), 2.42 (m), 4.16 (m),1.21 (d) pl
3-hydroxyphenyl propionic acid α-CH2,  β-CH2, 2-CH 2.47 (t), 2.85 (t), 6.8 (m) st
3-methyl-2-oxovalerate 
β-CH, half γ-CH2,  half γ-CH2, γ-CH3, β-CH3 2.93(m), 1.7(m), 1.46(m), 0.9(t), 1.1(d)
st
5-aminovalerate 5-CH2, 2-CH2, 3,4-CH2 3.02 (t), 2.24 (t), 1.65 (m) st
acetate CH3 1.91(s) pl, ur, st
acetoacetate α-CH2, γ-CH3, 2.29 (s), 3.45 (s) pl
alanine α-CH, β-CH3 3.81(q), 1.48(d) pl, ur, st
allantoin CH 5.4 (s) pl, ur
arginine α-CH, β-CH2, γ-CH2, δ-CH2, 3.76(t), 1.89(m), 1.59(m), 3.17(t) st
asparagine α-CH, half β-CH2, half β-CH2 4.01(m), 2.87(dd),2.96(dd) st
aspartate α-CH, half β-CH2, half β-CH2, 3.92(m), 2.70(m),2.81(m) st
bile acids CH3 0.7 (m) st
butyrate  α-CH2, β-CH2, γ-CH3 2.16(t), 1.56(m),0.9(t) st
choline 3xCH3, α-CH2, β-CH2 3.21 (s), 4.07 (m), 3.52 (m) pl
citrate 1-CH2, 3-CH2 2.69 (d), 2.54 (d) pl, ur, st
creatine CH3, CH2 3.04 (s), 3.93 (s) pl, ur, st
creatinine CH3, CH2 3.05 (s), 4.06 (s) ur
dihydroxythymine CH2, CH, CH3 3.17 (m), 2.47 (m), 1.07 (d) pl
dimethylamine 2xCH3 2.71 (s) ur
dimethylglycine 2xCH3, CH2 2.89(s), 3.71(s) ur
ethanolamine NH-CH2, HO-CH2 3.15(t), 3.78(t) st
formate CH 8.45 (s) pl, ur, st
fumarate CH 6.53 (s) st, ur
glutamate α-CH, β-CH2, γ-CH2 3.78(m), 2.06(m), 2.36(m) st
glutamine α-CH, β-CH2, γ-CH2 3.78(m), 2.15(m), 2.46(m) st
glycerol half α,γ-CH2, half α,γ-CH2, β-CH 3.56 (dd), 3.64 (dd), 3.87 (m) st
glycerophosphocholine
3xCH3, half α-CH2, half α-CH2, half β-CH2, 
half β-CH2, γ-CH2
3.23 (s), 4.32 (t), 3.6(dd), 3.68(t), 3.89(m), 
3.72(dd) pl
glycine CH2 3.55(s) st
glycolate CH2 3.94 (s) ur
guanidinoacetate CH2 3.8 (s) ur
hippurate CH2, 2,6-CH, 3,5-CH, 4-CH 3.97 (d), 7.84 (d), 7.55 (t), 7.64 (t) ur
hypoxanthine 3-CH, 7-CH  8.099 (s), 8.11 (s) st
indoxylsulfate 5-CH, 6-CH, 4-CH, 7-CH 7.2 (t), 7.27 (t), 7.51 (d), 7.7 (d) ur
isoleucine α-CH, β-CH, half γ-CH2, half γ-CH2, δ-CH3, 
β-CH3, 
3.68(d), 1.93(m), 1.25(m),1.47(m), 0.99(d), 
1.02(d)
pl, st
lactate CH, CH3 4.12(q), 1.33(d) pl, ur, st
leucine
α-CH, β-CH2, γ-CH, δ-CH3, δ-CH3
3.72(t), 1.96(m),1.63(m), 1.69(m), 0.91(d), 
0.94(d)
pl, st
lysine α-CH, β-CH2, γ-CH2, δ-CH2, ε-CH2 3.77(t), 1.92(m), 1.73(m), 1.47(m), 3.05(t) st
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Table 4.2. (continued) 
 
p-cresol is taken up by the blood stream where it binds to serum proteins and is later excreted, 
after conjugation with glucuronic acid in the liver and kidney 
118
. Other bacteria in the gut 
degrade dietary choline and carnitine to trimethylamine (TMA) which is then oxidized further 
in the liver to trimethylamine-N-oxide (TMAO) 
119, 120
. Again, an E. caproni-induced change 
of the microbiotal community is suggested by the disturbance of the TMA and TMAO 
equilibrium in urine and the subsequent depletion of choline/glycerophosphocholine in the 
plasma. 
Metabolite Coupling pattern (Hz) δ (ppm) Biofluid
mannitol α-CH2, β-CH. γ-CH 3.78(m), 3.88(dd), 3.68(dd) ur
methanol CH3 3.36 (s) pl
methionine α-CH, β-CH2, γ-CH2, CH3 3.87(m), 2.10(m), 2.65(dd), 2.15(s) pl, st
methyl crotonate CH, CH3, CH3 5.65(s), 1.70(s), 1.71(s) ur
methylamine CH3  2.61 (s) ur
methylguanidine CH3 2.83 (s) ur
myoinositol 1,3-CH, 2-CH, 5-CH, 4,6-CH 3.53(dd), 4.06(t), 3.28(t), 3.63(t) st
N -methyl-nicotinamide CH3, 6-CH, 2-CH, 5-CH, 4-CH 4.48 (s), 8.97 (d), 9.28 (s), 8.19 (t), 8.9 (d) ur
p -cresolglucuronide 2-Ch, 6-CH, 3-CH ,5-CH, 7.06(d), 7.23(d), 2.3(s), 5.07(d) ur
phenylacetic acid CH2, 2,6-CH, 3,5-CH 3.52 (s), 7.29 (t), 7.36 (t) st
phenylacetylglycine 2,6-CH, 3,5-CH, 4-CH, ArCH2, NCH2 7.43 (m), 7.36 (s), 7.37 (m), 3.75 (d), 3.68 (s) ur
phenylalanine 2,6-CH, 3,5-CH, 4-CH, CH2, CH 7.44(m), 7.39(m), 7.33(m), 3.17(dd),3.30(dd), 
3.99(dd)
st
proline α-CH, half β-CH2, half β-CH2, γ-CH2, δ-CH2 4.15(dd), 2.05(m),2.38(m), 2.00(m), 3.39(m)
st
propionate CH2, CH3 2.19(q), 1.06(t) st
pyridoxamine-5-phosphate OCH2, CH2N, CH3 7.67 (s),4.34 (s), 2.48 (s) ur
scyllo -inositol 6xCH 3.35 (s) pl
succinate 2x CH2 2.41 (s) ur, st
taurine CH2N, CH2S 3.27 (t), 3.43 (t) ur
threonine α-CH, β-CH, γ-CH3 3.60(d), 4.26(m), 1.33(d) st
trimethylamine 3xCH3 2.88 (s) ur
trimethylamine-N -oxide 3xCH3 3.27 (s) ur
tryptophan 4-CH, 7-CH, 2-CH, 5-CH, 6-CH,α-CH, half 
β-CH2, half β-CH2
7.79(d), 7.56(d), 7.34(s), 7.29(t), 7.21(t), 
4.06(dd), 3.49(dd),3.31(dd)
st
tyrosine 2,6-CH, 3,5-CH, CH2, α-CH 7.23(d), 6.91(d), 2.93(t), 3.25(t) st
uracil 5-CH, 6-CH 5.81(d), 7.59(d) t
ureidopropanoate α-CH2, β-CH2 2.38 (t), 3.3 (t) ur
urocanate α-CH, β-CH, 5-CH, 2-CH 6.4(d), 7.13(d), 7.41(s), 7.89(s) ur, st
valine α-CH, β-CH, γ-CH3, γ'-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d) pl, st
α-glucose
1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-
CH2, half 6-CH2
5.24(d), 3.56 (dd), 3.7(t), 3.4(t), 3.83(m), 
3.72(dd), 3.85(m) pl, ur, st
β-glucose
1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-
CH2, half 6-CH2
4.65(d), 3.25 (dd), 3.47(t), 3.4(t), 3.47(ddd), 
3.78(dd), 3.9(dd) pl, ur, st
lipids fractions CH3 0.84 (t) pl
(CH2)n 1.25 (m) pl
β-CH2CH2CO 1.57 (m) pl
CH2C=C 1.97 (m), 2.00 (m) pl
CH2CO 2.23 (m) pl
C=CCH2C=C 2.69 (m), 2.71 (m), 2.72 (m) pl
CH=CH 5.23 (m), 5.26 (m), 5.29 (m) pl
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The results generated by multivariate data analysis can be ordered chronologically to display 
the metabolic response in a host-parasite model over the duration of the time course of 
infection. This can be a useful tool in characterizing the stage of an infection and may provide 
useful information in determining a therapeutic strategy for disease management. An example 
of such a response or ―trajectory‖ is depicted in Fig 4.5, which illustrates the evolving 
response in the urine profile. Key features include decreased levels of hippurate, 2-
ketoisocaproate, and taurine, and subsequent increases in trimethylamine, p-cresol 
glucuronide, TMAO, and phenylacetylglycine. 
Stool. As with the urine profiles, the faecal water samples from mice infected with E. caproni 
were characterised by alteration in gut microbial metabolites. Spectra from faecal extracts 
contained bile acids, the short chain fatty acids (SCFAs) butyrate, acetate, and propionate, and 
the amino acids including lysine, arginine, tryptophan and glutamine, amongst others which 
were also present in plasma and/or urine (Table 4.2). 
 
 
Figure 4.5. 2D and 3D time trajectory of urine samples from E. caproni-infected mice obtained from 
the mean PC1 and PC2 values over a 33-day time period. Biological samples were collected at secen 
time points postinfection (e.g., days 1, 5, 8, 12, 19, 26, and 33). The error bars reflect two standard 
deviations of the mean 
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Nearly all changes observed in the faecal samples due to an experimental infection with 
E. caproni can be attributed to a changed gut microbial composition. The SCFAs (e.g., 
propionate, butyrate, and acetate) are produced by colonic bacteria via fermentation, and 
undergo a decrease in the faecal samples of infected animals compared to the non-infected 
control group. Acetate is the main SCFA in the colon, and is, together with propionate, taken 
up into the peripheral blood circulation where they have antagonistic functions in cholesterol 
synthesis, e.g., acetate increases, whilst propionate is known to decrease synthesis. Butyrate is 
the main source of energy for the colonic mucosa 
121
. The changed gut microbiota is also 
reflected in the increased concentration of 5-aminovalerate in infected animals, which is 
normally degraded by a Clostridium subspecies (e.g., C. aminovalericum) to propionate and 
acetate 
122, 123
. The increase of the metabolite could indicate a depletion of this sub-strain. 
Increased levels of the BCAAs in stool are due to malabsorption caused by the parasite. 
Utility of biofluids as a matrix for diagnostics. Based on our findings with the E. caproni-
mouse model, the combination of all three assessed biofluids would deliver the most 
comprehensive metabolic fingerprint, and would reflect the overall picture of the infection 
impact, most accurately (Saric et al. submitted). However, in reality it is more conceivable to 
select the most suitable template and to further optimize it, since collection of all three 
biofluids in human populations may not always be practical. Comparing the three biofluids in 
terms of their biomarker potential, plasma would be the diagnostic matrix of choice in terms 
of biomarker quantity. Urine also has good potential, with 10 identified biomarkers and this 
biofluid is particularly convenient for sample collection. Faecal samples would be the least 
suitable template, as the inter- and intra-individual variation in healthy individuals is already 
considerable, which might be due to the extremely variable dynamics over time and diversity 
of bacterial strains in general. 
 
4.4.4 Biomarker identification in tissue via MAS 
1
H NMR spectroscopy 
MAS NMR spectroscopy allows solid and semi-solid tissues to be profiled (Andrew 1959). 
The utility of this technology lies mainly in the evaluation in disease mechanisms in animal 
models, since it is a necessarily invasive approach. However, under some circumstances, e.g., 
differentiation of benign and malignant tumors, it is a potentially valuable clinical tool. Since 
candidate biomarkers identified in biofluids such as urine or plasma can originate from 
different tissues or organs, direct analysis of these tissues can provide a better understanding  
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of the etiology of the biomarker. Each tissue has a characteristic and unique metabolic profile 
reflecting the different cellular structures and functions specific to that tissue. 
Kidney. The heterogeneous structure of the kidney is reflected in the region specific 
metabolic profiles. The cortex and medulla both contain various amino acids, e.g., 
glutamate/glutamine, aspartate, lysine, threonine, the aromatic amino acids phenylalanine, 
tyrosine, and the BCAAs (Fig 4.6A). However, characteristic for the renal medulla is the 
presence of higher concentrations of various osmolytes, like taurine, betaine, myo- and scyllo-
inositol, together with glucose, choline, glycerophosphocholine (GPC), phosphocholine, and 
creatine. Analysis of E. caproni-infected and non-infected control animals showed no 
difference in the biochemical composition of the renal medulla, whilst the cortex manifested 
in increase of alanine, glutamate, aspartate, and scyllo-inositol in infected animals. GPC was 
found to be in lower concentrations in the renal cortex of infected mice, which could reflect 
the decrease of the metabolite in the plasma, but could also indicate a changed ionic cellular 
environment, e.g., NaCl, as GPC uptake into cells is known to be increased in case of high 
tonicity outside the cell membrane 
124, 125
. Other osmotically active substances like betaine 
and inositols, e.g. scyllo-inositol, are found in kidney, but also in other organs such as the 
brain or liver are known to change inversely with the GPC concentration. In fact, infection 
with E. caproni appeared to be positively associated with scyllo-inositol concentrations in the 
cortical part of the kidney. Amino acid re-absorption occurs predominantly in the proximal 
tubules of the kidney. The dicarboxylic amino acids glutamate and aspartate have separate 
carrier molecules, whilst alanine belongs to the neutral amino acids, which are carried by 
specific transporters 
126, 127
. 
It is probable that the resulting immune response, initiated by the infection, plays a central 
role in the renal amino acid changes, namely cytokines and antigen-antibody complexes, 
which circulate through the kidney. In the literature, the immunological consequence of an 
infection with E. caproni seems to be inconsistent, based on the varying ratio of T-helper cell 
subgroups (e.g., TH1/TH2), which is partially responsible for the establishment of an infection, 
and induces different groups of cytokines and immunoglobulin 
128
. However, both, antibody-
antigen complexes as well as cytokines are known to be involved in pathological processes in 
the kidney, and are likely to induce minor biochemical changes. 
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Figure 4.6. Typical 600-MHz 1H-1D spectra of four selected tissues of an uninfected control mouse, 
aged 11 weeks; (a) kidney cortex), (b) liver, (c) spleen, and (d) ileum. Key: gpc, 
glycerophosphocholine; bcaa, branched chain amino acids 
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Secretory products of E. caproni, could hypothetically act as renal stimulator as well, but due 
to low concentration in plasma the compounds would be below detection limit of NMR and 
were therefore not detected.  
Liver. Phosphocholine and betaine were present in significantly higher concentrations in the 
liver of E. caproni-infected mice. However, choline and GPC levels, which are in the same 
pathway, remained unaffected. We speculate that the increased amount of free amino acids 
and triacylglycerols in plasma is taken up into the hepatic cell in the form of 
phosphatidylcholine, degraded to GPC and subsequently to choline with the same rate of 
turnover. In a further degradation step choline is converted to betaine (irreversible) and 
phosphocholine, which are present in relatively higher levels in the liver of infected mice, 
compared to the non-infected control animals 
129, 130
. 
Spleen. In accordance with the studies of Brunet et al. 
128
, where the mesenteric lymph nodes 
showed immunologic activity as response to an infection with E. caproni, but not the spleen, 
no infection-related changes in metabolic composition were observed in the spleen. 
 
4.4.5 Changes in the intestinal profiles 
The metabolic monitoring of the gut is of particular interest after an infection with an 
intestinal fluke for obvious reasons. On the one hand, there is well documented structural 
damage following an infection with E. caproni, whereby the most obvious histopathological 
changes in the host derived from the direct action of the fluke, which remains after 
excystation in ICR mice, for 8 weeks in the jejunum and ileum of the small intestinal part, and 
then shifts to duodenum and jejunum, which is more anterior 
13
. 
On the other hand, analysis of the biofluids indicated a strong infection-induced effect on 
the host microflora. Indeed, it is unthinkable that a parasitic worm, living in such proximity to 
the microbial community, would not influence the dynamics of the microorganisms in one 
way or another, which in turn bears potential consequences for the intestinal tissue in 
particular, and the whole organism in general. 
Jejenum and ileum are functionally and histologically quite similar, with the main 
difference that the ileum contains the highest density of the Peyer‘s patches, which are 
immunologically active sites. The jejunum is larger in diameter, and hence its overall 
absorptive capacity is higher than that of the ileum. Digestion is completed in the small 
intestine and the products and fluids are absorbed. In contrast, the colon (large intestine) bears  
Use of Echinostoma spp. in studies 
104 
 
 
the highest density of bacteria and is the major site for fermentation of dietary carbohydrates 
to SCFAs (e.g., butyrate, acetate, and propionate). Acetate is known to increase the colonic 
blood flow and is the main SCFA in the colon. It enters the blood circulation and can be taken 
up by muscle cells (e.g. longitudinal muscle of the small intestine) in order to generate 
energy, whilst propionate is taken up by the liver cells as substrate for gluconeogenesis. 
Butyrate is the main energy source for colonocytes 
121
. Comparing the spectral profiles of the 
two parts of the small intestine (jejunum and ileum) with the large intestine, the SCFAs 
account for the main difference. Butyrate and propionate were only found in colon spectra, 
whilst acetate was a feature of all three regions of the gut, but was found in much higher 
relative concentrations in colon than in ileum/jejunum. The characteristic spectral 
composition for non-infected tissues for ileum is illustrated in Figs 4.6D and 4.7. 
 
 
Figure 4.7. MAS 600 MHz 
1
H-
1
H 2D TOCSY spectra of ileum from an uninfected control mouse. 
Key: ala, alanine; asp, asparagine; cho, choline; eth, ethanolamine; glu, glutamate; gpc, 
glycerophosphocholine; lac, lactate; leu, leucine; lip, lipid; lys, lysine; met, methionine; tau, taurine; 
thr, threonine; val, valine 
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All three parts of the gut showed significantly different metabolite profiles between infected 
and non-infected animals with the greatest effect on ileum where a disturbance of the 
intestinal transport (e.g. a disturbed Na
+
 electrochemical gradient) was evident. Increased 
tissue concentration of glucose was found in the ileum, which is consistent with the 
documented increase in serum mucosal flux induced by pro-inflammatory cytokines such as 
IL-1α, IL-6, and IL-8, which leads to an increased uptake of glucose into the ileal cells via the 
sodium-glucose linked co-transporter (SGLT1) 
126, 127
. The high uptake rate of glucose 
resulted in lower concentrations of glycine in infected animals, due to a glucose competitive 
mechanism 
131
. Further metabolic change included a decrease in tissue concentration of 
ascorbate, alanine, glutamine, aspartate, isoleucine, and valine, in the ileum of infected 
animals 36 days post-infection. This may be associated with inhibition of transporters, 
including SLC1A1 (excitatory amino acid carrier), B
0
AT1/SLC6A19 (neutral amino acid 
transport system), and SVCT1 (ascorbic acid transporter) which are known to regulate the 
uptake of anionic amino acids (aspartate), neutral amino acids, and the ascorbate, respectively 
127
. Additionally, the E. caproni-induced hypertrophy leads to an increased consumption of 
glutamine in the intestinal, over-proliferating cells and thus contributes to the depletion of 
glutamine stores in the ileum 
15, 132
. 
The two aromatic amino acids tyrosine and phenylalanine were increased in jejunum, but 
even though they share the same mechanism of re-absorption as the other neutral amino acids, 
which were depleted in ileum, their increase appears to contradict to a higher demand in the 
jejenal tissue, rather than a disturbed electrochemical gradient. 
The observed decrease on myo-inositol signals in the metabolic profiles results from 
mechanic disruption of the intestinal mucosa cells. Myo-inositol, taurine and betaine are small 
organic solutes, which are kept in the cell to maintain osmotic homoeostasis. This is 
obviously important in intestinal epithelia cells due to the digestive activities, which can 
potentially induce a hypertonic condition 
133, 134
. Increased levels of trimethylamine were 
observed in the colon of infected animals, which together with increased urinary excretion, 
would appear to indicate a general increase in the production of this metabolite 
119, 120
. 
 
 
 
 
Use of Echinostoma spp. in studies 
106 
 
 
4.4.6 Integrative metabonomics: an approach to understand host-parasite-gut microbiota 
interactions 
The direct impact of a pathological agent on an individual tissue can be ascertained by 
histology or by measurement, for example, of inflammatory markers. However, pathologies 
rarely target single organs and in order to achieve an accurate mechanistic understanding of 
how a disease progresses, it is usually necessary to evaluate the response of an organism 
across several physiological compartments. The application of metabolic profiling allows the 
extraction of latent information derived from numerous biofluid and tissue matrices and by 
integration of this knowledge can deliver a holistic framework of responses at a global 
systems level. 
 
Echinostoma caproni-induced consequences on osmotic micro-environment and cross-
cellular transport. Various osmotically active substances showed changes in relative 
concentrations during the course of an E. caproni infection, such as betaine which increased 
in the liver, scyllo-inositol (increased), and GPC in the kidney (decreased), and myo-inositol 
in jejunum which decreased. All those metabolites serve as osmotic regulators in the tissue 
cells, whereas GPC is the only osmolyte in which uptake into the cell is induced by high NaCl 
levels. Thus the lower GPC levels could be either due to the changed tonicity (NaCl to water 
ratio) or directly relatable to the depletion of plasma concentrations. However, its decrease 
seems to induce an increased intracellular concentration of scyllo-inositol in the renal tubes, 
which is known to change concentration inversely to GPC. The decrease of myo-inositol in 
the ileum is probably due to mechanic disruption of the intestinal mucosa cells, rather than 
due to osmotic necessity, as this would imply a higher uptake of an osmolyte to increase the 
cell influx of liquid and subsequently nutrients. 
In the gut, it appears that the Na
+
-dependent transport is disturbed, which may be due to 
disruption of the NaCl concentration with the resulting changes in membrane potential and 
gradient, which regulate carrier-dependent as well as independent transport. The 
malabsorption of the anionic amino acids aspartate, ascorbate and the neutral amino acids 
alanine, isoleucine, and valine, perhaps indicates inhibition of specific Na
+
-dependent 
transporters, such as SLC1A1, SVCT1, and B
0
AT1/SLC6A19. 
In the renal cortex increased tissue concentrations of aspartate, glutamate, and alanine showed 
an increased concentration. Specifically, Na
+
-dependent carrier molecules for transport of the  
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two dicarboxylic amino acids aspartate and glutamate seem to be impaired in the infection 
with E. caproni. 
Holistic influence of the gut microbiota. Trimethylamine increased in urine and colon of 
E. caproni-infected mice, which implies an increased synthesis in infected animals, compared 
to the healthy state of the rodent. As compensation to this overproduction, both colonic uptake 
and urinary excretion are increased.A shift in the microbial composition toward bacterial 
species, which are able to degrade trimethylammonium compounds like choline, carnitine, or 
GPC to TMA with further oxidation to TMAO, could explain the increase of the TMA and 
TMAO in urine, as well as the depletion of choline and GPC in plasma. On the other hand, 
this microbial shift is unlikely to contribute to the changed concentrations of GPC in the 
kidney and phosphocholine in the liver, respectively, as the osmotic imbalance in the former 
and the higher rate of lipid degradation in the latter will outweigh the microbial contribution. 
Interestingly, the decrease of the SCFAs in the faecal samples of E. caproni-infected mice is 
not reflected in any of the assessed gut tissues, whereas, particularly in the case of colon, a 
reduced propionate, acetate and butyrate concentration would be expected to mirror the 
decrease in the feces. Acetate was the only urinary SCFA which demonstrated a subsequent 
depletion. 
The presence of an intestinal fluke would be expected to have a considerable impact on the 
microbial community of the gut because of the proximity and thus direct interaction of the 
fluke and bacterial colonies. Yet, our integrated data suggest that the overall expression of 
metabolites, which are related to a changed gut microbiota, is not stronger compared to two 
previously assessed blood fluke-rodent models; indeed S. mansoni-infected mice and S. 
japonicum-infected hamsters showed the same urinary pattern of gut microbial modified 
metabolites, including changes in hippurate and trimethylamine 
105, 106
. 
Metabolite flow through different physiological compartments. It is possible to monitor 
some of the metabolic changes across different physiological compartments. Most of these 
changes have their origin in the malabsorption of the ileum, such as isoleucine and valine, 
which are excreted in the feces in higher concentrations and thus, show lower levels in ileum 
and plasma. Also alanine and aspartate seem to be absorbed at lower rate in the ileum, but are 
increased in the kidney. Glucose, in contrast, shows increased levels in the ileum, which 
reflects in higher uptake from the blood circulation at the beginning of the infection. The 
marked decrease of plasmatic leucine, probably induces the relatively lower levels of 2- 
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ketoisocaproate in urine, as it is a transamination product of the former, in the urine 
114
.
 
Finally, creatine is excreted in higher amounts in urine, reflecting the depletion in plasma. 
A further use of metabolic profiling is the characterization of the parasite itself. The main 
biochemical components of E. caproni consisted of creatine, taurine, and betaine and the 
primary excretion products released in the intestinal are free fatty acids and sterols 
135
. It is 
possible that the fluke-derived compounds affect the metabolic profile in the host. However, 
since we illustrate a protocol using an infection with the intestinal fluke with an average of 28 
worms counted upon dissection of infected mice, the host weight to parasite mass ratio would 
be approximately 300:1, thus it is unlikely to see a contribution of those excretory products in 
the host organism. 
 
4.5 Concluding remarks  
The pressing need for novel trematocidal drugs has been emphasised 
136
. We have 
summarized different studies that have demonstrated that the E. caproni-mouse model and 
Echinostoma cultured in vitro are useful tools for trematocidal drug discovery. 
Metabolic profiling of an array of biological samples derived from mice infected with 
E. caproni demonstrates a novel angle for diagnosis in parasitology. A variety of disease-
specific biomarkers have been demonstrated, and the approach is non-invasive and highly 
efficient. Furthermore, the potential of metabolic profiling to recover metabolic information in 
nearly every physiological compartment of a host organism allows cross-linking different 
pathological events and delivers a global picture of disease, which makes it a promising tool 
in systems biology for the purpose of infection diagnosis and eventually will provide 
opportunities for monitoring response to trematocidal agents.  
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5.1  Abstract 
Background. Metabolic profiling holds promise with regard to deepening our understanding 
of infection biology and disease states. The objectives of our study were to assess the global 
metabolic responses to an Echinostoma caproni infection in the mouse, and to compare the 
biomarkers extracted from different biofluids (plasma, stool, and urine) in terms of 
characterizing acute and chronic stages of this intestinal fluke infection. 
Methodology/Principle Findings. Twelve female NMRI mice were infected with 30 
E. caproni metacercariae each. Plasma, stool and urine samples were collected at 7 time 
points up to day 33 post-infection. Samples were also obtained from non-infected control 
mice at the same time points and measured using 
1
H nuclear magnetic resonance (NMR) 
spectroscopy. Spectral data were subjected to multivariate statistical analyses. In plasma and 
urine, an altered metabolic profile was already evident 1 day post-infection, characterised by 
reduced levels of plasma choline, acetate, formate and lactate, coupled with increased levels 
of plasma glucose, and relatively lower concentrations of urinary creatine. 
Conclusion/Significance. The current investigation is part of a broader NMR-based 
metabonomics profiling strategy and confirms the utility of this approach for biomarker 
discovery. In the case of E. caproni, a diagnosis based on all three biofluids would deliver the 
most comprehensive fingerprint of an infection. For practical purposes, however, future 
diagnosis might aim at a single biofluid, in which case urine would be chosen for further 
investigation, based on quantity of biomarkers, ease of sampling, and the degree of 
differentiation from the non-infected control group. 
 
Keywords: Echinostoma caproni, diagnosis, NMR spectroscopy, metabonomics, biomarker, 
multivariate data analysis 
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5.2 Author Summary 
Consumption of raw fish and other freshwater products can lead to unpleasant worm 
infections. Indeed, such worm infections are of growing public health and veterinary concern, 
but they are often neglected, partially explained by the difficulty of accurate diagnosis. In the 
present study we infected 12 mice with an intestinal worm (i.e., Echinostoma caproni) and 
collected blood, stool and urine samples 7 times between 1 and 33 days after the infection. At 
the same time points, blood, stool and urine were also sampled from 12 uninfected mice. 
These biofluid samples were examined with a spectrometer and data were analyzed with a 
multivariate approach. We observed important differences between the infected and the 
uninfected control animals. For example, we found an increased level of branched chain 
amino acids in the stool of infected mice and subsequent depletion in blood plasma. 
Additionally, we observed changes related to a disturbed intestinal bacterial composition, 
particularly in urine and stool. The combination of results from the three types of biofluids 
gave the most comprehensive characterization of an E. caproni infection in the mouse. Urine 
would be the biofluid of choice because the ease of sample collection and the high number 
and extent of changed metabolites. 
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5.3 Introduction 
An estimated 40 million individuals are infected with food-borne trematodes and, in many 
parts of the world, the diseases caused by these infections are emerging [1]. Yet, food-borne 
trematodiases are so-called neglected tropical diseases [2]. An infection with food-borne 
trematodes is acquired by the consumption of the larval stage of the parasite, present in 
aquatic food products (e.g., freshwater fish, crustacean, and water plants). Adult flukes reside 
either in the intestine (e.g., Echinostoma spp.), the lung (e.g., Paragonimus spp.), or the liver 
(e.g., Clonorchis sinensis, Fasciola spp., Opisthorchis spp.) and can lead to various forms of 
pathology [2,3]. 
A light infection with the intestinal fluke Echinostoma spp. in humans causes no marked 
deviation from the healthy state in the majority of cases, whereas the clinical symptoms due to 
a heavy infection include abdominal pain, violent diarrhea, anorexia, easy fatigue, and 
changes in the intestinal architecture, such as intestinal erosions, damage of intestinal mucosa, 
and catarrhal inflammation [4]. Histopathological investigations in mice and humans infected 
with Echinostoma spp. have revealed atrophied, fused and eroded villi, and a crypt 
hyperplasia in both lightly and heavily infected subjects [5-7]. 
At present, the most widely used diagnosis for infections with Echinostoma spp. and other 
food-borne trematodes, is by means of microscopic examination of stool samples for the 
presence of parasite eggs. However, light infection intensities, particularly at the onset of 
disease are often missed by this diagnostic approach. In addition, the detection of echinostome 
eggs in stool samples varies greatly due to species-dependent differences in egg laying 
capacity. Other means for diagnosis of food-borne trematode infections include 
immunological and molecular tests, such as the enzyme-linked immunosorbent assay 
(ELISA) [8] or polymerase chain reaction (PCR) [9], which depend on specificity of antigens 
and primers, respectively. 
In the current study we applied a combination of 
1
H nuclear magnetic resonance (NMR) 
spectroscopy and multivariate statistical analysis to identify candidate biomarkers of an 
E. caproni infection and disease states in the mouse, by metabolic profiling of blood plasma, 
stool, and urine samples. E. caproni is a suitable trematode model that has been widely and 
effectively used in the laboratory for drug screening, and to deepen our understanding of the 
immunology and pathology of echinostomes and other food-borne trematodes in the  
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vertebrate host [10-12]. NMR spectroscopy delivers a snapshot of the metabolite composition 
in biofluids, tissues and even bone/cartilage, and has found a large array of applications in 
biology and medicine, such as the detection and differentiation of coronary heart disease [13], 
and biomarker identification in schizophrenia patients [14]. The systemic metabolic profile of 
a biological sample is of special interest, because it can be characteristic of the entire 
organism, and hence finds increasing application in systems biology [15]. The use of 
multivariate statistical methods to analyze and interpret complex spectral datasets makes it 
possible to deal with large sample data banks, and to detect differences between 
physiologically or pathologically distinct states. Candidate biomarkers can be identified from 
these models, taking into consideration intra-group variations, sample preparation methods, 
and spectral data acquisition. Thus far, we have characterised the global metabolic responses 
to several parasitic infections in rodents, namely (i) Schistosoma mansoni in the mouse [16], 
(ii) S. japonicum in the hamster [17], (iii) Trichinella spiralis in the mouse [18], (iv) 
Trypanosoma brucei brucei in the mouse [19], and (v) Plasmodium berghei in the mouse 
(J.V. Li et al., unpublished data), mainly based on the urine and/or blood plasma metabolite 
profiles. Here we extend these initial host-parasite models to consider the relative merit of 
using biomarkers derived from a combined biological sample profile, and apply a metabolic 
profiling strategy for the first time to a food-borne trematode. 
 
5.4 Materials and Methods 
E. caproni-mouse model and animal husbandry. Our experiments were carried out in 
accordance with Swiss cantonal and national regulations on animal welfare (permission no. 
2081). Female NMRI mice (n = 24) were purchased from RCC (Itingen, Switzerland), and 
housed in groups of 4 in macrolon cages under environmentally-controlled conditions 
(temperature: ~25°C; humidity: ~70%; light-dark cycle: 12-12 h). Mice had free access to 
commercially available rodent food from Nafag (Gossau, Switzerland) and community tap 
water supply. 
Mice were 5 to 6-week-old at the onset of the experiments and had an average weight of 25.5 
g (standard deviation (SD) = 0.9 g). Half of the mice remained uninfected throughout the 
study and served as controls. The other 12 mice were orally infected with 30 E. caproni 
metacercariae each (provided by B. Fried; Lafayette College, Easton, PA, United States of  
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America) [20] on designated study day 0, which took place 1 week after arrival of animals to 
provide sufficient acclimatization time, and hence minimize stress-related impact on the 
metabolic profiles. Upon dissection of mice at the end of the experiment, however it was 
found that no infection had been established in 4 animals. Therefore these 4 mice were 
excluded from any further analysis. 
Collection of biofluids. Blood plasma, stool and urine samples were collected over a 33-day 
time course at 7 distinct sampling points (days 1, 5, 8, 12, 19, 26, and 33 post-infection), 
representative of different stages in the life of the E. caproni fluke, including acute and 
chronic infection stages. Collection was carried out between 08:00 and 10:00 hours in order to 
avoid potential variation of metabolite concentrations due to diurnal fluctuations. Stool and 
urine samples were collected into Petri dishes by gently rubbing the abdomen of the mice, and 
were immediately transferred into separate Eppendorf tubes and kept at -40°C. Blood samples 
(40-50 μl) were collected from the tail tip of each mouse into haematocrit tubes with sodium 
[Na] heparin-coat. Tubes were placed in a centrifuge (model 1-15, Sigma; Osterode am Harz, 
Germany) operated at 4,000 g for 4 min in order to separate plasma from red blood cells. The 
packed cell volume (PCV), i.e., length of red blood cells column in the microcapillary versus 
total length of blood sample column, was determined and expressed as percentage. 
Subsequently, the plasma fraction (~20 μl) was transferred into a separate Eppendorf tube and 
kept at -40°C. Animals were weighed at each sampling point, using a Mettler balance (model 
K7T; Greifensee, Switzerland). 
Mice were killed 36 days post-infection, using CO2. The small intestine was removed, and 
adult worms recovered from the ileum and jejunum and counted. Biological samples and an 
E. caproni specimen were forwarded to Imperial College London (United Kingdom) on dry 
ice and stored at -40°C prior to processing for 
1
H NMR spectroscopic data acquisition. 
Preparation of biofluids and E. caproni homogenate. Urine samples were prepared with a 
phosphate buffer (pH 7.4) containing 50% D2O (Goss Scientific Instruments; Chelmsford, 
United Kingdom) as a field frequency lock and 0.01% sodium 3-(trimethylsilyl) [2,2,3,3-
2
H4] 
propionate (TSP) (Cambridge Isotope Laboratories Inc.; Andover, MA, United States of 
America), as a chemical shift reference (δ 0.0). An aliquot of 25 μl of urine was added to 25 
μl phosphate buffer. Plasma samples were prepared by adding 30 μl of 0.9% saline made up 
in 50% D2O into the Eppendorf tubes containing ~20 μl of plasma. Because of the limited  
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volumes of urine and plasma, samples were transferred into 1.7 mm micro NMR-tubes 
(CortecNet; Paris, France) using a micro-syringe. 
Stool samples were prepared with the same buffer as for urine but using 90% D2O to reduce 
the water content. Two pellets of stool were mashed with 700 μl buffer and sonicated for 30 
min to inactivate gut bacteria and achieve biochemical stability in the sample. The samples 
were then centrifuged at 13,000 g for 2 min, and 550-600 μl of the supernatant was 
transferred into a new Eppendorf tube and stored at -40°C. Shortly before data acquisition, the 
stool supernatant was defrosted, centrifuged and transferred into NMR tubes of 5 mm outer 
diameter. 
A tissue extraction was performed on the E. caproni specimen for 
1
H NMR spectroscopic 
analysis. The adult E. caproni fluke was mashed in 1 ml of chloroform with a glass mortar 
and pestle. A total of 1 ml of methanol and 1 ml of water were added, and this mixture was 
transferred into a glass tube. Another 0.5 ml of each liquid was used to rinse the mortar and 
transferred into the same glass tube. The mixture was centrifuged at 2,500 g for 30 min. The 
aqueous and the chloroform phases were transferred into a new glass tube each, chloroform 
was evaporated over night and the aqueous phase was lyophilized. Prior to 
1
H NMR data 
acquisition, the powder obtained from the aqueous phase was resolved in 550 μl phosphate 
buffer (90% D2O), whereas the dry mass of the chloroform fraction was dissolved in 
deuterated chloroform (CDCl3). 
Acquisition of spectral data. 
1
H NMR spectra from plasma, stool, and urine samples, and the 
E. caproni homogenate were recorded on a Bruker DRX 600 NMR spectrometer, operating at 
600.13 MHz for proton frequency (Bruker; Rheinstetten, Germany). A Bruker 5 mm triple 
resonance probe with inverse detection was used, employing a standard NMR 1-dimensional 
(1D) experiment with pulse sequence [recycle delay (RD)-90
o
-t1-90
o
-tm-90
o
-ACQ], setting t1 
to 3 μs, and using a mixing time (tm) of 150 ms. Water suppression was achieved with 
irradiation of the water peak during the RD set to 2 s and mixing time. The 90
o
 pulse length 
was adjusted to ~10 s. A total of 256 transients were collected into ~32,000 data points for 
each spectrum with a spectral width of 20 ppm. For plasma, two additional pulse programs 
were applied, namely Carr-Purcell-Meiboom-Gill (CPMG), and diffusion edited spectroscopy 
(DOESY) [21] to focus on the low and high molecular weight components of the plasma 
profile, respectively. All free induction decays (FIDs) were multiplied by an exponential 
function equivalent to a 0.3 Hz line-broadening factor prior to Fourier transformation. 
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Assignments of the spectral peaks were made from literature values [22-25] and confirmed via 
statistical total correlation spectroscopy (STOCSY) in MATLAB [26] and via standard 2-
dimensional (2D) NMR experiments conducted on selected samples, including correlation 
spectroscopy (COSY), total correlation spectroscopy (TOCSY), and J-resolved NMR spectra 
[27,28]. 
Data processing and analysis. Data processing was as follows. First, spectra were corrected 
for phase and baseline distortions with an in-house developed MATLAB script. Second, the 
region containing the water/urea resonances (i.e.,  4.2-6.3 in urine,  4.4-5.2 in plasma, and  
4.7-5.5 in stool extracts) was excluded. Third, the spectra were normalized over the total 
remaining spectral area. Analysis of the spectral data was performed with principal 
component analysis (PCA) [29], projection to latent structure discriminant analysis (PLS-DA) 
and orthogonal (O)-PLS-DA [30]. PCA was used to explore any intrinsic similarity between 
samples. PCA models cannot be over-fitted since no prior information on infection status is 
included in the model. PLS-DA was then used to apply knowledge of infection status to 
optimize separation of classes and recovery of candidate biomarkers [30]. O-PLS-DA 
includes an orthogonal data filter in the PLS-DA and was used to further improve the 
extraction of infection-related biomarkers by removing the influence of systematic variation 
not related to infection status. The weight of contribution of the peaks is indicated by the color 
scale, whereby red symbolizes relatively high correlation with infection and blue indicates 
relatively low or no correlation. The metabolites which contributed the greatest weight to the 
O-PLS-DA coefficient plot were identified.The NMR spectral data were used as the X-matrix 
and class information (infected or non-infected control) as the Y-matrix to build the O-PLS-
DA models. A model consisting of one PLS component and one orthogonal component was 
generated using 7-fold cross validation. Finally, in order to more accurately profile the 
temporal behavior of the discriminatory metabolites characterizing an E. caproni infection, 
computational integration was performed. Resonances from several of the metabolites in each 
sample, which showed infection-dependent variations, were integrated using an automated 
curve fitting program. The relative concentration in relation to the total spectral integral, 
subsequent to removal of the water resonance, was determined. This was performed in 
MATLAB using a previously published method [31], and further modified by a colleague (K. 
Veselkov; Imperial College London, UK). The p-values for the metabolites were assessed 
using a non-parametric 1-way analysis of variance (Mann-Whitney U) test in MATLAB. 
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Figure 5.1. Previous page: Aliphatic region of a representative 600 MHz 1H-NMR 1D spectra of 
biological samples obtained from an uninfected control mouse, aged 7-8 weeks. Spectra of urine (A), 
plasma (B), and faecal water (C) are shown. Additionally, the same region was displayed for the 
extract of an individual E. caproni fluke (D). Key: 2-og, 2-oxoglutarate; 3-hb, 3-hydroxybutyrate; 2-
kic, 2-ketoisocaproate; 2-kiv, 2-ketoisovalerate; β-glu, β-glucose; aa, amino acids; ace, acetate; ala, 
alanine; arg, arginine; asn, asparagine; asp, aspartate; bcaa, branched chain amino acids; bet, betaine; 
but, butyrate; cit, citrate; cho, choline; cre, creatine; crt, creatinine; dht, dihydroxythymine; dma, 
dimethylamine; dmg, dimethylglycine; glc, glycolate; gln, glutamine; glu, glutamate; gly, glycine; 
gpc, glycerophosphocholine; gua, guanidinoacetate; hip, hippurate; lac, lactate; leu, leucine; lys, 
lysine; mea, methylamine; meg, methylguanidine; mel, methanol; met, methionine; nmna, N-methyl-
nicotinamide; phe, phenylalanine; pip, pipecolate; pro, proline; p5p, pyridoxamine-5-phosphate; pyr, 
pyruvate; scy, scyllo-inositol; suc, succinate; tau, taurine; thr, threonine; tma, trimethylamine; tmao, 
trimethylamine-N-oxide; ure, ureidopropanoate. 
 
5.6 Results 
Physiological monitoring of mice. E. caproni-infected mice showed no visible sign of ill-
health over the course of the experiment. The mean weight and mean PCV of E. caproni-
infected (n = 8) and non-infected control mice (n = 12) did not differ at any of the time points 
investigated. The PCV values maintained a constant level throughout the experiment (49.6-
55.1%). Upon dissection and worm count, an infection was confirmed in 8 out of the 12 mice 
(average worm count 26.5, SD = 12.0, range: 10-44 worms). The 4 animals with no 
established infection were excluded from further analyses. 
Composition of metabolite profiles. Prior to assessing the metabolic effects of an E. caproni 
infection, the 
1
H NMR spectra of plasma, stool, and urine samples obtained from non-infected 
mice were characterised and found to be inherently different in composition. All three types 
of biofluids contained lactate, alanine, glucose, and acetate. Unique to the urine metabolic 
profile was the presence of hippurate, indoxylsulfate, urocanate, taurine, trimethylamine-N-
oxide (TMAO), 2-oxoglutarate, ureidopropanoate, and 2-ketoisocaproate, amongst others 
(Figure 5.1A, Figure 5.2A and Table 5.1). The plasma spectral profiles were characterised by 
the predominance of various lipids and lipoprotein fractions, along with resonances from 
creatine, and several amino and organic acids (Figure 5.1B, Figure 5.2B and Table 5.2). Apart 
from the standard 1D acquisition, applied on all biofluids, a CPMG and DOESY pulse  
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Figure 5.2. Aromatic region of representative 600 MHz 
1
H-NMR 1D spectra of biological samples 
obtained from an uninfected control mouse, aged 7-8 weeks. Spectra of urine (A), plasma (B), and 
faecal water (C) are shown. Additionally, the same region of a 600 MHz 
1
H NMR 1D spectrum of 
E. caproni extract is depicted (D). Key: α-glu, α-glucose; alt, alantoin; for, formate; fum, fumarate; 
hip, hippurate; his, histidine; hom, homocarnosine; ind, indoxylsulfate; nmna, N-methyl-nicotinamide; 
pag, phenylacetylglycine; phe, phenylalanine; trp, tryptophan; tyr, tyrosine; ura, uracil; uri, uridine; 
uro, urocanate. 
A
D
C
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sequence was used in plasma profiling, to represent low and high molecular weight 
metabolites, respectively. Characteristic metabolic features of the stool extracts were bile 
acids and short chain fatty acids (SCFAs), such as butyrate, and propionate. In addition, other 
amino acids, such as tryptophan, lysine, arginine, and glutamine were more visible in stool 
spectra, compared to urine and plasma (Figure 5.1C, Figure 5.2C and Table 5.3) 
In order to establish whether excretory products of the parasite itself were likely to contribute 
to any of the biofluids analyzed, a standard 1D spectrum of an adult E. caproni was acquired. 
The spectrum of the parasite differed from the biofluids obtained from the mouse host in 
content of homocarnosine, histidinol, uridine, pipecolate, and betaine (Figure 5.1D, Figure 
5.2D), although betaine has been observed in 
1
H NMR spectra of urine in previous studies 
[32]. Tables 5.1-5.4 summarize key metabolites found in urine, plasma, and stool extracts of 
mice, and in the E. caproni homogenate, respectively. 
Multivariate analysis and global metabolic trajectories. In both PCA and PLS-DA scores 
plots of the urinary metabolite profiles, a clear separation of E. caproni-infected and non-
infected control mice was already visible 1 day post-infection. This separation was maintained 
in all later time points except day 5. Metabolic trajectories were constructed for each type of 
biofluids by taking the mean position in the principal component (PC) scores plot for each 
group of mice (E. caproni-infected and non-infected controls) separately, and connecting the 
coordinates chronologically to establish any systematic change in metabolic composition over 
the time course of the experiment. The control group showed no significant movement over 
the study duration (data not shown), whereas in the infected group, day 19 was significantly 
separated from all other days post-infection, and the whole time course of infection showed a 
shift from the upper left to the lower right quadrant (Figure 5.3A), whereby days 1 and 5 post-
infection differed significantly from the sampling end point (day 33). 
The plasma spectra of E. caproni-infected mice showed marked differences at days 1, 12, 26, 
and 33 post-infection, with the best discriminatory model at day 12 post-infection (goodness 
of prediction (Q
2
) according to PCA = 0.97; Q
2
 (PLS-DA) = 0.89). Comparing the 3 different 
pulse programs applied, plasma time trajectories, showed similar behavior. The control 
trajectories were generally clustered, indicating stability of the metabolite composition over 
the study period. However, the standard 1D trajectory showed a slight difference between 
early and late time points (e.g., day 1 was separated in space from days 19 to 33).  
 
Metabolic profiling of an Echinostoma caproni infection 
134 
 
 
Figure 3. PCA trajectory plot of urine 
(A), plasma (B), and faecal water 
spectra (C) obtained from the mean PC1 
and PC2 values for the E. caproni-
infected mice over a 33-day period. The 
collection of the biofluids was 
performed at days 1, 5, 8, 12, 19, 26, 
and 33 post-infection. The ellipses in 
the 3D plots (Figures 3B and C) are for 
illustration purposes only, and are not 
based on statistical boundaries. 
 
Table 5.1. Next page: List of 
metabolites found in urine over a 33-
day study period in NMRI female mice. 
The arrows show whether the metabolic 
change, associated with an E. caproni 
infection, is significantly increased (↑) 
or decreased (↓) in infected mice 
compared to non-infected control mice 
and the numbers, next to the arrows 
indicate the day of maximum 
significance. The p-values for the 
changing metabolites were assessed 
using a non-parametric 1-way analysis 
of variance (Mann-Whitney U) test in 
MATLAB, based on the integrals of the 
selected peaks and were all in the range 
of 0.001 to 0.05. 
 
 
 
 
 
Metabolic profiling of an Echinostoma caproni infection 
135 
 
Metabolite Maximal time of 
metabolic change 
Chemical moiety Chemical shift in ppm and 
multiplicity 
2-hydroxyisobutyrate  2xCH3 1.36(s) 
2-ketoisocaproate ↓ (d12) CH2, CH, 2xCH3 2.61(d), 2.10(m), 0.94(d) 
2-oxoglutarate  β-CH2, γ-CH2 3.02(t), 2.50(t) 
acetate ↓ (d8) CH3 1.91(s) 
alanine  α-CH, β-CH3 3.81(q), 1.48(d) 
allantoin  CH 5.40(s) 
citrate  1-CH2, 3-CH2 2.69(d), 2.54(d) 
creatine ↓ (d8) CH3, CH2 3.04(s), 3.93(s) 
creatinine  CH3, CH2 3.05(s), 4.06(s) 
dimethylamine  2xCH3 2.71(s) 
dimethylglycine  2xCH3, CH2 2.89(s), 3.71(s) 
formate  CH 8.45(s) 
fumarate  CH 6.53(s) 
α-glucose ↑ (d1); ↓ (d12)* 1-CH, 2-CH, 3-CH, 4-CH, 5-
CH, half 6-CH2, half 6-CH2 
5.24(d), 3.56(dd), 3.70(t), 3.40(t), 
3.83(m), 3.72(dd), 3.85(m) 
β-glucose ↑ (d1); ↓ (d12)* 1-CH, 2-CH, 3-CH, 4-CH, 5-
CH, half 6-CH2, half 6-CH2 
4.65(d), 3.25(dd), 3.47(t), 3.40(t), 
3.47(ddd), 3.78(dd), 3.90(dd) 
glycolate  CH2 3.94(s) 
guanidinoacetate  CH2 3.80(s) 
hippurate ↓ (d33) CH2, 2,6-CH, 3,5-CH, 4-CH 3.97(d), 7.84(d), 7.55(t), 7.64(t) 
indoxylsulfate  5-CH, 6-CH, 4-CH, 7-CH 7.20(t), 7.27(t), 7.51(d), 7.70(d) 
lactate  CH, CH3 4.12(q), 1.33(d) 
mannitol ↑ (d12) 2xα-CH2, 2xβ-CH, 2xγ-CH 3.78(m), 3.88(dd), 3.68(dd) 
methyl crotonate  β-CH, γ-CH3, γ'-CH3 1.66(s), 1.70(s), 1.71(s) 
methylamine  CH3 2.61(s) 
methylguanidine  CH3 2.83(s) 
N-methyl-nicotinamide  CH3, 6-CH, 2-CH, 5-CH, 4-CH 4.48(s), 8.97(d), 9.28(s), 8.19(t), 
8.90(d) 
p-cresolglucuronide ↑ (d12) 2,6-CH, 3,5-CH 7.06(d), 7.23(d), 2.30(s), 5.07(d) 
phenylacetylglycine ↑ (d26) 2,6-CH, 3,5-CH, Ph-CH2, N-
CH2 
7.43(m), 7.37(m), 3.75(d), 3.68(s) 
pyridoxamine-5-
phosphate 
 OCH2, CH2N, CH3 7.67(s), 4.34(s), 2.48(s) 
succinate ↑ (d33) 2xCH2 2.41(s) 
taurine ↓ (d19) CH2N, CH2S 3.27(t), 3.43(t) 
trimethylamine ↑ (d12) 3xCH3 2.88(s) 
trimethylamine-N-
oxide 
↑ (d12) 3xCH3 3.27(s) 
ureidopropanoate  α-CH2, β-CH2 2.38(t), 3.3(t) 
urocanate  α-CH, β-CH, 5-CH, 2-CH 6.40(d), 7.13(d), 7.41(s), 7.89(s) 
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Table 5.2. List of plasma metabolites found in mice over a 33-day study period. Arrows indicate 
significantly changing substances comparing plasma of E. caproni-infected mice with non-infected 
control mice (↑, increased; ↓, decreased in infected animals) and the numbers in brackets indicate the day 
of maximum significance. *glucose was the only metabolite found, which changed its directionality with 
time, i.e., it increased significantly after one day of infection and at day 8 post-infection was present in 
significantly lower concentrations, compared to uninfected control mice. The p-values for the changing 
metabolites were assessed using a non-parametric 1-way analysis of variance (Mann-Whitney U) test in 
MATLAB, based on the integrals of the selected peaks and were all in the range of 0.001 to 0.05. 
Metabolite Maximal time of 
metabolic change 
Chemical moiety Chemical shift in ppm and 
multiplicity 
2-ketoisovalerate  CH, 2xCH3 3.02(m), 1.13(d) 
3-hydroxybutyrate  half α-CH2, half α-CH2, β-CH, γ-CH3 2.32(m), 2.42(m), 4.16(m),1.21(d) 
acetate ↑ (d12) CH3 1.91(s) 
acetoacetate  α-CH2, γ-CH3 2.29(s), 3.45(s) 
alanine  α-CH, β-CH3 3.81(q), 1.48(d) 
allantoin  CH 5.40(s) 
choline ↓ (d33) 3xCH3, α-CH2, β-CH2 3.21(s), 4.07(m), 3.52(m) 
citrate  1-CH2, 3-CH2 2.69(d), 2.54(d) 
creatine ↓ (d12) CH3, CH2 3.04(s), 3.93(s) 
dihydroxythymine  CH2, CH, CH3 3.17(m), 2.47(m), 1.07(d) 
formate ↑ (d12) CH 8.45(s) 
α-glucose ↑ (d1); ↓ (d12)* 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, 
half 6-CH2, half 6-CH2 
5.24(d), 3.56(dd), 3.70(t), 3.40(t), 
3.83(m), 3.72(dd), 3.85(m) 
β-glucose ↑ (d1); ↓ (d12)* 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, 
half 6-CH2, half 6-CH2 
4.65(d), 3.25(dd), 3.47(t), 3.40(t), 
3.47(ddd), 3.78(dd), 3.90(dd) 
Glycerophospho-
choline 
↓ (d12) 3xCH3, half α-CH2, half α-CH2, half 
β-CH2, half β-CH2, γ-CH2 
3.23(s), 4.32(t), 3.60(dd), 3.68(t), 
3.89(m), 3.72(dd) 
isoleucine ↓ (d33) α-CH, β-CH, half γ-CH2, half γ-CH2, 
δ-CH3, β-CH3 
3.68(d), 1.93(m), 1.25(m), 
1.47(m), 0.99(d), 1.02(d) 
lactate  CH, CH3 4.12(q), 1.33(d) 
leucine ↓ (d33) α-CH, β-CH2, γ-CH, δ-CH3, δ-CH3 3.72(t), 1.96(m), 1.63(m), 1.69(m), 
0.91(d), 0.94(d) 
methionine  α-CH, β-CH2, γ-CH2, CH3 3.87(m), 2.10(m), 2.65(dd), 2.15(s) 
scyllo-inositol  6xCH 3.35(s) 
valine ↓ (d33) α-CH, β-CH, γ-CH3, γ'-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d) 
lipid fraction ↑ CH3 0.84(t) 
lipid fraction ↑ (CH2)n 1.25(m) 
lipid fraction ↑ β-CH2CH2CO 1.57(m) 
lipid fraction ↑ CH2C=C 1.97(m), 2.00(m) 
lipid fraction ↑ CH2CO 2.23(m) 
lipid fraction ↑ C=CCH2C=C 2.69(m), 2.71(m), 2.72(m) 
lipid fraction ↑ CH=CH 5.23(m), 5.26(m), 5.29(m) 
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Table 5.3. Metabolites found in faecal water of mice over a 33-day study period. Arrows indicate 
differences in the spectral profiles between E. caproni-infected mice and non-infected control mice (↑, 
increased; ↓, decreased in infected animals) and the numbers in brackets show the day post-infection of 
maximum concentration difference of the respective metabolite. The p-values for the changing metabolites 
were assessed using a non-parametric 1-way analysis of variance (Mann-Whitney U) test in MATLAB, 
based on the integrals of the selected peaks and were all in the range of 0.001 to 0.05. 
Metabolite Maximal time 
of metabolic 
change 
Chemical moiety Chemical shift in ppm and 
multiplicity 
2-hydroxyisovalerate  α-CH, β-CH, γ-CH3, γ'-CH3 3.85(d), 2.02(m), 0.79(d), 0.84(d) 
2-ketoisocaproate  CH2, CH, 2xCH3 2.61(d), 2.10(m), 0.94(d) 
2-ketoisovalerate  CH, 2xCH3 3.02(m), 1.13(d) 
3-aminopropionic acid  α-CH2, β-CH2 2.56(t), 3.19(t) 
3-hydroxyphenylpropionate  α-CH2, β-CH2, 2-CH 2.85(t), 2.47(m), 6.80(m) 
2-oxoisoleucine  CH, half γ-CH2, half γ-CH2, δ-
CH3, β-CH-CH3 
2.93(m), 1.70(m), 1.46(m), 
0.90(t), 1.10(d) 
5-aminovalerate ↑ (d26) 5-CH2, 2-CH2, 3,4-CH2 3.02(t), 2.24(t), 1.65(m) 
acetate ↓ (d12) CH3 1.91(s) 
alanine ↓ (d12) α-CH, β-CH3 3.81(q), 1.48(d) 
arginine  α-CH, β-CH2, γ-CH2, δ-CH2 3.76(t), 1.89(m), 1.59(m), 3.17(t) 
asparagine  α-CH, half β-CH2, half β-CH2 4.01(m), 2.87(dd), 2.96(dd) 
aspartate  α-CH, half β-CH2, half β-CH2 3.92(m), 2.70(m), 2.81(m) 
bile acids  CH3 0.70(m) 
butyrate ↓ (d26) α-CH2, β-CH2, γ-CH3 2.16(t), 1.56(m), 0.90(t) 
ethanolamine  NH-CH2, HO-CH2 3.15(t), 3.78(t) 
formate  CH 8.45(s) 
fumarate  CH 6.53(s) 
α-glucose  1-CH, 2-CH, 3-CH, 4-CH, 5-CH, 
half 6-CH2, half 6-CH2 
5.24(d), 3.56(dd), 3.70(t), 3.40(t), 
3.83(m), 3.72(dd), 3.85(m) 
β-glucose  1-CH, 2-CH, 3-CH, 4-CH, 5-CH, 
half 6-CH2, half 6-CH2 
4.65(d), 3.25 (dd), 3.47(t), 3.40(t), 
3.47(ddd), 3.78(dd), 3.90(dd) 
glutamate  α-CH, β-CH2, γ-CH2 3.78(m), 2.06(m), 2.36(m) 
glutamine  α-CH, β-CH2, γ-CH2 3.78(m), 2.15(m), 2.46(m) 
glycerol  half α,γ-CH2, half α,γ-CH2, β-CH 3.56(dd), 3.64(dd), 3.87(m) 
glycine ↓ (d12) CH2 3.55(s) 
hypoxanthine  3-CH, 7-CH 8.10(s), 8.11(s) 
isoleucine ↑ (d26) α-CH, β-CH, half γ-CH2, half γ-
CH2, δ-CH3, β-CH3 
3.68(d), 1.93(m), 
1.25(m),1.47(m), 0.99(d), 1.02(d) 
lactate  CH, CH3 4.12(q), 1.33(d) 
leucine ↑ (d8) α-CH, β-CH2, γ-CH, δ-CH3, δ-
CH3 
3.72(t), 1.96(m), 1.63(m), 
1.69(m), 0.91(d), 0.94(d) 
lysine  α-CH, β-CH2, γ-CH2, δ-CH2, ε-
CH2 
3.77(t), 1.92(m), 1.73(m), 
1.47(m), 3.05(t) 
methionine  α-CH, β-CH2, γ-CH2, CH3 3.87(m), 2.10(m), 2.65(dd), 
2.15(s) 
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myo-inositol  1,3-CH, 2-CH, 5-CH, 4,6-CH 3.53(dd), 4.06(t), 3.28(t), 3.63(t) 
phenylacetic acid  CH2, 2,4,6-CH, 3,5-CH 3.52(s), 7.29(t), 7.36(t) 
phenylalanine  2,6-CH, 3,5-CH, 4-CH, CH2, CH 7.44(m), 7.39(m), 7.33(m), 
3.17(dd), 3.30(dd), 3.99(dd) 
proline  α-CH, half β-CH2, half β-CH2, γ-
CH2, δ-CH2 
4.15(dd), 2.05(m), 2.38(m), 
2.00(m), 3.39(m) 
propionate ↓ (d26) CH2, CH3 2.19(q), 1.06(t) 
succinate  2x CH2 2.41(s) 
threonine  α-CH, β-CH, γ-CH3 3.60(d), 4.26(m), 1.33(d) 
tryptophan  4-CH, 7-CH, 2-CH, 5-CH, 6-
CH,α-CH, half β-CH2, half β-CH2 
7.79(d), 7.56(d), 7.34(s), 7.29(t), 
7.21(t), 4.06(dd), 3.49(dd), 
3.31(dd) 
tyrosine  2,6-CH, 3,5-CH, CH2, α-CH 7.23(d), 6.91(d), 2.93(t), 3.25(t) 
uracil ↑ (d8) 5-CH, 6-CH 5.81(d), 7.59(d) 
urocanate  α-CH, β-CH, 5-CH, 2-CH 6.40(d), 7.13(d), 7.41(s), 7.89(s) 
valine ↑ (d26) α-CH, β-CH, γ-CH3, γ'-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d) 
 
In contrast, for the E. caproni-infected animals, there was a significant movement from early 
(day 1) to intermediate time points post-infection (days 5 and 12) in the first component and 
finally to late time points (days 26 and 33) in the third component (Figure 5.3B). This 
movement pattern was consistent across the datasets acquired by all three pulse programs. 
With regard to the 
1
H NMR spectra obtained from stool samples, a clear separation was found 
at day 5 post-infection in both the PCA and PLS-DA scores plot between E. caproni-infected 
and non-infected control mice, with maximum model fit for the PLS-DA model at day 26 
post-infection (Q
2
 = 0.79). At the final time point (day 33), the two groups were metabolically 
similar; there was no separation between infected and non-infected mice using PCA, and the 
PLS-DA model revealed a lower, but still significant Q
2
 value than all previous time points. 
By comparing the time trajectories of the non-infected control with the E. caproni-infected 
group of mice, the controls were more tightly clustered, but showed a significant movement 
from day 8 post-infection onwards along PC1. In the 2D time trajectory plot of the 
E. caproni-infected mice, all time points were tightly clustered with the exception of days 8 
and 12 post-infection, which comprised a separate cluster (Figure 5.3C). Introducing an 
additional PC brought about clear differentiation of the late time points (days 19, 26, and 33) 
from day 1 post-infection. 
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Table 4. List of metabolites found in extracts of an adult E. caproni. 
Metabolite Chemical moiety Chemical shift in ppm and multiplicity 
3-hydroxybutyrate half α-CH2, half α-CH2, β-CH, γ-CH3 2.32(m), 2.42(m), 4.16(m), 1.21(d) 
acetate CH3 1.91(s) 
alanine α-CH, β-CH3 3.81(q), 1.48(d) 
betaine CH2, CH3 3.90(s), 3.27(s) 
choline 3xCH3, α-CH2, β-CH2 3.21(s), 4.07(m), 3.52(m) 
formate CH 8.45(s) 
α-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-
CH2, half 6-CH2 
5.24(d), 3.56(dd), 3.70(t), 3.40(t), 
3.83(m), 3.72(dd), 3.85(m) 
β-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, half 6-
CH2, half 6-CH2 
4.65(d), 3.25(dd), 3.47(t), 3.40(t), 
3.47(ddd), 3.78(dd), 3.90(dd) 
glutamine α-CH, β-CH2, γ-CH2 3.78(m), 2.15(m), 2.46(m) 
glycerophosphocholine 3xCH3, half α-CH2, half α-CH2, half β-
CH2, half β-CH2, γ-CH2 
3.23(s), 4.32(t), 3.60(dd), 3.68(t), 
3.89(m), 3.72(dd) 
glycine CH2 3.55(s) 
histidinol 5-CH, 3-CH, γ-CH2, β-CH, α-CH 7.89(s), 7.12(s), 3.85(dd), 3.67(m), 
3.62(m) 
homocarnosine 5-CH, 3-CH, half ring-CH2, half ring-
CH2, N-CH, N-CH2, CO-CH2, CH2 
7.90(s), 7.01(s), 3.17(dd), 2.96(dd), 
4.48(m), 2.92(m), 2.36(m), 1.89(m), 
3.21(t) 
isoleucine α-CH, β-CH, half γ-CH2, half γ-CH2, δ-
CH3, β-CH3,  
3.68(d), 1.93(m), 1.25(m),1.47(m), 
0.99(d), 1.02(d) 
lactate CH, CH3 4.12(q), 1.33(d) 
leucine α-CH, β-CH2, γ-CH, δ-CH3, δ-CH3 3.72(t), 1.96(m), 1.63(m), 1.69(m), 
0.91(d), 0.94(d) 
lysine α-CH, β-CH2, γ-CH2, δ-CH2, ε-CH2 3.77(t), 1.92(m), 1.73(m), 1.47(m), 
3.05(t) 
methionine α-CH, β-CH2, γ-CH2, CH3 3.87(m), 2.10(m), 2.65(dd), 2.15(s) 
phenylalanine 2,6-CH, 3,5-CH, 4-CH, CH2, CH 7.44(m), 7.39(m), 7.33(m), 3.17(dd), 
3.30(dd), 3.99(dd) 
pipecolate half 3,4,5-CH2, half 4,5-CH2, half 3-CH2, 
half 6-CH2, half 6-CH2, 2-CH 
1.60-1.66(m), 1.86(m), 2.22(m), 3.02(m), 
3.43(m), 3.60(m) 
proline α-CH, half β-CH2, half β-CH2, γ-CH2, δ-
CH2 
4.15(dd), 2.05(m), 2.38(m), 2.00(m), 
3.39(m) 
propionate CH2, CH3 2.19(q), 1.06(t) 
scyllo-inositol 6xCH 3.35(s) 
succinate 2xCH2 2.41(s) 
threonine α-CH, β-CH, γ-CH3 3.60(d), 4.26(m), 1.33(d) 
tryptophan 4-CH, 7-CH, 2-CH, 5-CH, 6-CH,α-CH, 
half β-CH2, half β-CH2 
7.79(d), 7.56(d), 7.34(s), 7.29(t), 7.21(t), 
4.06(dd), 3.49(dd), 3.31(dd) 
tyrosine 2,6-CH, 3,5-CH, CH2, α-CH 7.23(d), 6.91(d), 2.93(t), 3.25(t) 
uridine 6-CH, 5-CH, 2'-CH, 3'-CH, 4'-CH, 5'-
CH(d), half CH2OH, half CH2OH 
7.87(d), 5.90(s), 5.92(d), 4.36(t), 4.24(t), 
4.14(q), 3.92(dd), 3.81(dd) 
valine α-CH, β-CH, γ-CH3, γ'-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d) 
Metabolic profiling of an Echinostoma caproni infection 
140 
 
 
Pair wise comparison of time points across different types of biofluids. O-PLS-DA was 
used to extract information on specific metabolic changes induced by an E. caproni infection 
over the duration of the study. Changes in urinary, plasma and faecal metabolites are 
presented in Figures 5.4-5.6 for selected time points and the complete set are summarized in 
Figure 5.7. Amongst the most significantly changed urinary metabolites were hippurate 
(decreased at day 33), 2-ketoisocaproate (decreased from day 8 onwards), trimethylamine 
(TMA; increased at days 8, 12, 19, and 33), taurine (decreased at days 8, 12, and 19), p-cresol 
glucuronide (increased at days 8, 12, 19, and 26), mannitol (increased from day 5 onwards), 
TMAO (increased at days 8, and 12), phenylacetylglycine (increased from day 12 onwards), 
acetate (decreased at days 8, and 19) and creatine (decreased at days 1, 5, 8, and 12). Plasma 
from infected mice showed changes in the relative concentration of acetate (increased at all 
time points except day 5), creatine (decreased from day 8 onwards), lipids (increased from 
day 8 onwards), formate (decreased at days 1, 8, 12, and 19, but increased at day 33), lactate 
(decreased at days 1, 8, 12, 19, and 26), glucose (increased at days 1, and 33, but decreased at 
days 12, 19, and 26), glycerophosphorylcholine (GPC; decreased at days 12, 26, and 33), 
choline (decreased at days 1, 12, 26, and 33) and branched chain amino acids (BCAAs; 
decreased at days 12, 26, and 33). The changes in stool samples from infected animals 
included the BCAAs (increased at days 8, and 26), uracil (increased at day 8), butyrate 
(decreased at days 12, 19, and 26), propionate (decreased at days 12, 19, and 26) and 5-
aminovalerate (increased from day 5 onwards). 
Analysis of relative concentrations of key metabolites over study duration. Figure 5.8 
shows the relative concentration of some of these metabolites both for control (blue) and 
infected mice (colored according to biofluid). The error bars signify 2 SDs of the mean. 
According to this 3 x 3 diagram, the selected plasma and urine metabolites showed a more 
robust pattern of group separation over time when compared to faecal water extracts. Whereas 
some overlap was observed in the scores plot relating to the faecal water samples, there was a 
tendency toward increasing discrimination of urinary metabolites with time over the course of 
an E. caproni infection, whereas the discrimination became smaller toward the end of the 
experiment in the selected plasma metabolites. 
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Figure 5.4. O-PLS-DA coefficients plots of urine comparing non-infected control mice (control) with 
E. caproni-infected mice (infected) at 3 different sampling time points, i.e., day 8 (A), day 12 (B), and 
day 33 (C) post-infection. The color scale indicates the relative contribution of the peak/region to the 
strength of the differentiation model and the peak intensity is measured relative to the whole peak 
contribution in arbitrary units (a.u.). Note that the aromatic region (left part) is magnified by a factor 5. 
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Figure 5.5. Pair-wise comparison via O-PLS-DA between non-infected control mice (control) and 
E. caproni-infected mice (infected) at 3 different sampling time points, i.e., day 8 (A), day 12 (B), and 
day 33 (C) post-infection. The color scale indicates the relative contribution of the peak/region to the 
strength of the differentiation model and the peak intensity is measured relative to the whole peak 
contribution in arbitrary units (a.u.). The CPMG spectrum represents small molecular weight 
components. 
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Figure 5.6. O-PLS-DA pair-wise comparison of faecal water comparing non-infected control mice 
(control) with E. caproni-infected mice (infected) at 3 different sampling time points, i.e., day 8 (A), 
day 12 (B), and day 33 (C) post-infection. The color scale indicates the relative contribution of the 
peak/region to the strength of the differentiation model and the peak intensity is measured relative to 
the whole peak contribution in arbitrary units (a.u.). Note that the aromatic region (left part) is 
magnified by a factor 5. 
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5.7 Discussion 
1
H NMR-based metabolic profiling of biofluids is an established method for deepening our 
understanding of host-parasite interactions and for investigating disease states in clinical 
studies [15,19,33]. Sample preparation and spectral acquisition of a biofluid takes little time, 
and often an overview of the metabolic state of the organism can be obtained by visual 
assessment of the spectra. Identification of biomarkers from different types of biofluids is 
similarly convenient, although stool samples need slightly more preparation time and require 
sonication and an additional centrifugation step, due to the high amount of sediments in the 
stool-buffer mixture [34]. 
A number of potential biomarkers for diagnosis of an E. caproni infection in the mouse were 
found here for each of the biofluids employed; 12 in plasma, 10 in urine and 7 in stool. 
Hence, if for practical purpose, a diagnosis was required based on a single biofluid, either 
plasma or urine would be the first choice for further development. Stool is the least suitable 
biological sample not only in terms of a lower number of potential biomarkers, but also 
because of the more difficult sample preparation, a lower robustness of metabolites (Figures 
5.7 and 5.8), and larger inter- and intra-individual variation. The latter issue makes it difficult 
to determine if the change is related to the actual infection, or results from other factors, e.g., 
age and/or microbiotal presence or activity [34]. Although the high degree of individual 
variation in the faecal metabolite profiles derived from laboratory studies can be overcome 
with parallel monitoring of metabolic time-related changes in a control group, this issue needs 
to be addressed in future applications of metabonomics for diagnosis of parasitic infections 
and disease states, and hence for monitoring disease control programs. If the stability of the 
urine profiles compared to plasma over the study duration is taken into account, then urine 
would be the biofluid of choice on which to base a diagnostic. Morevoer, urine collection is 
less invasive than blood collection. 
Hence, the systemic movement over time observed in the infected group is most likely to be 
related to the establishment and progression of the E. caproni infection. 
In stool and plasma, the time trajectories of the infected animals demonstrated a markedly 
greater magnitude from the baseline position than the non-infected animals. The greatest 
differentiation between E. caproni-infected mice and non-infected control animals was found 
in the PC scores plots based on the urine spectral profiles. 
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Figure 7. Summary of key E. caproni infection-related features for urine (yellow), plasma (red), and 
faecal water (green). The colored regions show the differences between E. caproni-infected mice and 
non-infected control animals, whereas the changes in direction are indicated by arrows (↑, indicates an 
increase in the metabolite signal in infected mice with respect to the control group; ↓, indicates a 
decreased metabolite signal in infected mice). 
 
The smallest differentiation was observed in the stool. From the scale of the PC scores plot 
axes the trajectory of the infected group occupied a 1.5 and 50 times larger space for stool and 
plasma, respectively than the non-infected group, whereas in urine, the control trajectory 
occupied a 10
6
 times bigger space, compared to the trajectory of infection. The magnitude of 
infection-induced metabolic disturbance in the urine profile again clearly points to the greater 
suitability of urine as a diagnostic biological matrix. 
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Intestinal re-absorption. The considerable increase in concentration of lipids in the plasma, 
e.g., fatty acids, triaglycerols, and lipoproteins, reflects the action of the parasite in the hosts 
gut. In mice harboring a 2-week-old E. caproni-infection, an increased breakdown of 
membrane lipids in the host intestinal tissue has been observed [35], which is consistent with 
the present findings of a maximum lipid increase on day 12 post-infection [36]. The excretory 
products of E. caproni in the intestinal mucosa are primarily free sterols, triaglycerols, and 
free fatty acids [37],
 
but it is unlikely that the amounts excreted by the parasite make a 
substantial contribution to the host metabolic profile, given that the total parasite mass to host 
weight ration is ~1:300. 
 
Figure 8. Statistical integration for 3 selected metabolites in the spectra of each of the 3 different types 
of biofluids (A, urine; B, plasma; C, faecal water). The relative concentration of each of these 
metabolites is shown for non-infected control mice (blue), and E. caproni-infected mice (yellow 
representing urine, red representing plasma, and green representing faecal water). The error bars 
signify 2 standard deviations of the mean. 
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Whilst the simple diffusion of lipid micelles into mucosal cells seems unaffected by the 
parasite, the Na
+
-dependent active transport of amino acids could be impaired as the increase 
of the BCAAs in stool and subsequent decrease in plasma suggests. Depletion of the carrier  
molecules at the brush border of the mucosal cells, or a change of the electrochemical 
gradient for Na
+
 might explain the selective impact on trans-luminal gut transport [38]. 
The observed decrease of leucine in plasma, in turn, might induce the significant reduction in 
levels of 2-ketoisocaproate in urine, which is a transamination product of the former [39].
 
Taurine is mainly conjugated with cholic acid and chenodeoxycholic acid in the liver to form 
primary bile salts, and is excreted via the urine after deconjugation from the bile salt or it 
leads into the sulphur- or pyruvate metabolism. Once the taurine conjugated bile salt has 
transformed the lipids into a micellar form, which is necessary to cross the intestinal wall, 
taurine is deconjugated by gut bacterial species and reabsorbed into the liver via blood 
circulation [40]. The decreased levels of excreted taurine in the urine of the infected mice may 
result from the higher demand for increased lipid digestion, resulting from the action of 
E. caproni in the gut. 
Gut microbiota. The changes in hippurate, phenylacetylglycine, p-cresol-glucuronide, and 
TMA in urine, and 5-aminovalerate, and the SCFA levels in stool, are associated with a 
change in gut microbiotal presence or activity, as all of these metabolites undergo 
modification via gut microbial species before excretion. For instance, 5-aminovalerate is 
formed by several different Clostridium species which convert ornithine and proline, but to 
our knowledge, only C. aminovalericum degrades 5-aminovalerate further to mainly 
propionate and acetate [41-43]. This may imply that the presence of E. caproni in the gut 
disturbs the microbial balance resulting in depleted C. aminovalericum.
 
The formation of p-
cresol is likewise known to be performed by a Clostridium subspecies (i.e., C. difficile and 
C. scatologenes) [44,45], with the bacterium-specific enzyme p-hydroxyphenylacetate. It is 
then conceivable that p-cresol is taken up by the bloodstream, bound to serum proteins and 
glucuronidated in the kidney prior to excretion [46]. Increased excretion of p-cresol-
glucuronide might be coupled with a higher activity or higher presence of this bacterial strain 
as the kidney function does not seem to be impaired. PCR analyses on several different 
Clostridium sub-strains are ongoing and will be discussed in forthcoming publications. 
The decrease of the SCFAs in stool may also be indicative of an unbalanced microbiota, as 
dietary carbohydrates (e.g., starches and fibres) are fermented by colonic bacteria to mainly  
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acetate, propionate, and butyrate. Whilst butyrate serves as main energy source for 
colonocytes, acetate and propionate pass through the intestinal wall and move via peripheral 
blood to the liver where they have antagonistic functions on the cholesterol synthesis. Whilst 
the former increases cholesterol synthesis, the latter was shown to act as an inhibitor. The 
uptake from colon by the blood system is four times higher in the case of acetate, than 
propionate, which is a possible explanation for depletion of the SCFA, also reflected by the 
observed decrease in levels of acetate in both urine and plasma [47,48]. 
The increased concentration of TMA and phenylacetylglycine, and the decrease of hippurate 
in urine, observed at the later time points of our experiment, are concomitant phenomena of 
the changed gut microbiota [49,50]. Trimethylammonium compounds like choline and 
carnitine, which are ingested in the normal diet, are degraded by intestinal bacteria to TMA, 
and then oxidized in the liver to TMAO in a second step [51,52]. A microbial shift toward 
choline degrading bacteria might explain the choline/GPC depletion in plasma and the 
subsequent increase of TMAO in urine. 
Specificity of biomarkers for diagnosis. An infection with E. caproni induces changes in the 
concentration of a range of metabolites in urine, plasma, and stool. To be useful as a ‗real‘ 
biomarker, the candidate must be reproducible, robust, specific and, ideally, easy to measure 
[53]. From the current analyses an anomalous increase in urinary mannitol was noted in 
infected animals. Mannitol is likely to derive from the diet, since it is not synthesized by 
vertebrates. However, the higher amounts of urinary mannitol in E. caproni-infected mice, 
reflect the higher intestinal permeability, compared to the control group [54]. 
To assess the specificity of the biomarkers identified for potential diagnosis of infection, the 
obtained E. caproni fingerprint was compared to altered metabolite patterns, associated with 
other parasite-rodent models [16-18]. Interestingly, E. caproni seems to alter the gut 
microbiota in a similar way to the biologically-related blood flukes, i.e., S. mansoni [16], and 
S. japonicum [17]. Hippurate, phenylacetylglycine, and TMA are modified by several gut 
microbial species before excretion in urine. In the 3 disease models, hippurate was found to 
decrease significantly, whereas phenylacetylglycine, p-cresol-glucuronide and TMA showed 
increased levels in infections with all 3 parasites, which suggests a common trematode-
inherent influence on gut microbial composition. The change in 2-ketoisocaproate in urine 
was unique to the infection with E. caproni and 5-aminovalerate in stool may also deliver an 
E. caproni-specific marker but, at the time being, cannot be compared to other disease  
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models, as the metabonomic assessment of stool was applied only in the present parasite-
rodent model. The metabolic effect of a nematode infection (T. spiralis) in NIH Swiss mice 
has also been reported by Martin and colleagues [18]. T. spiralis has a similar initial 
mechanism of pathogenicity and also induces a state of inflammation of the gut before it 
migrates from the intestine to muscle tissue and induces hypercontractility [55]. While 
comparison between the study conducted by Martin et al. [18] and the current study revealed 
a number of biomarkers, which were the same in both models, the directionality of these 
metabolites was different. For example, a decrease in choline and creatine concentrations was 
observed in E. caproni-infected mice, whereas the same metabolites were reported to be 
increased in T. spiralis-infected mice compared to non-infected controls. Furthermore, the 
lipids (e.g., triaglycerides, saturated and unsaturated fatty acids) which undergo a marked 
increase in E. caproni-infected animals, showed a significant decrease in the mice infected 
with T. spiralis. 
Future studies evaluating additional laboratory host-parasite models, and applying 
complementary metabolic profiling methods, such as ultra performance liquid 
chromatography (UPLC), in combination with mass spectrometry (MS), will help to confirm 
the specificity of the metabolic perturbations associated with an E. caproni infection. In 
conclusion, we have shown that metabolic profiling of plasma, urine, and stool delivers a 
comprehensive fingerprint of an E. caproni infection, composed of general as well as highly 
specific biomarkers (e.g., 2-ketoisocaproate and 5-aminovalerate). Keeping in mind the long-
term objective of developing novel diagnostic assays for trematode-borne diseases, one would 
emphasise the value of further development, particularly based on the urine profiles. 
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6.1 Abstract 
Metabolic effects of three distinct trematode infections, namely Schistosoma mansoni and 
Echinostoma caproni in mouse and Fasciola hepatica in the rat brain were investigated using 
1
H NMR spectroscopy. Twelve rodents were infected with each parasite e.g. 80 S. mansoni 
cercariae in the mouse host (n=12); 30 E. caproni metacercariae in the mouse (n=12); 20-25 
F. hepatica metacercariae in the rat (n=12) and brain samples were obtained at a timepoint 
where chronic infection had established. Aqueous extracts of the brain were analysed by 
1
H 
NMR spectroscopy coupled with multivariate statistical analysis and compared to brain 
extracts from corresponding uninfected animals.  
Distinct trematode-induced effects on the metabolic profile of the brains of mice and rats 
infected with S. mansoni and F. hepatica, respectively, were observed, whereas an E. caproni 
infection did not result in any perturbation of the biochemical profile of the mouse brain. 
Metabolic changes, induced by S. mansoni-infected mice included increased glutamate and 
decreased γ-aminobutyric acid (GABA) and phosphocholine. These changes were different to 
the metabolic signature induced by F. hepatica, which was characterised by perturbation of 
the nucleotide balance, e.g. increased levels of inosine and decreased concentrations of 
adenosine and phosphorylated species of both. Together with the observation of increased 
plasma levels of IL5 and IL13, and decreased IFN suggests modulation of immune reactions 
towards lowered inflammatory response, which may infer some degree of protection for the 
parasite. Increased phenylalanine and tyrosine levels were also features of the F. hepatica-
infected rats possibly reflecting the liver pathology induced by fascioliasis. These findings 
may contribute to elucidating the mechanism of how a trematode infection impacts on the 
central nervous system, and warrant further investigations on the impact of parasitic infections 
on the host brain. 
 
Keywords: brain; Echinostoma caproni; Fasciola hepatica; inosine; metabonomics; mouse; 
NMR spectroscopy; rat; Schistosoma mansoni; trematode 
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6.2 Introduction 
Trematode infections belong to the neglected tropical diseases and exert a heavy burden 
on population health and economy in Sub-Saharan Africa and South-East Asia. There is a 
pressing need to investigate the mechanisms of infection pathology and behaviour to improve 
surveillance and parasite control. Although the main trematode species share a similar basic 
physiology, their niches within the mammalian hosts are diverse, as are their pathologic 
mechanisms
1-3
. However, many trematode infections have been reported to invoke a response 
in the central nervous system (CNS) and even to change host behaviour
4-7
. 
The direct contact of a human trematode parasite with the compartments of the CNS can 
result in overt pathological and biochemical changes. Eggs, secreted by the blood fluke 
Schistosoma, for example, can reach the CNS and cause inflammation in the spinal cord or 
brain
8
. Serendipitous ectopic worm manifestations in the brain by Paragonimus westermani
9
, 
or Fasciola hepatica
10
 have also been reported to cause lesions and haemorrhages. However, 
for most host-parasite interactions, the molecular mechanisms of neurological damage or 
altered behaviour are less direct and poorly understood. 
A series of metabolic profiling experiments employing different host-parasite models, 
have characterised the direct biochemical consequences of parasite-induced changes in host 
biofluids (e.g. blood plasma, feacal water and urine) and target tissues (e.g. intestinal tissues, 
kidney, liver, spleen)
11-16
. Within the framework of these investigations, we have established 
three trematode-rodent models, i.e. the blood fluke Schistosoma mansoni in the mouse
11, 17
, 
the intestinal fluke Echinostoma caproni in the mouse
14
 and the liver fluke Fasciola hepatica 
in the rat. Here, we extend these investigations by assessing whether any of these trematode 
infections not only have direct biochemical impact on target tissue but also more remote 
effects on the host CNS. We compare the metabolic effects across these three 
phylogenetically similar trematodes, with topographically different locations. It is widely 
acknowledged that S. mansoni causes liver pathology
18
, but eggs deposited in the CNS may 
also cause changes in brain metabolism of the host
8
. While F. hepatica induces liver damage 
prior to settling in the bile ducts
19
, to our knowledge, no direct association with the CNS are 
reported in the extant literature. Since the existence of a bidirectional communication between 
brain and gut via the blood brain barrier interface has been described previously
20, 21
 we also 
selected an intestinal trematode, e.g. E. caproni, for investigation. All infections were  
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patent prior to removal of the brains of the host animals were removed for subsequent 
metabolic assessment. Here we implement a multilevel statistical approach combined with 
1
H 
nuclear magnetic resonance (NMR) spectroscopy
20-25
 to obtain an integrative profile of the 
CNS response of the rodent host to three trematodes, based on differential metabolite, 
immunological and biometric responses.  
 
6.3 Materials and methods  
Animal experiments and trematode-rodent models. All experiments were carried out at the 
Swiss Tropical Institute (STI; Basel, Switzerland), adhering to local and national guidelines of 
animal welfare (permission no. 2070 and 2081). Mice and rats were kept under 
environmentally-controlled conditions (temperature, 22°C; relative humidity, 60-70%; 
light/dark cycle, 12/12 hours) and had free access to commercially available rodent diet 
obtained from Nafag (Gossau, Switzerland) and water. Prior to the experiments, all animal 
were acclimatized for 1-2 weeks.  
With regard to the S. mansoni-mouse model, 20 female outbred NMRI strain mice (age: 
~3 weeks; weight: 20-25 g) were purchased from RCC (Füllinsdorf, Switzerland). Mice were 
individually marked and group-housed in sizes of 5 animals per cage. Half of the mice were 
infected subcutaneously with ~80 S. mansoni cercariae. We used a Liberian strain of 
S. mansoni, which has been passaged through Biomphalaria glabrata (intermediate host snail) 
and hamster (definitive host) at STI over the past 20 years (Wang et al. 2004, PNAS). The 
other 10 mice remained uninfected, serving as the control group. Infected mice were 
sacrificed by cervical dislocation on day 74 post-infection. Uninfected control mice were 
killed at the same time point. 
For the E. caproni-mouse model, 24 female outbread NMRI strain mice were obtained 
from RCC, individually marked and group-housed in sizes of 4 animals per cage. Half of the 
mice were orally infected with 30 E. caproni metacercariae each, after removal from the 
kidney-pericardial region of infected B. glabrata as described before (Keiser et al. 2006, 
Journal of Antimicrobial Chemotherapy). The remaining mice were left uninfected and served 
as controls. All mice were euthanised using CO2 35 days post-infection and at the same time 
point for the uninfected control mice,  
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With regard to the F. hepatica-rat model, a total of 24 Wistar female rats, were purchased  
from RCC. Rats were individually marked and group-housed in sizes of 4 animals per cage. 
Twelve rats were orally infected with 30 F. hepatica metacercariae (Cullompton isolate) 
obtained from Mr. G. Graham (Addleston, UK). The remaining 12 rats were left uninfected 
and served as the control group. Rats were killed using CO2 on day 77 post -infection and at 
the same time point for the uninfected control rats. 
The whole brains of all mice and rats regardless of their infection status were removed 
upon dissection and the left hemispheres were transferred into cryo-tubes, snap frozen in 
liquid nitrogen and stored at -80ºC pending 
1
H NMR spectroscopic data acquisition. 
Brain extraction. Each brain sample collected from mice infected with E. caproni and rats 
infected with F. hepatica (and from the corresponding uninfected control animals) was placed 
in a mortar, mashed using a 1 ml mixture of H2O and acetonitrile (1:1, v:v) and transferred 
into a glass tube. Another 2 ml of this mixture was used to rinse the mortar twice with the 
solution and also and transferred into the same glass tube. The resulting mixture was 
centrifuged for 6 min at 10,000 g. The supernatant was collected into a new glass vial, 
evaporated over night and lyophilized. The dry mass was resuspended into 600 µl of D2O and 
transferred into 5 mm-diameter NMR tube for subsequent analyses.  
 The extraction protocol for the S. mansoni-mouse model was slightly extended, in order 
to gain additional information regarding potential changes in the lipid metabolic profile, as a 
pharmacological intervention was involved in the original study protocol. Each brain sample 
obtained from mice infected with S. mansoni and the corresponding control mice was 
transferred into a 2 ml Eppendorf tube containing a metal bead, 0.75 ml of water and 0.75 ml 
of methanol. The Eppendorf tube was placed in the tissue lyser and shaken for 5 min at the 
speed of 22 Hz. The resulting homogenate was transferred into a glass tube. A further 0.75 ml 
of each liquid was used to rinse the Eppendorf tube and transferred into the same glass tube. 
A total of 1.5 ml of chloroform was added into the mixture and centrifuged at 2,500 g for 30 
min. The aqueous and the chloroform phases were transferred into a new glass tube each and 
both were left to evaporate over night and lyophilized. Prior to 
1
H NMR analysis, the powder 
obtained from the aqueous phase was dissolved in 550 μl phosphate buffer (D2O:H2O=9:1, 
v:v, 0.01% of sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 [TSP], pH=7.4), whereas the 
dry mass of the chloroform fraction was dissolved in deuterated chloroform (CDCl3).  
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Acquisition of NMR spectral data. All 
1
H NMR spectra from mouse and rat brain extracts  
were recorded on a Bruker Avance 600 NMR spectrometer (Bruker; Rheinstetten, Germany), 
operating at 600.13 MHz for proton frequency. A 5 mm triple resonance probe with inverse  
detection was used (Bruker), employing a standard 1-dimensional (1D) NMR experiment with 
pulse sequence [recycle delay (RD)-90
o
-t1-90
o
-tm-90
o
-ACQ]. Optimal water suppression was 
achieved by irradiating the water frequency during the RD set to 2 s. The 90
o
 pulse length was 
adjusted to 10.62 s for the brain extracts of both the E. caproni-mouse and the F. hepatica-
rat models and 13.5 s for the S. mansoni-mouse model. A total of 128 numbers of scans were 
acquired for all three models into 32 K data points for each spectrum employing a spectral 
width of 20 ppm. All free induction decays (FIDs) were multiplied by an exponential function 
equivalent to a 0.3 Hz line-broadening factor prior to Fourier transformation. 
Assignments of the spectral peaks were made from the literature
26
 and confirmed via 
statistical total correlation spectroscopy (STOCSY)
27
, or via standard 2-dimensional (2D) 
NMR experiments conducted on selected samples, including correlation spectroscopy 
(COSY)
28
, total correlation spectroscopy (TOCSY)
29
, and J-resolved NMR spectra
30
. High-
performance liquid chromatography (HPLC) was performed in order to separate the brain 
extract fractions and gain additional information about the previously unknown spectral 
regions at chemical shifts of δ 6.15 (doublet), δ 8.6 (singlet), δ 8.27 (singlet) and δ 4.02 
(multiplet). For this purpose, fractions were separated using an Agilent 1100 HPLC with 
Eclipse XDB-C18 column, 5 µm, 4.6x150 mm (Agilent, USA), attached to an Esquire 6000 
mass spectrometer (MS; Bruker Rheinstetten Germany). An aliquot of 100 µl of brain extract 
was injected at a flow rate of 1 ml/min and signals were detected by UV at 214nm and by MS 
in positive mode. A gradient of 98% water to 2% acetonitrile was used for the first 25 min 
and a standard gradient sequence was applied for the remaining 25 minutes. Fractions were 
collected over the first 8 min and then lyophilized and resuspended in D2O for NMR analysis. 
Inosine, inosine-monophosphate, inosine-diphosphate, inosine-triphosphate, adenosine, 
adenosine-monophosphate, adenosine-diphosphate and adenosine-triphosphate were 
confirmed by adding authentic standards purchased from Sigma Aldrich (Gilingham, Dorset, 
UK).  
Data processing and analysis. The raw spectra were corrected with an in-house developed 
MATLAB script in order to reduce phase and baseline distortions and manually calibrated to 
the lactate CH3 signal at δ 1.33 ppm. Although water saturation was efficient, the region  
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containing the water resonance was removed to avoid any interference with the analysis (i.e., 
 4.65-5.08 in brain extracts in the E. caproni-mouse model,  4.55-5.40 in brain extracts in  
the F. hepatica-rat model, and δ 4.71-4.90 in the brain extracts in the S. mansoni-mouse 
model). Finally, all spectra were normalized over the total sum of the remaining spectral area.  
In an initial stage, principal components analysis (PCA) was applied to the processed 
spectral data in order to gain an overview of the degree of differentiation or grouping in each 
parasite-rodent model
31
 between infected and uninfected control animals. PCA reduces the 
multivariate data to a lower-dimensionality scores plot, without requiring any prior class 
information and delivers a snapshot of the similarity between observations e.g. brain spectral 
data, based on the sum of the spectral components. In a second step, projection to latent 
structure discriminant analysis (PLS-DA) was applied, as a supervised method, which utilizes 
prior information of class membership and hence optimizes separation
32
.  
Orthogonal (O)-PLS-DA is a further development of PLS-DA applied for optimal 
recovery of biomarkers
32
, and removes systematic variation unrelated to infection status via 
an orthogonal filter. The O-PLS-DA model was build by a X-matrix containing all spectral 
information and a binary dummy matrix, as Y-determining class affiliation. Sevenfold cross 
validation was applied
33
 in order to limit over fitting of the models. The color code in the 
resulting coefficient plot indicates the strength of association of each data point or signal with 
differentiation due to infection.  
Cytokine multiplex quantification. Plasma from F. hepatica infected rats and uninfected 
control rats from previous spectral preparation (e.g. saline D2O:H2O=1:1), over six different 
timepoints from 5 individuals each were tested by Mesoscale multiplex assay (MS6000 Rat 
Demonstration 7-Plex Ultra-Sensitive Kit, Mesoscale Discovery ). The rat demonstration 7-
Plex Ultra-Sensitivity Kit was used for this purpose which includes IFN-γ, IL-1β, IL-4, IL-5, 
IL-13, KC/GRO and TNF-α. Each sample was assessed in duplicates and split in 15 μl per 
well in a 96 well plate. The incubation time was extended to 4 hours in order to counteract the 
1:1 dilution. The rest of the protocol was followed according to the manufacturer‘s 
specifications. A MSD Sector imager was utilized to read the plates. For the S. mansoni 
cytokine assessment, 5 plasma samples were chosen from infected and control animals each 
and treated the same way as described above. A 96-well multi-spot plate of TH1/TH2 
cytokines (MS2400 Mouse TH1/TH2 9-Plex Tissue Culture Kit) including TNF-α, MKC, IL-
5, IL-4, IL-2, IL-1β, IL-12, IL-10 and IFN-γ, was selected for the mouse samples.  
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Metabolite Chemical moiety Chemical shift in ppm and multiplicity
3-hydroxybutyrate half α-CH2, half α-CH2, β-CH, γ-CH3 2.32(m), 2.42(m), 4.16(tqa),1.21(d)
acetate CH3 1.91(s)
adenosine
14-CH, 8-CH, 1-CH, 2-CH, 3-CH, 4-CH, half 
5-CH, half 5-CH
8.32(s), 8.22(s), 6.05(d), 4.79(dd), 4.44(dd), 
4.30(dt), 3.93(dd),  3.85(dd)
adenosine 5' -monophosphate
14-CH, 8-CH, 1-CH, 2-CH, 3-CH, 4-CH, half 
5-CH, half 5-CH
8.59(s), 8.25(s), 6.04(d), 4.46(dd), 4.38(dt), 
4.01(m)
adenosine 5'-diphosphate
14-CH, 8-CH, 1-CH, 2-CH, 3-CH, 4-CH, half 
5-CH, half 5-CH
8.52(s), 8.23(s), 6.14(d), 4.77(dd), 4.63(dd), 
4.40(m), 4.24(m)
adenosine 5'-triphosphate
14-CH, 8-CH, 1-CH, 2-CH, 3-CH, 4-CH, half 
5-CH, half 5-CH
8.51(s), 8.22(s), 6.12(d), 4.60(dd), 4.40(dt), 
4.25 (m)
alanine α-CH, β-CH3 3.81(q), 1.48(d)
asparagine α-CH, half β-CH2, half β-CH2 4.01(m), 2.87(dd),2.96(dd)
aspartate α-CH, half β-CH2, half β-CH2, 3.92(m), 2.70(m),2.81(m)
choline 3xCH3, α-CH2, β-CH2 3.21(s), 4.07(m), 3.52(m)
creatine CH3, CH2 3.04(s), 3.93(s)
formate CH 8.45(s)
fumarate CH 6.53(s)
glutamate α-CH, β-CH2, γ-CH2 3.78(m), 2.06(m), 2.36(m)
glutamine α-CH, β-CH2, γ-CH2 3.78(m), 2.15(m), 2.46(m)
glycerophosphocholine
3xCH3, half α-CH2, half α-CH2,                   
half β-CH2, half β-CH2, γ-CH2
3.23(s), 4.32(t), 3.60(dd), 3.68(t), 3.89(m), 
3.72(dd)
guanosine 14-CH, 1-CH, 3-CH, 4-CH, 5-CH 8.13(s), 5.91(d), 4.41(dd), 4.34(dt), 4.09(AB)
inosine
14-CH, 8-CH, 1-CH, 2-CH, 3-CH,                   
4-CH, half 5-CH, half 5-CH
8.35(s), 8.23(s), 6.10(d), 4.75(dd), 4.45(dd), 
4.30(dt), 3.90(dd), 3.84(dd)
inosine 5' -monophosphate
14-CH, 8-CH, 1-CH, 3-CH, 4-CH, half 5-CH, 
half 5-CH
8.58(s), 8.23(s), 6.14(d), 4.52(m), 4.37(m), 
4.00(m)
inosine 5'-diphosphate
14-CH, 8-CH, 1-CH, 2-CH, 3-CH,          4-
CH, half 5-CH, half 5-CH
8.52(s), 8.23(s), 6.16(d), 4.59(d), 4.41(m), 
4.24(m), 4.10(s), 3.67(d), 3.37(d)
inosine 5'-triphosphate
14-CH, 8-CH, 1-CH, 2-CH, 3-CH,             4-
CH, half 5-CH, half 5-CH
8.48(s), 8.22(s), 6.14(d), 4.60(dd), 4.40(dd), 
4.26(m), 4.25(m) 
isoleucine
α-CH, β-CH, half γ-CH2, half γ-CH2,       δ-
CH3, β-CH3, 
3.68(d), 1.93(m), 1.25(m),1.47(m), 0.99(d), 
1.02(d)
lactate CH, CH3 4.12(q), 1.33(d)
leucine α-CH, β-CH2, γ-CH, δ-CH3, δ-CH3 3.72(t), 1.63(m), 1.69(m), 0.91(d), 0.94(d)
lysine α-CH, β-CH2, δ-CH2, γ-CH2, ε-CH2 3.77(t), 1.92(m), 1.73(m), 1.47(m), 3.05(dd)
myo -inositol 1,3-CH, 2-CH, 5-CH, 4,6-CH 3.53(dd), 4.06(t), 3.28(t), 3.63(t)
N -acetylaspartate α-CH, half β-CH2, half β-CH2, CH3, 2.03(s), 2.51(dd), 2.70(dd), 4.40(m)
nicotinurate CH2, 2-CH, 4-CH, 5-CH, 6-CH 3.99(s), 8.94(dd), 8.25(d), 7.60(dd), 8.71(d)
phenylalanine
2,6-CH, 3,5-CH, 4-CH, half β-CH2,               
half β-CH2, α-CH
7.44(m), 7.39(m), 7.33(m), 3.17(dd), 3.30(dd), 
3.99(dd)
phosphocholine CH3, α-CH2, β-CH2 3.24(s), 3.60(m), 4.18(m)
scyllo -inositol 6xCH 3.35(s)
taurine CH2N, CH2S 3.27(t), 3.43(t)
tyrosine 2,6-CH, 3,5-CH, CH2, α-CH 7.23(d), 6.91(d), 2.93(t), 3.25(t)
uridine
6-CH, 5-CH, 2'-CH, 3'-CH, 4'-CH,                     
5'-CH(d), half CH2OH, half CH2OH
7.87(d), 5.90(s), 5.92(d), 4.36(t), 4.24(t), 
4.14(q), 3.92(dd), 3.81(dd)
valine α-CH, β-CH, γ-CH3, γ'-CH3 3.62(d), 2.28(m), 0.98(d), 1.03(d)
γ-aminobutyrate α-CH2, γ-CH2, δ-CH2  2.30(t), 1.91(m), 3.02(t)
Lipid fractions CH2CH2C=C, CH3CH2, CH3CH2CH2C= 1.68(m), 0.94(m), 0.88(m)
Table 6.1. List of metabolites found in brain metabolic spectra of female NMRI mice and Wistar rats. 
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6.4 Results 
Neural metabolite profiles of uninfected control mice and rats. 
1
H NMR spectra obtained 
from the brain removed from the control groups of unifected mice and rats indicated that these 
two rodent species shared a similar metabolic profile as expected. Creatine, N-acetylaspartate 
(NAA), lactate, myo-inositol, taurine, choline, acetate, glutamate, aspartate and γ-
aminobutyrate (GABA) were amongst the dominating metabolites in the aliphatic region of 
the spectra (Figure 6.1A), whilst inosine and adenosine species and the two aromatic amino 
acids phenylalanine and tyrosine are characteristic for the aromatic regions in rat and mouse 
brain profile (Figure 6.1B, Table 6.1). 
 
Wistar rat
NMRI mouse
4.5 2.53.03.54.0 1.01.52.0 d 1 H
4.5 2.53.03.54.0 1.01.52.0
lactate
lactate
alanine
valine isoleucine
alanine
acetate
N -acetylaspartate
glutamate
g -aminobutyrate
creatine
choline
phosphorylcholine
creatine
lactate
acetate
creatine
choline
glycerophosphocholine
lactate
myo  - inositol
creatine
myo - inositol
taurine
scyllo  - inositol
phosphocholine
N -acetylaspartate
glutamatescyllo - inositol
g -aminobutyrate
aspartate
aspartate
taurine
A
leucine
valine isoleucine
leucine
glutamine
glutamine/glutamate
glutamine/glutamate
glutamine
d 1 H
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Fig. 6.1. (A) Previous page: Aliphatic region (δ 0.5-4.3) of a typical 600 MHz 1H NMR spectra of 
brain extracts obtained from a non-infected control rat and control mouse. (B); Aromatic region (δ 6.5-
8.0), magnified 8 fold compared to corresponding spectra in (A). 
 
Infection burden and mouse physiology. For each trematode-rodent model, bodyweight and 
the packed cell volume (PCV) ratio was monitored for each animal at regular intervals. These 
two measures were used for the overall appraisal of animal wellbeing, with PCV often 
employed as a proxy for anaemia
159
. Upon dissection of experimental animals, E. caproni 
trematodes were removed from the intestine, F. hepatica from the bile ducts and S. mansoni 
from both the liver and mesenteric veins in order to confirm infection and assess worm 
burden
11, 35
. These description parameters are summarized in Table 6.2. 
 
Wistar rat
NMRI mouse
8.5
8.5
6.06.57.07.58.0
8.0 7.5 7.0 6.5 6.0
inosine
phenylalanine
tyrosine
fumarate
fumarate
inosine
inosine/adenosine
inosine
phenylalanine
tyrosine
formate
nicotinurate
nicotinurate
formate
inosine
AMP
AMP
IMP
IDP/ITP
AMP/ADP/ATP
nicotinurate
IMP/ADP/ATP
adenosine
nicotinurate
adenosine
uridine
uridine
uridine
uridine
guanosine
B
IMP/ADP/ATP
AMP/ADP/ATP
inosine
IDP/ITP
IMP
guanosine
d 1 H
d 1 H
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Table 6.2. Physiological parameters and assessment of wormburden after establishment of chronic 
infection in all three trematode-rodent models. 
Host                   
number of control 
(C) and infected 
(T) animals
Number of 
animals with 
established 
infection
Mean worm 
burden     
(range; SD)
PCV at last 
sampling 
timepoint
E. caproni
Mouse            
n(C)=12                     
n(T)=12 8
26.5                  
(10-44; 12.0)
C=52.30% 
T=52.55%
F. hepatica
Rat                  
n(C)=12                     
n(T)=12 12
5.5                
(2-10; 2.6)
C=50.80% 
T=42.00%
S. mansoni
Mouse            
n(C)=10                     
n(T)=10 8
36                    
(26-46; 7)
C=54.70% 
T=33.70%  
 
Multivariate statistical differentiation. PCA and PLS-DA were initially applied to the brain 
extract spectra of all three trematode-rodent models. An infection with either F. hepatica or 
S. mansoni, induced obvious changes in the metabolic composition of the host brain, as 
indicated by the clear visual separation of the infected and control animals in the PCA scores 
plots. Additional PLS-DA analysis confirmed class separation of F. hepatica-infected and 
control rats (Q
2
Y = 0.46) and S. mansoni-infected and control mice, respectively (Q
2
Y = 0.61). 
Only E. caproni-infected animals were not differentiated from the corresponding control 
group. The goodness of fit of the PCA model, which is expressed as Q
2
X, in a 3 principal 
component (PC) model was high (Q
2
X = 0.68) for the E. caproni model but visualization of 
the scores plot did not show clear separation between controls and infected animals, and the 
model predictivity of the PLS-DA analysis was poor (Q
2
Y = -0.21) (Figure 6.2). Therefore 
this group of samples was not explored further. 
Pair wise comparison between infected and uninfected control rodents. The O-PLS-DA 
analysis further underscored whether or not there were remote metabolic changes in the host 
brain due to a trematode infection. Whereas an E. caproni infection in the mouse did not 
induce any significant differentiation from the healthy state (data not shown), the other two 
trematodes showed a considerable effect on neurochemical profiles. For instance F. hepatica 
induced significant increase of inosine and the two aromatic amino acids (AAA) tyrosine and  
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phenylalanine. On the other hand, the concentrations of glycerophosphocholine (GPC), 
succinate, inosine mono-, di- and triphosphate, adenosine and adenosine mono- di- and  
triphosphate were relatively lower in the brains of infected animals (Figure 6.3A). Infection 
with S. mansoni was characterised by higher levels of glutamine, but lower concentrations of 
γ-aminobutyric acid (GABA), choline, phosphocholine and scyllo-inositol (Figure 6.4). 
Multivariate analyses between physiological compartments. To reveal systematic effect of 
the changed brain metabolic profile of the F. hepatica infected rats, prominent, but minimally 
overlapped resonances for all significantly differentiating metabolites were chosen and 
integrated for all 24 animals. The 
1
H NMR urine and plasma spectra obtained immediately 
prior to the end of the experiment (e.g. day 71) were individually fitted and correlated with 6 
brain spectral integrals (Figure 6.5). The results from both analyses are summarized in Table 
6.3. 
 
Fig. 6.2. PCA and PLS-DA analysis of (A) F. hepatica in the rat, (B) S. mansoni in the mouse and (C) 
E. caproni in the mouse. The outlier (T39) died before the timepoint of dissection. 
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Fig. 6.3. (A) Pair wise comparison via O-PLS-DA analysis of F. hepatica infected (upwards oriented 
peaks) and non-infected control animals (downwards oriented peaks). The color scale indicates the 
magnitude of contribution to the class difference and the peak height is expressed in arbitrary units 
(a.u.) relatively to the total peak contribution. (B) Statistical TOtal Correlation SpectroscopY analysis 
(STOCSY) of correlated peak regions, revealing spectral regions which belong to the same molecule 
or close pathway connections.  
 
Fig. 6.4. O-PLS-DA differential plot of S. mansoni infected (upwards oriented peaks) and non-
infected control animals (downwards oriented peaks). The colour scale indicates the weight of 
contribution to the class differentiation of the data points.  
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Plasma cytokine level assessment. In order to ascertain whether the metabolic shift from 
adenosine towards inosine was reflected in the expression of cytokine levels, the 
concentrations of various cytokines were assessed. Levels of both IL-13 and IL-5 were 
significantly higher in F. hepatica infected rats, compared to the uninfected control group on 
day 22 post-infection, whereby the former maintained significance on day 43 post-infection 
(Figure 6.6). Although not statistically significant, a trend towards lower levels in the infected 
animals during the course of infection was apparent. Comparing the plasma cytokine levels of 
five 5 S. mansoni infected mice with the corresponding control mice, concentrations of IFN-γ, 
IL-2, IL-12, IL-4 and IL-5, were higher in all infected animals at day 53 post-infection.  
 
Table 6.3. Correlations between neural concentrations of adenosine species, inosine, phenylalanine, 
succinate and tyrosine and plasma and urinary metabolites, respectively.   
 
6.6 Discussion 
 S. mansoni and F. hepatica both induced a marked perturbation of the neurochemical 
prfiles of the host animals. Interestingly, the third trematode employed (E. caproni) was not 
associated with any clear perturbations in the 
1
oH NMR spectra obtained from host brain. The 
patterns of differentiating metabolites in the S. mansoni-mouse and the F. hepatic-rat models 
were unique for these two trematode-rodent models apart from exhibiting decrease in  
plasma adenosine
 species inosine succinate tyrosine phenylalanine
O -acetyl GP -0.57 -0.62 0.55
N -acetyl GP -0.53 -0.42 0.57
betaine -0.50 0.76
lactate 0.60
N -acetylcysteine? -0.48 0.57
creatine -0.65 0.65
urine 
α-ketoglutarate -0.45 0.41 0.60 0.60
taurine -0.45 -0.51
α-aminoadipate -0.66 0.52 -0.68 0.66
3-hydroxyphenylpropionic acid 0.55 -0.61 -0.47
m -hydroxyphenylacetate -0.54
succinate -0.59
oxaloacetate or pyruvate -0.61 0.75
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the lipid concentrations of lipid degradation products, such as choline, phosphocholine and 
GPC, which all have a role in cell membrane formation.  
Lipid homoeostasis. Food-derived or de novo synthesized choline has three major fates in 
mammals, (i) further synthesis to phosphocholine, a basic component of membrane 
anabolism, (ii) oxidation into betaine in the liver and kidney, where it functions as an 
osmolyte or methyldonor for homocysteine
36
; or (iii) conversion into acetylcholine
37
. Choline 
and phosphocholine were found in lower concentrations in the brains of mice infected with 
S. mansoni, which indicate increased second messenger action, increased membrane 
maintenance or use of host lipid fractions for parasite lipid anabolism. 
The members of the fatty acid binding proteins (FABPs) gene family are also believed to 
contribute to the decrease in lipid fractions. Esteves et al. hypothesised that plathelminthic 
FABPs play a role in scavenging host membrane lipids, as flatworms are not able to 
synthesize their own lipids de novo, and are dependent on free fatty acid pools
38
. This 
hypothesis may explain a global decrease of lipids leading to the observed depletion of 
cerebral choline and phosphocholine due to a chronic infection with S. mansoni, and lower 
GPC (and the trend in lower choline and phosphocholine) levels after infection with 
F. hepatica.  
Parasite specific perturbations of neural profiles. Nucleotide degrading enzymes have been 
found to be excreted in a variety of ecto- and endoparasitic organisms, such as ticks, blood 
sucking insects and helminths and serve the primary purpose of minimizing immune reactions 
in the host organism in order to prolong the survival
39. 40
. The found shift from adenosine 
concentrations (decreased) and inosine levels (increased) reflects an attenuated inflammatory 
response as both nucleotides induce mast cell degranulation, but adenosine is the more potent 
activator and is converted into the inosine by adenosine deaminase
41
. Thus far, adenosine 
deaminase has been found in secretory channels of Trichinella spiralis and Fasciola 
gigantica
42, 43
. Inosine is mainly formed by intracellular conversion of adenosine via 
adenosine deaminase, or by the 5‘-nucleotidase which hydrolyses inosine-monophosphate 
(Figure 6.6A). 
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Fig. 6.5. O2-PLS analysis generated using 
1
H NMR urine spectra as the x-matrix and the integrals of 
the control/infection-differentiating metabolites of the brain extracts (ade, adenosine-species; GPC, 
glycerophosphocholine; ino, inosine; phe, phenyalanine; suc, succinate; tyr, tyrosine;) as the y-matrix. 
The x-axis shows the most explanatory urine spectral regions, whereas y reveals which descriptor in 
the y-matrix is best explained by the x-data set, e.g. which metabolite. The resulting cross plot shows 
the correlation strength of urinary and brain metabolites. Red frame: positive correlation of urinary 
and brain metabolites; Blue frame: negative correlation of urinary metabolites with increasing brain 
metabolic integrals; black filled boxes indicate a correlation coefficient of 0.4-0.5; gry fill, 0.5-0.6; 
white fill, 0.6-0.8. 
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Fig. 6.6. (A) Schematic of: Intra- and extracellular adenosine-inosine interconversion in the brain by 
two main enzymes, 
1
 adenosine dehydrogenase and 
2 
5-nucleotidase; A, adenosine; I, Inosine. (B) The 
shift from adenosine towards inosine leads to TH2 subset triggered immune mechanisms characterised 
by relatively higher levels of IL-5, IL-13 and lower concentrations of IFN-γ which acts as TH2 
inhibitor. Plasma concentrations of the three cytokines (C) confirmed significantly lower levels of IL-5 
and IL-13 in the F. hepatica infected animals (light blue and green) at day 22 post-infection and day 
43 post-infection, respectively, and a trend towards lower levels of IFN-γ throughout the main course 
of infection, compared to the uninfected control animals (blue).  
 
Our data may suggest that F. hepatica not only secrets adenosine deaminase but also a 5‘-
nucleotidase analogue catalytic active molecule. The increased conversion from adenosine, 
phosphorylated adenosine and phosphorylated inosine species to inosine in the host brain is 
believed to reflect the systemic state and is potentially beneficial to the parasite as inosine is 
not only less potent in mast cell activation, but is also known to suppress the synthesis of pro-
inflammatory cytokines, such as IFN-γ, IL-1, IL-12 and TNF-α in vitro44. Indeed, additional  
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cytokine concentration measurements in the plasma of F. hepatica-infected and uninfected 
control rats at 6 different time points revealed a TH2 emphasised immune response (Figure 
6.6B) with significantly higher levels of IL-5 and IL-13 and a trend toward lower levels of 
IFN-γ in the infected group (Figure 6.6C). Both, the increase of IL-13 and the enhanced TH2 
immune response counteract mechanisms of inflammation since IL-13 is an important 
negative regulator of inflammatory cytokines, and the TH1 cytokine subset is usually 
associated with tissue injury and excessive inflammation, which would be expectable in a 
massive liver damage, as caused by F. hepatica. Again, minimization of such an intense 
immune reaction and hence undetected co-existence in the host at earlier stages of infection is 
obviously beneficial for the survival of the worms.  
Characteristic modulation of neurochemical profile following Schistosoma mansoni 
infection. Metabolic alterations associated with a S. mansoni infection comprised relatively 
increased tissue concentrations of glutamine with depleted levels of GABA, choline species 
and scyllo-inositol. Glutamine is a substrate for both excitatory and inhibitory 
neurotransmitters, including GABA. The inverse association of glutamine and GABA in the 
current study may indicate an inhibitory mechanism on glutamate decarboxylase, mediated by 
S. mansoni-induced immune reactions in the CNS. It is known that glutamate decarboxylase 
converts glutamate directly to GABA
45
. It is therefore interesting to note that an infection with 
the West Nile virus, which induces meningitis and encephalitis, has been associated with the 
development of anti-glutamate decarboxylase antibodies, leading to motor neurotic 
disturbances
46
. 
The inflammation which S. mansoni presence causes is also reflected in the increased 
concentrations of the pro-inflammatory cytokines IFN- γ and IL-12 in the plasma of infected 
mice, in contrast to the F. hepatica induced attenuation of inflammatory reactions. 
GABA has been reported to decrease in the brain of mice with CNS diseases. It is well 
documented that both GABA and glutamate are associated with inflammatory responses, and 
hence they may play a role in the cross-talk between immune cells and neurons
47, 48
.  
Interplay of liver pathology and neural profile. Both S. mansoni and F. hepatica infections 
cause liver damage, via egg induced inflammation
49
, leading to damage of blood vessels, 
necrosis and structural change of the liver tissue
50
, and direct mechanical damage by the 
juvenile worm, respectively
19
. The inflammation caused by trapped S. mansoni eggs in the 
liver tissue seem to result in malfunction, including failed detoxification of ammonia derived  
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from the intestinal degradation of nutrients. Compensatory locations for ammonium 
detoxification are muscle cells and the brain, combining ammonia and glutamate to 
glutamine
51, 52
, which could also contribute to the relatively higher levels of glutamine in the 
brain extracts of S. mansoni-infected mice documented in the current investigation. The 
subsequent decrease of the second messenger GABA indicates that the main fait of glutamate 
is indeed the detoxification rather than the generation of GABA. The impact of F. hepatica on 
the liver is due on direct, mechanical damage of the tissue by the migration and feeding of the 
juvenile worm for 5-7 weeks until it reaches maturity and finally resides in the bile duct
19
. 
The consequent hepatic dysfunction in F. hepatica infection manifested in increased 
circulating toxins, such as ammonia, mercaptans and phenols
53
, which are typically released 
after hepatic failure, because of failing degradation of aromatic amino acids and ammonia. 
Animals, infected with F. hepatica showed increased neural concentrations of the two 
aromatic amino acids phenylalanine and tyrosine. Indeed it has been shown that hepatic 
failure induces an increased passive permeability of the blood-brain barrier for several 
substances, amongst which phenylalanine and tyrosine were found to increase up to 30% in 
the brain
54
. Although there is no direct sign of ammonia detoxification in the brain metabolic 
profiles of F. hepatica infected rats, the positive correlation of α-ketoglutarate in the urine 
with increasing levels of the two aromatic amino acids in the brain indicates potential 
ammonia degrading capacity with severity of disease, as ammonia is known to inhibit α-
ketoglutarate dehydrogenase which accumulates α-ketoglutarate but allows degradation to 
glutamate and glutamine, respectively
55
.  
We have demonstrated a clear effect of two helminth infections on the biochemical 
composition of the brain whereas a third helminth failed to induce any response in the neural 
metabolic profile. However, the neurometabolic signature of S. mansoni and F. hepatica were 
distinctive with S. mansoni indicating markers of inflammation such as increased GABA and 
glutamate and increased pro-inflammatory cytokines (IFN-γ and IL-12). All other assessed 
cytokines which underwent increase after infection indicated a mixed TH subgroup response 
with IL-2, IL-12 and IFN-γ being characteristic for TH1 guided immune mechanisms and IL-4 
and IL-5 linked to TH2 responses. F. hepatica on the other hand demonstrated a more 
focussed response primarily associated with the hypothesised worm-induced shift from 
inosine towards adenosine and the subsequent induction of a TH2 focussed immune response. 
Although there is no need to emphasise that the TH1/TH2 dogma is not strictly applicable in  
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vivo, and much more complex than the strict categorization to two possible outcomes, we 
show here that the sum of effects of a helminth infection reflects in the biochemical 
composition of the biofluids and tissues as response to the trematode antigens, and the direct 
mechanical effect of larvae and egg which offers a new way to further explore the dynamic 
action of the immune system and circumvent sub type-assumption.  
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7 Discussion 
 
The ‗-omics-sciences‘ have been portrayed as providing new avenues for personalised 
healthcare in industrial countries (Kussmann et.al., 2006; Martini et.al., 2008; Sigdel and 
Sarwal, 2008). Metabonomics, which is one of the ‗-omics sciences‘ has already established 
itself as an important contributor for this purpose (Nicholson, 2006; Rochfort, 2005; Yap 
et.al., 2006). For tropical parasitic diseases, however, approaches that are readily adopted to 
resource-constrained settings must be found, which implies rapid and inexpensive screening 
programmes rather than highly optimised personal health care. Comparing efficiency, cost 
and practicality between proteomics, genomics and metabonomics, we believe that the latter 
holds particular promise to fulfil some of these prerequisites. The present Ph.D. thesis is part 
of a longer term investigation with the overarching aim to critically evaluate the scope and 
limits of 
1
H NMR-based metabolic profiling as a new tool to further our understanding of 
host-parasite interactions, with particular consideration to diagnostic and prognostic potential. 
In the current thesis, we focussed on the evaluation of potential diagnostic matrices and 
biomarker recovery and quality assessment issues of a number of trematode infections in 
selected rodent models. 
Of all biological samples, urine has been best characterised by 
1
H NMR spectroscopy due 
to the ease of sample collection and its availability in large quantities (Clayton et.al., 2004; 
Foxall et.al., 1993; Holmes et.al., 1994; Nicholls et.al., 2003). Another biofluid widely used 
in metabonomics is blood plasma (Beckonert et.al., 2007; Nicholson et.al., 1995; Tang et.al., 
2004). In order to gain the best preparation protocol for faecal water data acquisition, and to 
conclude on the significance of identified metabolites for eventual diagnosis, we performed a 
thorough characterisation of faecal water. Based on these findings, a comparison was done on 
three biofluids (i.e., urine, plasma and faecal water) obtained from E. caproni-infected mice 
and uninfected control mice that were matched for age and sex. Biomarkers were recovered 
via 
1
H NMR at several time points post-infection, which included acute and chronic stages of 
infection. Quantity of biomarkers, stability over time and practicality were assessed to gain an 
idea over the potential diagnostic range which biofluids can be used for the metabolic assay. 
In the case of an E. caproni infection in the mouse, once the infection had progressed to a 
chronic stage (i.e. 5 weeks post-infection), mice were killed and a number of different organs 
recovered for further assessment of disease impact on the murine host. The purpose of this 
part of the study was to gain further insights into systems level changes due to this intestinal  
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fluke infection and to uncover subtle changes at a molecular level in different 
physiological compartments, which had not been chosen for assessment before. The results 
indeed showed unexpected changes in locations remote from any direct impact of the 
intestinal fluke, namely in the liver and kidney. 
In view of conflicting results of whether or not helminth infections have a negative effect 
on the cognitive performance of the human host, and whether anthelminthic treatment can 
revert such effects (Boivin, 1996; de Clercq et.al., 1998; Jukes et.al., 2002; Watkins and 
Pollitt, 1997), we performed additionally analysis on the brains of E. caproni-infected mice, 
S. mansoni-infected mice and F. hepatica-infected rats (unpublished data), including age- and 
sex- matched uninfected control animals. These experiments resulted in revelation of strategic 
behaviour of F. hepatica via immune modulation of the host. 
 
7.1 Potential biological matrices for diagnosis  
The main criteria when looking for a suitable template for diagnostics are availability in terms 
of volume, a non-invasive way of obtaining the sample, inherent stability of the sample, and 
the potential of offering a quantitatively and qualitatively robust panel of biomarkers. 
With view to finding a non-invasive approach, diagnosis based on tissue, spinal and 
lymph fluid are not considered as an option here, due to obvious practical reasons and the 
challenge in rural settings in the developing world, respectively. Even if there are medical 
facilities present to operate tests such as spinal puncture for example, which still needs to be 
applied to confirm the neuro-encephalitic stage of human African trypanosomiasis (Kennedy, 
2004), there is a pressing need to circumvent these highly invasive methods, because of the 
considerable risk of catching a secondary infections. 
There are many available biological samples with potential capacity of disease 
biomarkers, but some of them are limited in volume (e.g. tears and sweat) and others are 
difficult to obtain or not accepted, for ethical reasons, such as faeces or sperm, respectively. 
Apart from the ethical issues in some cultures, stool samples seem to be a suitable candidate 
for a diagnostic template, due to the ease of sampling and the sheer amount which can be 
obtained. In-depth assessment of faecal material on species-differences, gender-differences 
and stability over time showed a high degree of fluctuation over several time-points and 
species-related grouping of the assessed mouse, rat and human samples, whereas rat and  
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mouse, as expected, seemed to be closer to each other than the human faecal samples. 
Furthermore male and female separation was seen due to differences in short chain fatty acid 
(SCFA) composition. The corresponding loadings revealed differentiation due to 
concentration differences rather than qualitative differences of all three groups, which indicate 
certain constancy in the biomarker composition amongst the species. In fact, glycerol and β-
alanine were the only two compounds which appeared in a single species only (i.e. human and 
rat), but apart from that, all species and gender-differences were based on quantitative 
differences of metabolites. 
The main driver to include faecal samples in the biofluid assessment of an E. caproni-
infection in the mouse was the fact that approximately one-third of all identified urinary 
biomarkers in the previous parasite-rodent models depend on microbial modification before 
being excreted. The gut microbiota, which consist of 300-500 different bacterial species is 
responsible for the production of ~60% of the total faecal mass (Guarner and Malagelada, 
2003), hence it would be likely that an intestinal fluke, which is in direct interaction with gut 
microbial species, would impose some changes in the microbial dynamics. 
Evaluating the quantity of the identified biomarkers and stability over time, we focussed – 
apart from faecal water – on urine and plasma, for which metabolic composition across 
several species is already well characterised (Foxall et.al., 1993; Nicholson et.al., 1995) and 
which are obtained easily and in relatively large quantities (>0.25 ml). Comparing quantity 
and stability over time, as expected, faecal water could not reach the potentially high 
diagnostic level of urine or plasma but could add valuable information to gut microbial 
activities. The results indicate the depletion of certain microbial species which are normally 
responsible for the degradation of 5-aminovalerate (e.g. Clostridium aminovalericum) (Barker 
et.al., 1987; Hardman and Stadtman, 1960) and dietary carbohydrates to SCFAs (Cook and 
Sellin, 1998; Wong et.al., 2006), but after infection with E. caproni failed to do so. 
Even though water is not an ideal template for diagnosis, the informative value of this 
additional data set should not be underestimated, and hence might be included in every future 
experimental set-up to in order to gain direct correlation of molecular compounds and 
bacterial strains. Both urine and plasma samples showed a similar quantity of extracted 
biomarkers for identification of an E. caproni infection in mice (ten and 12, respectively) with  
a very good indication of stability. From day 8 post-infection onwards, when the most 
significant changes started to manifest, four more time-points were assessed. Five biomarkers  
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in urine and seven in plasma differentiated the infection-status significantly on, at least four of 
these five time-points, which is a promising finding. Whereas plasma holds the higher 
quantity of candidate biomarkers in the experimental measures, urine advances through the 
easy of sample collection under field conditions (e.g. minimally trained personnel can do it 
such as school teachers), and would make sterile blood-sampling material redundant. 
However both, urine and plasma will be given the same attention in future biomarker 
extraction. 
 
7.2 Specificity of biomarkers 
The quality and quantity of the biomarkers are important criteria for choosing a suitable 
diagnostic template and can be easily assessed in one single parasite-rodent model, but this 
will not give any conclusion about how well an underlying condition is reflected by the 
biomarkers. The decisive question of how specific a marker is to a certain infectious-disease 
is perhaps the most difficult to answer and extensive evaluation over several infection models. 
Furthermore, parasite-induced pathology can resemble other none infection-related disease 
states, such as the mechanical liver damage, caused by an infection with the liver fluke 
F. hepatica and alcohol-induced liver cirrhosis, and could potentially generate the same 
biomarkers. However, it is obvious that different causes of organ damage can induce a similar 
pathological manifestation but this obstacle can be overcome by creating fingerprints of 
disease with different subsets of biomarkers, as one health impact is never restricted to a 
single physiological compartment but rather introduces homeostatic changes in the whole of 
the system and will also reveal traces of the causative agent, whether it is an invading 
parasite, a genetic defect or a nutritional ill-condition. 
Table 7.1 shows a direct comparison of the complete set of recovered urine biomarkers 
across five parasite-rodent models, whereas Table 7.2 represents the plasma markers from 
four of these five models. No urine samples were available of Trichinella spiralis-infected 
mice, and neither plasma from both schistosome models has been sampled, and hence, no 
biomarkers are listed in the corresponding tables. The markers were evaluated according to a 
colour code, with red indicating absolute specificity according to parasite-infection, taking 
directional changes (increased or decreased in infected animals in comparison to 
corresponding controls) of the markers in account, yellow indicating the up-coming of the  
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marker in two of the infection models, light blue markers were present in three and dark 
blue coded markers in all listed parasite-rodent models. Interestingly, the most unspecific 
urinary markers were all gut microbiota-related, which indicates a general infection-induced 
impact on the host microbiota. Indeed, bacterial species, which are pathway-linked to 
hippurate, p-cresolglucuronide, phenylacetylglycine and trimethylamine, seem to be affected 
the most. 
 
 
Figure 7.1. Hypothetic disease fingerprint composed of three biomarker sub-panels, which include 
general markers of infection, family-specific and parasite-specific markes. 
 
Other microbiota-related metabolites, such as SCFAs did not seem to respond to the 
general infection pattern in such a high degree. In contrast, the more general marker found in 
plasma were composed of functionally very different metabolites, such as the branched chain 
amino acids (BCAAs) valine, leucine and isoleucine, which showed depletion in 
Trypanosoma brucei brucei and both intestinal worms, most probably due to their important 
role in tissue regeneration. Glycerophosphocholine, glucose and lactate also showed high 
biomarker presence amongst the infection, reflecting the general anaerob metabolism (e.g. 
glycolysis of parasitic organisms). However, these metabolites were only directly coupled 
within the protozoan infections, where they showed a clear depletion of glucose and 
subsequent increase of lactate, which reflects the immense glycolytic turnover of the 
trypanosomes (Mehta et.al., 2005; Visser and Opperdoes, 1980) and erythrocytes infected by 
Plasmodium berghei, respectively, using mainly glucose as substrate. Although trematodes 
and other helminths inhabit the same principal pathway, using glucose and glycogen as 
substrate, the glycolysis does not seem to be particularly efficient and glucose is often not 
completely catabolised. The end products are composed of mainly lactate but also acetate, 
succinate and large amounts of SCFA end products (Schmidt, 2000), hence lactate does not 
come up as a biomarker in the present helminth infections. A combination of the two markers 
lactate (increased) and glucose (depleted) would be predestined for a second subset of the  
E. caproni
T.b.brucei
general fam specific
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hypothetic disease fingerprint for some kind of dipstick that might eventually be 
developed and used under field conditions. All parasite-host models delivered also a third 
complementary subset of biomarkers, which were highly parasite specific (Tables 7.1 and 7.2 
and Figure 7.1). A three-subset strategy as shown here would optimize diagnostic and 
circumvent false positive as well as false negative results, by optimized broadness and 
sensitivity, respectively, through several biomarker subsets. 
 
7.3 Analytical tools 
Once the metabolic fingerprints of various single infections in suitable rodent models have 
been established, obviously the chances of cross-over of biomarkers will increase. In order to 
counteract this potential problem, the biomarker recovery process has to be further improved. 
One of the key problems, NMR spectroscopy has to face is the lack of sensitivity, which was 
indicated by the inability to directly profile parasite derived biomarkers, such as secreted 
enzymes and peptides and surface molecules, respectively (Hewitson et.al., 2008). In fact 
only in the T. b. brucei model we could be certain, that the increase of lactate in the mouse 
plasma and urine was directly parasite derived. The missed potential is not to underestimate in 
a global analysis, because such parasite secreted, low abundant compounds would be highly 
interesting potential biomarkers in terms of specificity and thus, more sensitive spectroscopic 
methods have to be emphasised in future metabolic profiling, MS in particular. MS coupled 
with chromatographic separation methods, such as liquid and gas chromatography or capillary 
electrophoresis (UPLC-MS, GC-MS or CE-MS or MS-MS), can elevate biomarker recovery 
to a new level, and e.g. complete the third subset of a disease-specific fingerprint. Highly 
accurate and mass sensitive mass spectrometers such as the quadrupole-orthogonal Time-of-
Flight MS (Q-ToF) (Plumb et.al., 2005; Plumb et.al., 2006; Wilson et.al., 2005) or the 
Orbitrap mass analyzer, which has got a mass resolution of 100,000 and a mass accuracy of 1 
part per million (ppm) (Breitling et.al., 2006; Kamleh et.al., 2008), hold promise for 
extending mass databases and facilitate recovery and identification of potential biomarkers. 
Furthermore, the NMR platform is extremely compatible and can be coupled with all the 
described MS systems, which means that after component separation and mass detection, 
spectra can be acquired in the same experimental set-up (LC/GC-MS-NMR, MS-MS-NMR), 
and facilitate identification of unknown compounds. 
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7.4 Systems integration 
Assessment of the biological fluids after an infection with E. caproni, gave a comprehensive 
overview on parasite-impact in the mouse host and could already enable to establish links 
between liquid compartments for one particular event, such as the disturbance of the 
microbiota which manifest as various metabolic changes in urine, plasma and also the faeces. 
Some major disturbances which have not been revealed or have only been hypothesised by 
looking at the biofluids could be captured by comparing the tissues of E. caproni-infected and 
uninfected mice. 
The initial finding of depleted BCAAs valine, leucine and isoleucine in the plasma but 
increased levels of the same BCAAs in stool of infected animals indicated a malabsorption 
due to an impaired Na
+
-transporter system. Magic angle spinning (MAS) analysis of all 
selected tissues revealed relatively lower levels in the ileum (isoleucine, valine) and in the 
liver, which showed relatively lower levels of all three BCAAs. The malabsorption of various 
other metabolites in the ileum (e.g. ascorbate, alanine, glutamine, aspartate), confirmed a 
disturbed intestinal cross-membrane transport of particularly Na
+
-coupled transporters, and 
indicated a low tonicity in the small intestinal part. The resulting malabsorption of 
metabolites, in particular the diminished BCAA uptake is not dramatic in an infection with 
E. caproni, but could have serious adverse effects in the case of a concomitant liver damage 
(e.g. cirrhosis or liver fluke infection), as the liver would depend in this case on the 
regenerative function of the BCAAs (Nishitani et.al., 2005; Tomiya et.al., 2004). 
A variety of additionally recovered biomarkers showed osmolytic activity that could 
suggest a potential hypertonic state in the liver, by increased betaine and phosphocholine, or 
hypotonic conditions in the cortical part of the kidney, manifested by decreased GPC and 
increased scyllo-inositol, respectively. However, it is more likely that the increase of 
phosphocholine and betaine in the liver are the response to the E. caproni-induced lipid 
degradation in the gut, which manifested in increased plasma lipid fractions from day 8 post- 
infection onwards, whereas the depletion of plasmatic GPC-levels is likely to be responsible 
for the low renal concentrations. 
 
7.5 Trematode impact on the host central nervous system 
A high worm burden and multiple infections with helminths as it is normally found in tropical 
and sub-tropical regions can lead to a deficient mental development of children and expresses  
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in cognitive impairment, including speed of information processing and short-term memory 
(Jukes et.al., 2002). Helminth-induced anaemia, iron-deficiency and malnutrition are the main 
associated factors for the negative mental performance of heavily infected individuals 
(Guyatt, 2000; Jasti et.al., 2007; Nokes and Bundy, 1994). The obvious and already well 
described link of helminth infections and the behaviour of the host encouraged to look for 
subtle biochemical changes in brain-extracts of three rodent models, i.e. S. mansoni and E. 
caproni in the mouse and F. hepatic in the rat. Apart from the known negative impact on 
educational outcome, schistosomes can also induce cerebral complications, particularly in 
normally non-exposed humans, e.g. travellers, where eggs can get in the central nervous 
system (CNS) and cause inflammation (Carod-Artal, 2008). 
Infection with E. caproni did not induce any NMR-detectable changes in the neural 
profile, which could be either due to the relatively low sensitivity of the spectroscopic method 
or there was simply no effect. The S. mansoni-induced changes reflect an impaired ammonia 
detoxification by the liver (increased glutamine and decreased γ-aminobutyric acid) and 
disruption of the host lipid composition (decreased choline/phosphocholine). Also 
F. hepatica-infected rats showed response to liver damage in the neural profile. Whereas the 
liver damage following a S. mansoni infection is triggered by trapped eggs which induce local 
inflammation and necrosis (Manzella et.al., 2008). F. hepatica larvae cause direct mechanical 
damage while migrating through the hepatic tissue (Lim et.al., 2007). Increased passive 
permeability of the blood-brain barrier and failed degradation of the aromatic amino acids are 
likely to have contributed to the relatively higher concentrations of phenylalanine and tyrosine 
in the brains of the F. hepatica-infected rats. The assessment of the brain metabolic profile 
unravelled a complete systematic network between parasite-secreted enzymes, the neural 
nucleotide-composition of the host and the host-immunity. The initially found increase of 
inosine and decrease of adenosine and phosphorylated species of both, are hypothesised to be 
based on parasite secreted 5-nucleotidase and adenosine-dehydrogenase which convert 
phosphorylated inosine/adenosine and adenosine, respectively to inosine. The nucleotide shift 
towards inosine, in turn was believed to result in a TH2-subtype immune response, with 
reduced pro-inflammatory activity to increase the host tolerance for worm-co-existence, and 
could be confirmed with additional cytokine concentration assessment in plasma of 
F. hepatica-infected rats (increased IL-5, IL-13 and decreased IFN-γ). 
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Whereas the integration of physiological compartments in the E. caproni-mouse model 
gives an overview on metabolite flow through the host system and parasite impact in a 
holistic manner, the additional cytokine information together with the neural changes revealed 
by the F. hepatica-rat model leads to one step further and opens up interconnection not only 
on multi-physiological, but also on multidisciplinary level which will ultimately lead to a 
deeper understanding of host-parasite dynamics, which might be harnessed for discovery of 
novel diagnostics, drug and vaccine targets. 
It will be a challenge to gain direct applicable benefit from the identified neural 
biomarkers, as it is very difficult to relate metabolite quality and quantity directly to mental 
processes, but correlation analysis with worm burden, which has been shown to be related to 
severity of cognitive impairment, could be one way to gain more precise information about 
the causality. Ideally, one could perform behaviour tests with trematode-infected rodents and 
related the measures of mental performance to the neural metabolic information. 
 
7.6 Immune response from a metabolic view 
Placing the markers of an infection into a biological context, it became clear that also immune 
features are reflected in the metabolism of the host organism. N-acetyl-glycoprotein, for 
example, showed elevated plasma levels in T. spiralis-infected Swiss mice, and is being 
secreted by the liver as response to pro-inflammatory cytokines. The same metabolite came 
up again in F. hepatic infected Wistar rats. Inter-matrix data integration of the plasma spectra 
on one hand and the integrals of the neural disease markers on the other hand revealed a 
positive dependence of N- and O-acetyl-glycoproteine, on the neural levels of aromatic amino 
acids (e.g. phenylalanine and tyrosine), which acted as disease specific biomarkers in this 
trematode-rodent model. In-depth concentration analysis of the cytokine expression pattern 
introduced by the chronic infection with F. hepatica showed increased plasma IL-5 and IL-13 
and decreased IFN-γ, which undermined our hypothesised link between the trematode-
induced nucleotide imbalance and a shift in the Th-subset towards Th2 and reduced 
inflammation. Although general patterns can be seen amongst all infectious diseases, 
protozoan parasites trigger different mechanisms of immune reactions. Whereas T. b. brucei 
also induced increased concentrations of O-actetyl-glycoprotein levels in the plasma of 
infected NMRI mice, there were additional immune features reflected in the metabonome,  
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based on immune-evasion mechanisms of T. b. brucei. Degradation of the plasmatic 
lipoproteins and phosphatidylcholine with subsequent increase of free choline can be 
explained by the high turnover of the trypanosome variant surface coat (VSG) and the 
constant modulation of the glycoprotein (GP) anchor, for which host lipids are known to be 
utilized by the protozoan. 
Early indication of the explanatory role which the metabolism can inhabit in immune 
mechanisms and our initial success to connect immune measures to metabolic compounds, 
e.g. cytokine levels, endorse further development towards this interdisciplinary approach and 
may help resolving important immunological questions in parasite induced immune 
mechanisms, and finding key triggers for susceptibility/resistance or Th-subset control. 
 
7.7 Conclusion 
In the current project, the main tool for metabolic profiling of biofluids and tissues obtained 
from rodents experimentally infected with either E. caproni, F. hepatica or S. mansoni has 
been 
1
H NMR spectroscopy, because of high throughput and data generation capacities, and 
excellent reproducibility. Initial exploratory experiments with few sampling time-points and 
matrices, e.g. urine, showed the scope and potential of this new method applied for purpose of 
parasite diagnosis, by showing the ease of sample collection, preparation and fast analysis and 
recovery of biomarkers (Wang et.al., 2004; Wang et.al., 2006). 
The present Ph.D. project shows some of the current imitations of the diagnostic potential 
of metabolic profiling, by evaluating diagnostic templates and technologies and defining 
biomarker criteria. There are a number of challenges to overcome before metabolic profiling 
indeed will lead to a rapid, non-invasive and practical diagnostic method, which would be 
applicable to all or most infectious diseases and safe the multi-diagnostic approach for 
parasite-infections. An attempt has been made to address potential limitations in this 
discussion, such as biomarker overlap between different parasitic infections, the 
transferability to human populations or the relatively low sensitivity of NMR for biomarker 
recovery, but at the same time I think that we are now in a position to provide a set of 
reasonable solutions. Even though we already get highly specific and qualitatively as well as 
quantitatively robust panels of biomarkers, we are confident that we can further enhance 
biomarker recovery to a higher level with additional spectroscopic methods to gain a broader  
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palette and detect low-abundant markers, such as parasite secretion products which would 
be highly disease-specific. The ultimately aim of such a strategy is to collect disease-specific 
fingerprints from one or two determined biological matrices, for each of the most important 
tropical parasite diseases, on a portable diagnostic dip-stick, which is cheap, field-applicable. 
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7.8 Future research  
 
▪Expansion of the metabolic profiling approach to other spectroscopic technologies for 
 broader metabolic coverage and higher sensitivity, with preferentially LC-MS, GC-
 MS and capillary electrophoresis (CE)-MS, using high resolution mass 
 spectrometers.  
▪Further comprehensive studies on biofluids and tissues in single-species parasitic infections 
 in suitable rodent models with patricular emphasis on biomarker extraction in the 
 biofluids and in depth-assessment of the CNS-impact.  
▪Thorough evaluation of the candidate diagnostic biomarkers. 
 Proposed criteria:  ▪Specificity to infection/disease 
    ▪Intra-species transferability 
    ▪Reproducibility 
    ▪Stability over time 
    ▪Transferability through species, human in particular 
    ▪Stability through different infection-intensities 
▪Extracting biomarkers in well selected human populations and compare to existing 
 rodent database. 
▪Extensive assessment of co- and multi-infection in suitable rodent models, primarily to  
assess the impact of additional parasite species to candidate single-infection 
biomarker, but also to exploring the benefits of different helminths to protozoan 
infections 
▪Higher degree of immunological and physiological monitoring of the host, including 
 cytokine-level assessment and gut-microbial co-monitoring of parasitic infections 
▪Metabolic profiling of parasite and intermediate host via NMR and MS-based methods in 
 order to profile different stages and habitats in the parasite life cycle and additionally 
 explore the metabolic features in drug-resistant parasite strains.  
▪Behaviour tests with trematode-infected rodents, relating the measures of mental 
 performance to the neural metabolic information.  
▪Assessment of the increased severity of a liver damage in a co-infection of F. hepatic and    
 E. caproni, compared to F. hepatica single-infection. 
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Table 7.1 
 
Plasmodium 
berghei
Trypanosoma 
b. brucei
Schistosoma 
mansoni
Schistosoma 
japonicum
Echinostoma 
caproni
Infections per 
marker
2-ketoisocaproate ▼ 1
2-oxoglutarate ▼ 1
2-oxoisocaproate ▲ ▼ 2
2-oxoisovalerate ▲ ▲ ▼ 3
3-carboxy-2-methyl-3-oxopropanamine ▲ 1
3-hydroxybutyrate ▲ 1
3-methyl-2-oxovalerate ▲ ▲ 2
4-hydroxyphenylacetic acid ▲ 1
acetate ▲ ▼ ▲ ▼ 4
alanine ▼ 1
butyrate ▼ 1
citrate ▼ ▼ 2
creatine ▲ ▼ 2
creatinine ▲ 1
dimethylamine ▲ ▼ 2
formate ▲ 1
glucose ▼ 1
glycerol ▲ 1
hippurate ▼ ▼ ▼ ▼ 4
lactate ▲ ▼ 2
malonate ▼ 1
mannitol ▲ 1
methylcrotonic acid ▼ 1
p -cresolglucuronide ▲ ▲ ▲ 3
phenylacetylglycine ▲ ▲ ▲ ▲ 4
pipecolic acid ▲ 1
propionate ▼ ▼ 2
pyruvate ▲ ▲ 2
succinate ▼ ▼ ▲ 3
taurine ▲ ▼ ▼ 3
trimethylamine ▲ ▲ ▲ ▲ 4
trimethylamine-N-oxide ▼ ▲ 2
tryptophan ▲ ▲ 2
β-alanine ▲ 1
Number of disease specific markers 7 5 8 3 6
Biomarkers in Urine
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Table 7.2 
 
Plasmodium 
berghei
Trypanosoma 
b. brucei
Echinostoma 
caproni
Trichinella 
spiralis
Infections per 
marker
3-hydroxybutyrate ▲ 1
acetate ▼ ▲ ▲ ▼ 4
acetoacetate ▲ 1
alanine ▲ 1
arginine ▲ 1
cholesterol ▲ ▼ 2
choline ▲ ▼ ▲ 3
citrate ▲ ▲ 2
creatine ▼ ▲ ▼ ▲ 4
ethanolamine ▲ 1
formate ▲ 1
glucose ▼ ▼ ▼ 3
glutamate ▲ 1
glutamine ▼ ▲ 2
glyceophosphocholine ▼ ▼ ▼ 3
glycerol ▲ 1
isoleucine ▼ ▼ ▼ 3
lactate ▲ ▲ ▲ 3
leucine ▼ ▼ 2
lipid fractions ▼ ▲ ▼ 3
lysine ▲ ▲ 2
methionine ▲ 1
N -acetyl-glycoproteine ▲ 1
O -acetyl-glycoproteine ▲ 1
oxaloacetate ▲ 1
phosphatidylcholine ▼ 1
phosphocholine ▲ 1
pyruvate ▲ 1
tyrosine ▲ 1
valine ▼ ▼ 2
Number of disease specific markers 1 5 3 13
Biomarkers in Plasma
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To my scientific Family 
 
―Quand tu veux construire un bateau, ne commence pas par rassembler du bois, couper des planches 
et distribuer du travail, mais reveille au sein des hommes le desir de la mer grande et large.‖ 
 
Antoine de Saint-Exupéry  
 
 
 
 
 
 
 
 
 
 
 
 
―If you want to build a ship, don't drum up people together to collect wood and don't assign them 
tasks and work, but rather teach them to long for the endless immensity of the sea‖ 
   
Antoine de Saint-Exupéry 
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